BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317. [PMID: 21677747 DOI: 10.1038/nature10209] [Cited by in Crossref: 1605] [Cited by in F6Publishing: 1683] [Article Influence: 133.8] [Reference Citation Analysis]
Number Citing Articles
1 Eiberg H, Olsson JB, Bak M, Bang-Berthelsen CH, Troelsen JT, Hansen L. A family with ulcerative colitis maps to 7p21.1 and comprises a region with regulatory activity for the aryl hydrocarbon receptor gene. Eur J Hum Genet 2023. [PMID: 36732664 DOI: 10.1038/s41431-023-01298-9] [Reference Citation Analysis]
2 Ouyang Y, Zhao J, Wang S. Multifunctional hydrogels based on chitosan, hyaluronic acid and other biological macromolecules for the treatment of inflammatory bowel disease: A review. Int J Biol Macromol 2023;227:505-23. [PMID: 36495992 DOI: 10.1016/j.ijbiomac.2022.12.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Abdelsameea AA, Alsemeh AE, Alabassery N, Samy W, Fawzy A, Abbas NAT. Icosapent ethyl alleviates acetic acid-induced ulcerative colitis via modulation of SIRT1 signaling pathway in rats. Int Immunopharmacol 2023;115:109621. [PMID: 36574744 DOI: 10.1016/j.intimp.2022.109621] [Reference Citation Analysis]
4 Dong C, Zhang Q, Zhang Y, Zhang Y, Ruan H, Qin T, Zhao J, Wu G, Zhu Z, Yang J. Comprehensive landscape of the IPAF inflammasomes in pan-cancer: A bulk omics research and single-cell sequencing validation. Computers in Biology and Medicine 2023. [DOI: 10.1016/j.compbiomed.2023.106622] [Reference Citation Analysis]
5 Qu Q, Li SP, Dong Q, Du HL, Wang ZH, Ma YM, Gong XP, Ding YQ, Zhou J, Chen JY, Liu MJ, Lv WJ, Guo SN. Transcriptome profiling Revealed the potential mechanisms of Shen Lin Bai Zhu San n-butanol extract on DSS induced Colitis in Mice and LC-MS analysis. Phytomedicine 2023;110:154645. [PMID: 36634382 DOI: 10.1016/j.phymed.2023.154645] [Reference Citation Analysis]
6 Kotla NG, Rochev Y. IBD disease-modifying therapies: insights from emerging therapeutics. Trends Mol Med 2023:S1471-4914(23)00015-1. [PMID: 36720660 DOI: 10.1016/j.molmed.2023.01.001] [Reference Citation Analysis]
7 Jung S, Kim Y, Park D, Lee Y, Park S, Baek J, Hwang SW, Park SH, Yang S, Ye BD, Han B, Song K, Lee H. Case–case genome-wide association analysis identifying genetic loci with divergent effects on Crohn’s disease and ulcerative colitis. Human Molecular Genetics 2023;32:677-684. [DOI: 10.1093/hmg/ddac241] [Reference Citation Analysis]
8 Fadeeva N, Khatkov I, Bodunova N, Knyazev O, Bordin D, Parfenov A, Nikolskaya K, Nikolaev S, Rumyantsev K, Polyakova V, Yanova T. Personalized Medicine for IBD Patients. BioNanoSci 2023. [DOI: 10.1007/s12668-023-01067-4] [Reference Citation Analysis]
9 Kong L, Pokatayev V, Lefkovith A, Carter GT, Creasey EA, Krishna C, Subramanian S, Kochar B, Ashenberg O, Lau H, Ananthakrishnan AN, Graham DB, Deguine J, Xavier RJ. The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity 2023:S1074-7613(23)00012-2. [PMID: 36720220 DOI: 10.1016/j.immuni.2023.01.002] [Reference Citation Analysis]
10 Zhang Y, Lei H, Wang P, Zhou Q, Yu J, Leng X, ma R, Wang D, Dong K, Xing J, Dong Y. Restoration of dysregulated intestinal barrier and inflammatory regulation through synergistically ameliorating hypoxia and scavenging reactive oxygen species using ceria nanozymes in ulcerative colitis.. [DOI: 10.21203/rs.3.rs-2457999/v1] [Reference Citation Analysis]
11 Khlynova OV, Stepina EA. Disturbance of intestinal permeability and its role in the development of cardiovascular complications in persons with inflammatory bowel diseases. jour 2023. [DOI: 10.31146/1682-8658-ecg-207-11-36-45] [Reference Citation Analysis]
12 Liu T, Ning Z, Liu P, Gao H. Cassane diterpenoid ameliorates dextran sulfate sodium-induced experimental colitis by regulating gut microbiota and suppressing tryptophan metabolism. Front Immunol 2022;13:1045901. [PMID: 36741371 DOI: 10.3389/fimmu.2022.1045901] [Reference Citation Analysis]
13 Huo J, Pei W, Liu G, Sun W, Wu J, Huang M, Lu W, Sun J, Sun B. Huangshui Polysaccharide Exerts Intestinal Barrier Protective Effects through the TLR4/MyD88/NF-κB and MAPK Signaling Pathways in Caco-2 Cells. Foods 2023;12:450. [DOI: 10.3390/foods12030450] [Reference Citation Analysis]
14 Khan N, Mahmud N, Patel M, Sundararajan R, Reinisch W. Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023. [PMID: 36645110 DOI: 10.1111/apt.17393] [Reference Citation Analysis]
15 Rizzello F, Gionchetti P, Spisni E, Saracino IM, Bellocchio I, Spigarelli R, Collini N, Imbesi V, Dervieux T, Alvisi P, Valerii MC. Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients. Int J Mol Sci 2023;24. [PMID: 36675009 DOI: 10.3390/ijms24021494] [Reference Citation Analysis]
16 Arabacı Tamer S, Akbulut S, Erdoğan Ö, Çevik Ö, Ercan F, Yeğen BÇ. Neuropeptide W Exhibits Preventive and Therapeutic Effects on Acetic Acid-Induced Colitis via Modulation of the Cyclooxygenase Enzyme System. Dig Dis Sci 2023. [PMID: 36631709 DOI: 10.1007/s10620-022-07811-2] [Reference Citation Analysis]
17 Zhao C, Yang J, Chen M, Chen W, Yang X, Ye H, Wang L, Wang Y, Shi J, Yue F, Ma X. Synthetic Lignin-Derived Therapeutic Nano Reagent as Intestinal pH-Sensitive Drug Carriers Capable of Bypassing the Gastric Acid Environment for Colitis Treatment. ACS Nano 2023;17:811-24. [PMID: 36521055 DOI: 10.1021/acsnano.2c11188] [Reference Citation Analysis]
18 Nasser KK, Shinawi T. Genotype-protein phenotype characterization of NOD2 and IL23R missense variants associated with inflammatory bowel disease: A paradigm from molecular modelling, dynamics, and docking simulations. Front Med (Lausanne) 2022;9:1090120. [PMID: 36703890 DOI: 10.3389/fmed.2022.1090120] [Reference Citation Analysis]
19 Kim D, Koo JS, Kim SH, Park YS, Choe JW, Kim SY, Hyun JJ, Jung SW, Jung YK, Yim HJ. The Effect of Necrosis Inhibitor on Dextran Sulfate Sodium Induced Chronic Colitis Model in Mice. Pharmaceutics 2023;15:222. [PMID: 36678851 DOI: 10.3390/pharmaceutics15010222] [Reference Citation Analysis]
20 Ren T, Yu Y, Wang H, Li F, Zhang J, Li J. Maternal inflammatory bowel disease during pregnancy and infectious disease in offspring under five years old: a population-based cohort study. Am J Gastroenterol 2023. [PMID: 36695745 DOI: 10.14309/ajg.0000000000002179] [Reference Citation Analysis]
21 Yuan S, Kim JH, Xu P, Wang Z. Causal association between celiac disease and inflammatory bowel disease: A two-sample bidirectional Mendelian randomization study. Front Immunol 2022;13:1057253. [PMID: 36685511 DOI: 10.3389/fimmu.2022.1057253] [Reference Citation Analysis]
22 Zudeh G, Franca R, Lucafò M, Bonten EJ, Bramuzzo M, Sgarra R, Lagatolla C, Franzin M, Evans WE, Decorti G, Stocco G. PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells. Life Sci Alliance 2023;6. [PMID: 36596605 DOI: 10.26508/lsa.202201610] [Reference Citation Analysis]
23 Zhou J, Fang C, Rong C, Luo T, Liu J, Zhang K. Reactive oxygen species-sensitive materials: A promising strategy for regulating inflammation and favoring tissue regeneration. Smart Materials in Medicine 2023. [DOI: 10.1016/j.smaim.2023.01.004] [Reference Citation Analysis]
24 Chen C, Li T, Chen G, Chen D, Peng Y, Hu B, Sun Y, Zeng X. Prebiotic effect of sialylated immunoglobulin G on gut microbiota of patients with inflammatory bowel disease by in vitro fermentation. Food Bioscience 2023. [DOI: 10.1016/j.fbio.2023.102393] [Reference Citation Analysis]
25 Applegate CC, Deng H, Kleszynski BL, Cross TL, Konopka CJ, Dobrucki LW, Nelson ER, Wallig MA, Smith AM, Swanson KS. Impact of administration route on nanocarrier biodistribution in a murine colitis model. Journal of Experimental Nanoscience 2022;17:599-616. [DOI: 10.1080/17458080.2022.2134563] [Reference Citation Analysis]
26 Shon WJ, Jung MH, Kim Y, Kang GH, Choi EY, Shin DM. Sugar-sweetened beverages exacerbate high-fat diet-induced inflammatory bowel disease by altering the gut microbiome. J Nutr Biochem 2022;113:109254. [PMID: 36572070 DOI: 10.1016/j.jnutbio.2022.109254] [Reference Citation Analysis]
27 Khatib A.a. Al-ruweidi M, Khater N, Rashid Alkaabi H, Hasan M, C. Yalcin H. Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology. Immunology of the GI Tract - Recent Advances 2022. [DOI: 10.5772/intechopen.106184] [Reference Citation Analysis]
28 Xia X, Lin H, Luo F, Wu X, Zhu L, Chen S, Luo H, Ye F, Peng X, Zhang Y, Yang G, Lin Q. Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage via Targeting the Gut Microbiota Accompanied by the TLR4/NF-κB/NLRP3 Cascade Response In Vivo. J Agric Food Chem 2022;70:15747-62. [PMID: 36474430 DOI: 10.1021/acs.jafc.2c04354] [Reference Citation Analysis]
29 Jarmakiewicz-Czaja S, Zielińska M, Sokal A, Filip R. Genetic and Epigenetic Etiology of Inflammatory Bowel Disease: An Update. Genes (Basel) 2022;13. [PMID: 36553655 DOI: 10.3390/genes13122388] [Reference Citation Analysis]
30 Narula N, Wong ECL, Pray C, Marshall JK, Rangarajan S, Islam S, Bahonar A, Alhabib KF, Kontsevaya A, Ariffin F, Co HU, Al Sharief W, Szuba A, Wielgosz A, Diaz ML, Yusuf R, Kruger L, Soman B, Li Y, Wang C, Yin L, Erkin M, Lanas F, Davletov K, Rosengren A, Lopez-Jaramillo P, Khatib R, Oguz A, Iqbal R, Yeates K, Avezum Á, Reinisch W, Moayyedi P, Yusuf S. Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study. Clin Gastroenterol Hepatol 2022:S1542-3565(22)01129-6. [PMID: 36528284 DOI: 10.1016/j.cgh.2022.11.037] [Reference Citation Analysis]
31 Thipart K, Gruneck L, Phunikhom K, Sharpton TJ, Sattayasai J, Popluechai S. Dark-purple rice extract modulates gut microbiota composition in acetic acid– and indomethacin-induced inflammatory bowel disease in rats. Int Microbiol 2022. [DOI: 10.1007/s10123-022-00309-x] [Reference Citation Analysis]
32 Feng C, Zhang W, Zhang T, He Q, Kwok LY, Tan Y, Zhang H. Heat-Killed Bifidobacterium bifidum B1628 May Alleviate Dextran Sulfate Sodium-Induced Colitis in Mice, and the Anti-Inflammatory Effect Is Associated with Gut Microbiota Modulation. Nutrients 2022;14. [PMID: 36558391 DOI: 10.3390/nu14245233] [Reference Citation Analysis]
33 Calzadilla N, Comiskey SM, Dudeja PK, Saksena S, Gill RK, Alrefai WA. Bile acids as inflammatory mediators and modulators of intestinal permeability. Front Immunol 2022;13:1021924. [PMID: 36569849 DOI: 10.3389/fimmu.2022.1021924] [Reference Citation Analysis]
34 Ji Y, Yang Y, Sun S, Dai Z, Ren F, Wu Z. Insights into diet-associated oxidative pathomechanisms in inflammatory bowel disease and protective effects of functional amino acids. Nutr Rev 2022;81:95-113. [PMID: 35703919 DOI: 10.1093/nutrit/nuac039] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Misra R, Sarafian M, Pechlivanis A, Ding N, Miguens-Blanco J, McDonald J, Holmes E, Marchesi J, Arebi N. Ethnicity Associated Microbial and Metabonomic Profiling in Newly Diagnosed Ulcerative Colitis. Clin Exp Gastroenterol 2022;15:199-212. [PMID: 36505887 DOI: 10.2147/CEG.S371965] [Reference Citation Analysis]
36 Yoon JI, Cho H, Jeon R, Sung MK. Therapeutic Efficacy of Novel HDAC Inhibitors SPA3052 and SPA3074 against Intestinal Inflammation in a Murine Model of Colitis. Pharmaceuticals (Basel) 2022;15. [PMID: 36558966 DOI: 10.3390/ph15121515] [Reference Citation Analysis]
37 Djouina M, Waxin C, Leprêtre F, Tardivel M, Tillement O, Vasseur F, Figeac M, Bongiovanni A, Sebda S, Desreumaux P, Launay D, Dubuquoy L, Body-malapel M, Vignal C. Gene/environment interaction in the susceptibility of Crohn's disease patients to aluminum. Science of The Total Environment 2022;850:158017. [DOI: 10.1016/j.scitotenv.2022.158017] [Reference Citation Analysis]
38 Dargenio VN, Castellaneta S, Panico S, Papagni ME, Dargenio C, Schettini F, Francavilla R, Cristofori F. Probiotics and gastrointestinal diseases. Minerva Pediatr (Torino) 2022;74:703-23. [PMID: 36315413 DOI: 10.23736/S2724-5276.22.07031-8] [Reference Citation Analysis]
39 Liu P, Xie XR, Wu H, Li H, Chi JS, Liu XM, Luo J, Tang Y, Xu CX. Conditioned medium of mesenchymal stem cells pretreated with H(2)O(2) promotes intestinal mucosal repair in acute experimental colitis. Sci Rep 2022;12:20772. [PMID: 36456585 DOI: 10.1038/s41598-022-24493-y] [Reference Citation Analysis]
40 Das TK, Pradhan S, Chakrabarti S, Mondal KC, Ghosh K. Current status of probiotic and related health benefits. Applied Food Research 2022;2:100185. [DOI: 10.1016/j.afres.2022.100185] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Son S, Nam AY, Kim SM, Rho Y, Shin K. Improvement effects of pectic polysaccharide isolated from Saururus chinensis leaves on dextran sulfate sodium-induced ulcerative colitis in BALB/c mice. Food Bioscience 2022;50:102027. [DOI: 10.1016/j.fbio.2022.102027] [Reference Citation Analysis]
42 Lê A, Mantel M, Marchix J, Bodinier M, Jan G, Rolli-Derkinderen M. Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics? Am J Physiol Gastrointest Liver Physiol 2022;323:G523-53. [PMID: 36165557 DOI: 10.1152/ajpgi.00002.2022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Serramito-Gómez I, Terraza-Silvestre E, Fernández-Cabrera Á, Villamuera R, Pimentel-Muiños FX. ATG16L1 WD40 domain-dependent IL10R (interleukin 10 receptor) signaling is insensitive to the T300A Crohn disease risk polymorphism. Autophagy 2022;18:3023-30. [PMID: 35311452 DOI: 10.1080/15548627.2022.2054241] [Reference Citation Analysis]
44 Robinson P, Magness E, Montoya K, Engineer N, Eckols TK, Rodriguez E, Tweardy DJ. Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn's Disease. J Clin Med 2022;11. [PMID: 36498596 DOI: 10.3390/jcm11237020] [Reference Citation Analysis]
45 Sun Y, Li Y, Zhang J. The causal relationship between psoriasis, psoriatic arthritis, and inflammatory bowel diseases. Sci Rep 2022;12:20526. [PMID: 36443384 DOI: 10.1038/s41598-022-24872-5] [Reference Citation Analysis]
46 Mohajeri S, Moayedi S, Mohajeri S, Yadegar A, Haririan I. Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1045575] [Reference Citation Analysis]
47 Wu X, Khatun A, Kasmani MY, Chen Y, Zheng S, Atkinson S, Nguyen C, Burns R, Taparowsky EJ, Salzman NH, Hand TW, Cui W. Group 3 innate lymphoid cells require BATF to regulate gut homeostasis in mice. J Exp Med 2022;219:e20211861. [PMID: 36048018 DOI: 10.1084/jem.20211861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ahmad T, Ishaq M, Karpiniec S, Park A, Stringer D, Singh N, Ratanpaul V, Wolfswinkel K, Fitton H, Caruso V, Eri R. Oral Macrocystis pyrifera Fucoidan Administration Exhibits Anti-Inflammatory and Antioxidant Properties and Improves DSS-Induced Colitis in C57BL/6J Mice. Pharmaceutics 2022;14:2383. [DOI: 10.3390/pharmaceutics14112383] [Reference Citation Analysis]
49 Wang X, Huang S, Zhang M, Su Y, Pan Z, Liang J, Xie X, Wang Q, Chen J, Zhou L, Luo X. Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice. Journal of Ethnopharmacology 2022. [DOI: 10.1016/j.jep.2022.115919] [Reference Citation Analysis]
50 Cosme D, Soares-da-Silva P, Magro F. Effect of Toll-like receptor-2, -4, -5, -7, and NOD2 stimulation on potassium channel conductance in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2022;323:G410-9. [PMID: 36040119 DOI: 10.1152/ajpgi.00139.2022] [Reference Citation Analysis]
51 Bootz-maoz H, Pearl A, Melzer E, Malnick S, Sharon E, Bennet Y, Tsentsarevsky R, Abuchatzera S, Amidror S, Aretz E, Azriel S, Gam Ze Letova C, Naama M, Shoval I, Yaron O, Karako-lampert S, Bel S, Yissachar N. Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome. Cell Reports 2022;41:111657. [DOI: 10.1016/j.celrep.2022.111657] [Reference Citation Analysis]
52 Taladrid D, Zorraquín-Peña I, Molinero N, Silva M, Manceñido N, Pajares R, Bartolomé B, Moreno-Arribas MV. Polyphenols and Ulcerative Colitis: An Exploratory Study of the Effects of Red Wine Consumption on Gut and Oral Microbiome in Active-Phase Patients. Mol Nutr Food Res 2022;66:e2101073. [PMID: 35633101 DOI: 10.1002/mnfr.202101073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Yan M, Zhu L, Wu S, Cao Y, Mou N, Chi Q, Wang G, Zhong Y, Wu W. ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel. Biomaterials Advances 2022;142:213126. [DOI: 10.1016/j.bioadv.2022.213126] [Reference Citation Analysis]
54 El-Harakeh M, Saliba J, Sharaf Aldeen K, Haidar M, El Hajjar L, Awad MK, Hashash JG, Shirinian M, El-Sabban M. Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disease and colorectal cancer. World J Gastroenterol 2022; 28(40): 5845-5864 [DOI: 10.3748/wjg.v28.i40.5845] [Reference Citation Analysis]
55 Zhang JL, Zhang MN, Wang HG, Yang XZ, Yu CG. Jatrorrhizine alleviates ulcerative colitis via regulating gut microbiota and NOS2 expression. Gut Pathog 2022;14:41. [PMID: 36271438 DOI: 10.1186/s13099-022-00514-z] [Reference Citation Analysis]
56 Mukanova S, Borissenko A, Kim A, Bolatbek A, Abdrakhmanova A, Vangelista L, Sonnenberg-riethmacher E, Riethmacher D. Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5–CCR5 axis. Front Immunol 2022;13:956691. [DOI: 10.3389/fimmu.2022.956691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Hu C, Chen Y, Zhang L, Liu M, Yang J, Huang F, Wang Y, Huang L. Curcumin analog C66 alleviates inflammatory colitis by inhibiting the activation of NF-κB. Inflammopharmacology 2022. [PMID: 36261684 DOI: 10.1007/s10787-022-01085-w] [Reference Citation Analysis]
58 Liang X, Wen K, Chen Y, Fang G, Yang S, Li Q. Oral Administration of Therapeutic Enzyme Capsule for the Management of Inflammatory Bowel Disease. Int J Nanomedicine 2022;17:4843-60. [PMID: 36262191 DOI: 10.2147/IJN.S378073] [Reference Citation Analysis]
59 Qiu X, Hou C, Yang Z, Wang Q, Li L. Inflammatory bowel disease and risk of coronary heart disease : A Mendelian randomization study. Wien Klin Wochenschr 2022. [PMID: 36239805 DOI: 10.1007/s00508-022-02095-y] [Reference Citation Analysis]
60 Li X, Cui L, Feng G, Yu S, Shao G, He N, Li S. Collagen peptide promotes DSS-induced colitis by disturbing gut microbiota and regulation of macrophage polarization. Front Nutr 2022;9:957391. [PMID: 36313077 DOI: 10.3389/fnut.2022.957391] [Reference Citation Analysis]
61 Dong Y, Huang C, Yang J, Zheng Z, Dai Z. Docosapentaenoic Acid (DPA, 22:5n-3) Alleviates Ulcerative Colitis via Modification of Gut Microbiota and Their Metabolism. Nutrients 2022;14:4204. [PMID: 36235856 DOI: 10.3390/nu14194204] [Reference Citation Analysis]
62 Zhu F, Qin Y, Wang Y, Zhang F, Xu Z, Dai F, Chu W, Wang Y, Zhou G. Critical roles of RGS16 in the mucosal inflammation of ulcerative colitis. Eur J Gastroenterol Hepatol 2022;34:993-9. [PMID: 35830366 DOI: 10.1097/MEG.0000000000002407] [Reference Citation Analysis]
63 McGregor CGC, Tandon R, Simmons A. Pathogenesis of Fistulating Crohn's Disease: A Review. Cell Mol Gastroenterol Hepatol 2022;15:1-11. [PMID: 36184031 DOI: 10.1016/j.jcmgh.2022.09.011] [Reference Citation Analysis]
64 Jiang ZF, Wu W, Hu HB, Li ZY, Zhong M, Zhang L. P2X7 receptor as the regulator of T-cell function in intestinal barrier disruption. World J Gastroenterol 2022; 28(36): 5265-5279 [DOI: 10.3748/wjg.v28.i36.5265] [Reference Citation Analysis]
65 Vafaei SY, Abdolghaffari AH, Mahjub R, Eslami SM, Esmaeili M, Abdollahi M, Atyabi F, Dinarvand R, Ahad A. Budesonide-Loaded Hyaluronic Acid Nanoparticles for Targeted Delivery to the Inflamed Intestinal Mucosa in a Rodent Model of Colitis. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/7776092] [Reference Citation Analysis]
66 Casadó-llombart S, Velasco-de Andrés M, Català C, Leyton-pereira A, Gutiérrez-cózar R, Suárez B, Armiger N, Carreras E, Esteller M, Ricart E, Ordás I, Gisbert JP, Chaparro M, Esteve M, Márquez L, Busquets D, Iglesias E, García-planella E, Martín-arranz MD, Lohmann J, Ayata CK, Niess JH, Engel P, Panés J, Salas A, Domènech E, Lozano F; ENEIDA Project of GETECCU. Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease. Front Immunol 2022;13:966184. [DOI: 10.3389/fimmu.2022.966184] [Reference Citation Analysis]
67 Gill VJS, Soni S, Shringarpure M, . A, Bhardwaj S, Yadav NK, Patel A, Patel A. Gut Microbiota Interventions for the Management of Obesity: A Literature Review. Cureus 2022. [DOI: 10.7759/cureus.29317] [Reference Citation Analysis]
68 Sivaraman K, Shanthi C. Purified fish skin collagen hydrolysate attenuates TNF-α induced barrier dysfunction in-vitro and DSS induced colitis in-vivo model. Int J Biol Macromol 2022;222:448-61. [PMID: 36116587 DOI: 10.1016/j.ijbiomac.2022.09.122] [Reference Citation Analysis]
69 Liu C, Yu R, Zhang J, Wei S, Xue F, Guo Y, He P, Shang L, Dong W. Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021. Front Immunol 2022;13:972079. [DOI: 10.3389/fimmu.2022.972079] [Reference Citation Analysis]
70 Delfini M, Stakenborg N, Viola MF, Boeckxstaens G. Macrophages in the gut: Masters in multitasking. Immunity 2022;55:1530-48. [PMID: 36103851 DOI: 10.1016/j.immuni.2022.08.005] [Reference Citation Analysis]
71 Boros É, Hegedűs Z, Kellermayer Z, Balogh P, Nagy I. Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease. Front Immunol 2022;13:991346. [DOI: 10.3389/fimmu.2022.991346] [Reference Citation Analysis]
72 Pawlak M, DeTomaso D, Schnell A, Meyer Zu Horste G, Lee Y, Nyman J, Dionne D, Regan BML, Singh V, Delorey T, Schramm MA, Wang C, Wallrapp A, Burkett PR, Riesenfeld SJ, Anderson AC, Regev A, Xavier RJ, Yosef N, Kuchroo VK. Induction of a colitogenic phenotype in Th1-like cells depends on interleukin-23 receptor signaling. Immunity 2022;55:1663-1679.e6. [PMID: 36070768 DOI: 10.1016/j.immuni.2022.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
73 Jo H, Lee D, Go C, Jang Y, Chu N, Bae S, Kang D, Im JP, Kim Y, Kang JS. Preventive Effect of Vitamin C on Dextran Sulfate Sodium (DSS)-Induced Colitis via the Regulation of IL-22 and IL-6 Production in Gulo(−/−) Mice. IJMS 2022;23:10612. [DOI: 10.3390/ijms231810612] [Reference Citation Analysis]
74 Telaku S, Veliu A, Sina M, Telaku M, Fejza H, Alidema F. Twin Brothers and a Sister With CD: A Case Report. Clin Med Insights Case Rep 2022;15:11795476221123537. [PMID: 36091422 DOI: 10.1177/11795476221123537] [Reference Citation Analysis]
75 Pérez-Jeldres T, Pizarro B, Ascui G, Orellana M, Cerda-Villablanca M, Alvares D, de la Vega A, Cannistra M, Cornejo B, Baéz P, Silva V, Arriagada E, Rivera-Nieves J, Estela R, Hernández-Rocha C, Álvarez-Lobos M, Tobar F. Ethnicity influences phenotype and clinical outcomes: Comparing a South American with a North American inflammatory bowel disease cohort. Medicine (Baltimore) 2022;101:e30216. [PMID: 36086782 DOI: 10.1097/MD.0000000000030216] [Reference Citation Analysis]
76 Li Y, Guo TL, Xie HQ, Xu L, Liu Y, Zheng L, Yu S, Chen G, Ji J, Jiang S, Xu D, Hang X, Zhao B. Exposure to dechlorane 602 induces perturbation of gut immunity and microbiota in female mice. Environ Pollut 2022;313:120141. [PMID: 36087894 DOI: 10.1016/j.envpol.2022.120141] [Reference Citation Analysis]
77 Hu S, Wei P, Li W, Liu Q, Chen S, Hu C, Guo X, Ma X, Zeng J, Zhang Y. Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies. Front Pharmacol 2022;13:937029. [DOI: 10.3389/fphar.2022.937029] [Reference Citation Analysis]
78 Lin Y, Wang D, Zhao H, Li D, Li X, Lin L. Pou3f1 mediates the effect of Nfatc3 on ulcerative colitis-associated colorectal cancer by regulating inflammation. Cell Mol Biol Lett 2022;27:75. [PMID: 36064319 DOI: 10.1186/s11658-022-00374-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Özsoy M, Stummer N, Zimmermann FA, Feichtinger RG, Sperl W, Weghuber D, Schneider AM. Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:1443-50. [PMID: 35247048 DOI: 10.1093/ibd/izac024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Grace A, Usman MA, Ochayi MO, Adams MD, Umar HD, Obalum CD, Akunna GG, Meraiyebu AB, Onwuchekwa C. Elucidating the Anti-Oxidant and Anti-Inflammatory Potentials of Triticum aestivum Against Ulcerative Colitis: an In Vivo and In Silico Study. Phytomedicine Plus 2022. [DOI: 10.1016/j.phyplu.2022.100350] [Reference Citation Analysis]
81 Abdulla M, Mohammed N. A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances. BTT 2022;Volume 16:129-140. [DOI: 10.2147/btt.s380027] [Reference Citation Analysis]
82 Xu Q, Sun W, Zhang J, Mei Y, Bao J, Hou S, Zhou X, Mao L. Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential. Front Immunol 2022;13:963291. [DOI: 10.3389/fimmu.2022.963291] [Reference Citation Analysis]
83 Petric Z, Goncalves J, Paixao P. Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars. Pharmaceutics 2022;14:1766. [DOI: 10.3390/pharmaceutics14091766] [Reference Citation Analysis]
84 Brown S, Wall CL, Frampton C, Gearry RB, Day AS. Dietary Nutrient Intake and Blood Micronutrient Status of Children with Crohn's Disease Compared with Their Shared-Home Environment, Healthy Siblings. Nutrients 2022;14:3425. [PMID: 36014931 DOI: 10.3390/nu14163425] [Reference Citation Analysis]
85 Liu H, Wang Q, Huang Y, Deng J, Xie X, Zhu J, Yuan Y, He YM, Huang YY, Luo HB, He X. Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases. Eur J Med Chem 2022;242:114631. [PMID: 35985255 DOI: 10.1016/j.ejmech.2022.114631] [Reference Citation Analysis]
86 Nishida A, Nishino K, Ohno M, Sakai K, Owaki Y, Noda Y, Imaeda H. Update on gut microbiota in gastrointestinal diseases. WJCC 2022;10:7653-64. [DOI: 10.12998/wjcc.v10.i22.7653] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Lin M, Yang Y, Lin L, Yu W, Chen H. Pulsatilla decoction suppresses matrix metalloproteinase-7-mediated leukocyte recruitment in dextran sulfate sodium-induced colitis mouse model. BMC Complement Med Ther 2022;22:211. [DOI: 10.1186/s12906-022-03696-w] [Reference Citation Analysis]
88 Ashton JJ, Barakat FM, Barnes C, Coelho TAF, Batra A, Afzal NA, Beattie RM. Incidence and Prevalence of Paediatric Inflammatory Bowel Disease Continues to Increase in the South of England. J Pediatr Gastroenterol Nutr 2022;75:e20-4. [PMID: 35666860 DOI: 10.1097/MPG.0000000000003511] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Xiao F, Dong F, Li X, Li Y, Yu G, Liu Z, Wang Y, Zhang T. Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism. Front Pharmacol 2022;13:902337. [DOI: 10.3389/fphar.2022.902337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Bharti S, Bharti M. The Business of T Cell Subsets and Cytokines in the Immunopathogenesis of Inflammatory Bowel Disease. Cureus 2022. [DOI: 10.7759/cureus.27290] [Reference Citation Analysis]
91 Inoue CJ, Flauzino T, Gonçalves BP, Paula JCC, Galvão TC, Miyazaki PK, Alcantara CC, Westmore LRES, Lozovoy MAB, Reiche EMV, Simão ANC. FOXP3 variants are independently associated with transforming growth factor Β1 plasma levels in female patients with inflammatory bowel disease. Clinics (Sao Paulo) 2022;77:100084. [PMID: 35905575 DOI: 10.1016/j.clinsp.2022.100084] [Reference Citation Analysis]
92 Hu K, He H, Yuan X, Du X, Liu R, Yang P, Yang Q, Zhang Y, Qiao J. Carboxymethyl Chitosan Oligosaccharide Holds Promise for Treatment of Stenosis Crohn’s Disease. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00035] [Reference Citation Analysis]
93 Hu M, Zhang X, Li J, Chen L, He X, Sui T. Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases. Front Microbiol 2022;13:940196. [DOI: 10.3389/fmicb.2022.940196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Song K, Wu D. Shared decision-making in the management of patients with inflammatory bowel disease. World J Gastroenterol 2022; 28(26): 3092-3100 [DOI: 10.3748/wjg.v28.i26.3092] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 34] [Article Influence: 34.0] [Reference Citation Analysis]
95 Das B, Rabalais J, Kozan P, Lu T, Durali N, Okamoto K, Mcgeough MD, Lee BJ, Barrett KE, Marchelletta R, Sivagnanam M. The effect of a fennel seed extract on the STAT signaling and intestinal barrier function. PLoS ONE 2022;17:e0271045. [DOI: 10.1371/journal.pone.0271045] [Reference Citation Analysis]
96 Akiyama S, Fukuda S, Steinberg JM, Suzuki H, Tsuchiya K. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases. World J Gastroenterol 2022; 28(25): 2843-2853 [DOI: 10.3748/wjg.v28.i25.2843] [Reference Citation Analysis]
97 Li Y, Xie HQ, Liu Y, Xu L, Zheng L, Yu S, Chen G, Ji J, Jiang S, Guo TL, Zhao B. Subacute effects of the chlorinated flame retardant dechlorane 602 on intestinal microenvironment in mice. Environ Int 2022;166:107394. [PMID: 35820366 DOI: 10.1016/j.envint.2022.107394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Wang J, Huang J, Fang L, Chen G. Inhibition of TLR4 Suppresses the Inflammatory Response in Inflammatory Bowel Disease (IBD) by Modulating the PDK1-Induced Metabolism Reprogramming via a m6A-Denpendent Manner. Computational and Mathematical Methods in Medicine 2022;2022:1-5. [DOI: 10.1155/2022/1335562] [Reference Citation Analysis]
99 Liu B, Ye D, Yang H, Song J, Sun X, Mao Y, He Z. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn’s Disease. Front Immunol 2022;13:921546. [DOI: 10.3389/fimmu.2022.921546] [Reference Citation Analysis]
100 Zhang X, Tu J, Ding S, Wang M, Ding Y, Lin Z, Lu G, Xiao W, Gong W. Increased angiopoietin-like 4 expression ameliorates inflammatory bowel diseases via suppressing CD8+ T cell activities. Biochemical and Biophysical Research Communications 2022;612:37-43. [DOI: 10.1016/j.bbrc.2022.03.153] [Reference Citation Analysis]
101 Wang F, Li Q, Xu T, Li Z, Jiang Y, Ma Y, Li X, Wang W, Qian H. An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment. Fundamental Research 2022. [DOI: 10.1016/j.fmre.2022.07.002] [Reference Citation Analysis]
102 El Hage Chehade N, Ghoneim S, Shah S, Chahine A, Mourad FH, Francis FF, Binion DG, Farraye FA, Hashash JG. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Inflamm Bowel Dis 2022:izac135. [PMID: 35766805 DOI: 10.1093/ibd/izac135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
103 Arjomand Fard N, Armstrong H, Perry T, Wine E. Appendix and Ulcerative Colitis: a Key to Explaining the Pathogenesis and Directing Novel Therapies? Inflamm Bowel Dis 2023;29:151-60. [PMID: 35749298 DOI: 10.1093/ibd/izac106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Alghoul Z, Yang C, Merlin D. The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease. Biomedicines 2022;10:1492. [PMID: 35884797 DOI: 10.3390/biomedicines10071492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 He M, Wong A, Sutton K, Gondim MJB, Samson C. Very-Early Onset Chronic Active Colitis with Heterozygous Variants in LRBA1 and CARD11, a Case of "Immune TOR-Opathies". Fetal Pediatr Pathol 2022;:1-10. [PMID: 35748740 DOI: 10.1080/15513815.2022.2088912] [Reference Citation Analysis]
106 da Silva EM, Yariwake VY, Alves RW, de Araujo DR, Andrade-Oliveira V. Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases. Peptides 2022;:170834. [PMID: 35753504 DOI: 10.1016/j.peptides.2022.170834] [Reference Citation Analysis]
107 Olbjørn C, Småstuen MC, Moen AEF. Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease. Microorganisms 2022;10:1273. [DOI: 10.3390/microorganisms10071273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Krela-Kaźmierczak I, Zakerska-Banaszak O, Skrzypczak-Zielińska M, Łykowska-Szuber L, Szymczak-Tomczak A, Zawada A, Rychter AM, Ratajczak AE, Skoracka K, Skrzypczak D, Marcinkowska E, Słomski R, Dobrowolska A. Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review. Nutrients 2022;14:2520. [PMID: 35745251 DOI: 10.3390/nu14122520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Eskandari M, Asgharzadeh F, Askarnia-Faal MM, Naimi H, Avan A, Ahadi M, Vossoughinia H, Gharib M, Soleimani A, Naghibzadeh N, Ferns G, Ryzhikov M, Khazaei M, Hassanian SM. Mebendazole, an anti-helminth drug, suppresses inflammation, oxidative stress and injury in a mouse model of ulcerative colitis. Sci Rep 2022;12:10249. [PMID: 35715495 DOI: 10.1038/s41598-022-14420-6] [Reference Citation Analysis]
110 Čipčić Paljetak H, Barešić A, Panek M, Perić M, Matijašić M, Lojkić I, Barišić A, Vranešić Bender D, Ljubas Kelečić D, Brinar M, Kalauz M, Miličević M, Grgić D, Turk N, Karas I, Čuković-Čavka S, Krznarić Ž, Verbanac D. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients. Gut Microbes 2022;14:2083419. [PMID: 35695669 DOI: 10.1080/19490976.2022.2083419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
111 Wang YJ, Li QM, Zha XQ, Luo JP. Intervention and potential mechanism of non-starch polysaccharides from natural resources on ulcerative colitis: A review. Int J Biol Macromol 2022;210:545-64. [PMID: 35513106 DOI: 10.1016/j.ijbiomac.2022.04.208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Liu L, Pu D, Wang D, Zhang M, Zhou C, Zhang Z, Feng B. Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis. Front Pharmacol 2022;13:905133. [DOI: 10.3389/fphar.2022.905133] [Reference Citation Analysis]
113 Koyama Y, Kobayashi Y, Hirota I, Sun Y, Ohtsu I, Imai H, Yoshioka Y, Yanagawa H, Sumi T, Kobayashi H, Shimada S. A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent. Sci Rep 2022;12:9634. [PMID: 35688905 DOI: 10.1038/s41598-022-13655-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Gamal A, Elshaer M, Alabdely M, Kadry A, McCormick TS, Ghannoum M. The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy. Cancers (Basel) 2022;14:2875. [PMID: 35740541 DOI: 10.3390/cancers14122875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
115 Meng W, Li Z, Zhang Y, Yang A, Wang Y, Zhou Y, Wu W, Qiu Y, Li L. ZhenQi FuZheng formula inhibits the growth of colorectal tumors by modulating intestinal microflora-mediated immune function. Aging (Albany NY) 2022;14:4769-85. [PMID: 35680568 DOI: 10.18632/aging.204111] [Reference Citation Analysis]
116 Dong Y, Liao W, Tang J, Fei T, Gai Z, Han M. Bifidobacterium BLa80 mitigates colitis by altering gut microbiota and alleviating inflammation. AMB Express 2022;12:67. [PMID: 35670877 DOI: 10.1186/s13568-022-01411-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
117 Huang C, Xu J, Li J, He S, Xu H, Ren X, Singh V, Wu L, Zhang J. Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease. Carbohydrate Polymers 2022;285:119252. [DOI: 10.1016/j.carbpol.2022.119252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Katsaounou K, Nicolaou E, Vogazianos P, Brown C, Stavrou M, Teloni S, Hatzis P, Agapiou A, Fragkou E, Tsiaoussis G, Potamitis G, Zaravinos A, Andreou C, Antoniades A, Shiammas C, Apidianakis Y. Colon Cancer: From Epidemiology to Prevention. Metabolites 2022;12:499. [DOI: 10.3390/metabo12060499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
119 Sunaga S, Tsunoda J, Teratani T, Mikami Y, Kanai T. Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology. Front Immunol 2022;13:867351. [DOI: 10.3389/fimmu.2022.867351] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Wang W, Liu Z, Yue W, Zhu L, Zhong H, Yang C, He T, Wan P, Geng J. Mucosa-Colonizing Microbiota Correlate With Host Autophagy Signaling in Patients With Inflammatory Bowel Disease. Front Microbiol 2022;13:875238. [DOI: 10.3389/fmicb.2022.875238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Vadapalli S, Abdelhalim H, Zeeshan S, Ahmed Z. Artificial intelligence and machine learning approaches using gene expression and variant data for personalized medicine. Brief Bioinform 2022:bbac191. [PMID: 35595537 DOI: 10.1093/bib/bbac191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Kim DW, Jeong HS, Kim E, Lee H, Choi CH, Lee SJ. Oral delivery of stem-cell-loaded hydrogel microcapsules restores gut inflammation and microbiota. J Control Release 2022:S0168-3659(22)00291-7. [PMID: 35597403 DOI: 10.1016/j.jconrel.2022.05.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
123 Priya S, Burns MB, Ward T, Mars RAT, Adamowicz B, Lock EF, Kashyap PC, Knights D, Blekhman R. Identification of shared and disease-specific host gene-microbiome associations across human diseases using multi-omic integration. Nat Microbiol 2022. [PMID: 35577971 DOI: 10.1038/s41564-022-01121-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
124 Nakane S. Recent advances in autonomic neurology: An overview. Neurology & Clinical Neurosc 2022;10:119-123. [DOI: 10.1111/ncn3.12524] [Reference Citation Analysis]
125 Ghorbaninejad M, Meyfour A, Maleknia S, Shahrokh S, Abdollahpour-alitappeh M, Asadzadeh-aghdaei H. Inhibition of epithelial SHH signaling exerts a dual protective effect against inflammation and epithelial–mesenchymal transition in inflammatory bowel disease. Toxicology in Vitro 2022. [DOI: 10.1016/j.tiv.2022.105382] [Reference Citation Analysis]
126 Țiburcă L, Bembea M, Zaha DC, Jurca AD, Vesa CM, Rațiu IA, Jurca CM. The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases. CIMB 2022;44:1851-66. [DOI: 10.3390/cimb44050127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Ananthakrishnan AN, Xavier RJ, Podolsky DK. Inflammatory bowel diseases: pathogenesis. Yamada's Textbook of Gastroenterology 2022. [DOI: 10.1002/9781119600206.ch62] [Reference Citation Analysis]
128 Nagao-Kitamoto H, Kitamoto S, Kamada N. Inflammatory bowel disease and carcinogenesis. Cancer Metastasis Rev 2022. [PMID: 35416564 DOI: 10.1007/s10555-022-10028-4] [Reference Citation Analysis]
129 Li Y, Chen Y, Sun-Waterhouse D. The potential of dandelion in the fight against gastrointestinal diseases: A review. J Ethnopharmacol 2022;293:115272. [PMID: 35405251 DOI: 10.1016/j.jep.2022.115272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Talebi M, Talebi M, Farkhondeh T, Samarghandian S. Therapeutic Effects of Resveratrol in Inflammatory Bowel Diseases: Shedding Light on the Role of Cellular and Molecular Pathways. Rev Bras Farmacogn 2022;32:160-173. [DOI: 10.1007/s43450-022-00247-9] [Reference Citation Analysis]
131 Lin L, Li Y, Zhou G, Wang Y, Li L, Han J, Chen M, He Y, Zhang S. Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice. JIR 2022;Volume 15:2523-37. [DOI: 10.2147/jir.s361039] [Reference Citation Analysis]
132 Yao Y, Kim G, Shafer S, Chen Z, Kubo S, Ji Y, Luo J, Yang W, Perner SP, Kanellopoulou C, Park AY, Jiang P, Li J, Baris S, Aydiner EK, Ertem D, Mulder DJ, Warner N, Griffiths AM, Topf-Olivestone C, Kori M, Werner L, Ouahed J, Field M, Liu C, Schwarz B, Bosio CM, Ganesan S, Song J, Urlaub H, Oellerich T, Malaker SA, Zheng L, Bertozzi CR, Zhang Y, Matthews H, Montgomery W, Shih HY, Jiang J, Jones M, Baras A, Shuldiner A, Gonzaga-Jauregui C, Snapper SB, Muise AM, Shouval DS, Ozen A, Pan KT, Wu C, Lenardo MJ. Mucus sialylation determines intestinal host-commensal homeostasis. Cell 2022;185:1172-1188.e28. [PMID: 35303419 DOI: 10.1016/j.cell.2022.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
133 Wang X, Li D, Meng Z, Kim K, Oh S. Latilactobacillus curvatus BYB3 Isolated from Kimchi Alleviates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice by Inhibiting IL-6 and TNF-R1 Production. J Microbiol Biotechnol 2022;32:348-54. [PMID: 35001008 DOI: 10.4014/jmb.2109.09054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Hyun HK, Zhang H, Yu J, Kang EA, Park J, Park SJ, Park JJ, Kim TI, Kim WH, Cheon JH. Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02225-w] [Reference Citation Analysis]
135 Touch S, Godefroy E, Rolhion N, Danne C, Oeuvray C, Straube M, Galbert C, Brot L, Salgueiro IA, Chadi S, Ledent T, Chatel J, Langella P, Jotereau F, Altare F, Sokol H. Human CD4+/CD8α+ regulatory T cells induced by Faecalibacterium prausnitzii protect against intestinal inflammation.. [DOI: 10.1101/2022.03.22.485277] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. Int J Mol Sci 2022;23:3464. [PMID: 35408838 DOI: 10.3390/ijms23073464] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
137 Li T, Liu W, Hui W, Shi T, Liu H, Feng Y, Gao F, Mi Y. Integrated Analysis of Ulcerative Colitis Revealed an Association between PHLPP2 and Immune Infiltration. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/4983471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
138 Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis 2022;14:e1540. [PMID: 35266651 DOI: 10.1002/wsbm.1540] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
139 Schneider AM, Özsoy M, Zimmermann FA, Brunner SM, Feichtinger RG, Mayr JA, Kofler B, Neureiter D, Klieser E, Aigner E, Schütz S, Stummer N, Sperl W, Weghuber D. Expression of Oxidative Phosphorylation Complexes and Mitochondrial Mass in Pediatric and Adult Inflammatory Bowel Disease. Oxid Med Cell Longev 2022;2022:9151169. [PMID: 35035669 DOI: 10.1155/2022/9151169] [Reference Citation Analysis]
140 Zeng F, Shi Y, Wu C, Liang J, Zhong Q, Briley K, Xu B, Huang Y, Long M, Wang C, Chen J, Tang Y, Li X, Jiang M, Wang L, Xu Q, Yang L, Chen P, Duan S, Xie J, Li C, Wu Y. A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease. J Nanobiotechnology 2022;20:107. [PMID: 35246140 DOI: 10.1186/s12951-022-01319-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
141 Shrestha N, Xu Y, Prévost JRC, McCartney F, Brayden D, Frédérick R, Beloqui A, Préat V. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease. Acta Biomater 2022;140:561-72. [PMID: 34923097 DOI: 10.1016/j.actbio.2021.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Chiang HY, Lu HH, Sudhakar JN, Chen YW, Shih NS, Weng YT, Shui JW. IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence. Nat Commun 2022;13:874. [PMID: 35169117 DOI: 10.1038/s41467-022-28478-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
143 Pan L, Fu T, Cheng H, Mi J, Shang Q, Yu G. Polysaccharide from edible alga Gloiopeltis furcata attenuates intestinal mucosal damage by therapeutically remodeling the interactions between gut microbiota and mucin O-glycans. Carbohydr Polym 2022;278:118921. [PMID: 34973740 DOI: 10.1016/j.carbpol.2021.118921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
144 Ruan J, Schlüter D, Naumann M, Waisman A, Wang X. Ubiquitin-modifying enzymes as regulators of colitis. Trends Mol Med 2022:S1471-4914(22)00025-9. [PMID: 35177326 DOI: 10.1016/j.molmed.2022.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Kanke M, Kennedy Ng MM, Connelly S, Singh M, Schaner M, Shanahan MT, Wolber EA, Beasley C, Lian G, Jain A, Long MD, Barnes EL, Herfarth HH, Isaacs KL, Hansen JJ, Kapadia M, Guillem JG, Feschotte C, Furey TS, Sheikh SZ, Sethupathy P. Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn's Disease Patients. Cell Mol Gastroenterol Hepatol 2022;13:1717-40. [PMID: 35158099 DOI: 10.1016/j.jcmgh.2022.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
146 Hamilton MK, Wall ES, Robinson CD, Guillemin K, Eisen JS. Enteric nervous system modulation of luminal pH modifies the microbial environment to promote intestinal health. PLoS Pathog 2022;18:e1009989. [DOI: 10.1371/journal.ppat.1009989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Zhai L, Peng J, Zhuang M, Chang Y, Cheng KW, Ning Z, Huang T, Lin C, Wong HLX, Lam YY, Tan HY, Xiao H, Bian Z. Therapeutic effects and mechanisms of Zhen-Wu-Bu-Qi Decoction on dextran sulfate sodium-induced chronic colitis in mice assessed by multi-omics approaches. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Guzzo GL, Andrews JM, Weyrich LS. The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:1112-22. [PMID: 35092426 DOI: 10.1093/ibd/izab343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
149 Shi C, Dawulieti J, Shi F, Yang C, Qin Q, Shi T, Wang L, Hu H, Sun M, Ren L, Chen F, Zhao Y, Liu F, Li M, Mu L, Liu D, Shao D, Leong KW, She J. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Sci Adv 2022;8:eabj2372. [PMID: 35089791 DOI: 10.1126/sciadv.abj2372] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
150 Dacquay LC, Tsang D, Chan D, Parkinson J, Philpott DJ, McMillen DR. E.coli Nissle increases transcription of flagella assembly and formate hydrogenlyase genes in response to colitis. Gut Microbes 2021;13:1994832. [PMID: 34751631 DOI: 10.1080/19490976.2021.1994832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Ishida T, Matsui H, Matsuda Y, Hosomi R, Shimono T, Kanda S, Nishiyama T, Fukunaga K, Yoshida M. Oyster (Crassostrea gigas) Extract Attenuates Dextran Sulfate Sodium-Induced Acute Experimental Colitis by Improving Gut Microbiota and Short-Chain Fatty Acids Compositions in Mice. Foods 2022;11:373. [DOI: 10.3390/foods11030373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Shentova-eneva R, Yankov I. Pediatric Ulcerative Colitis. Ulcerative Colitis [Working Title] 2022. [DOI: 10.5772/intechopen.102226] [Reference Citation Analysis]
153 Chandra S, Roy T, Bose P, Ghosh S, Paul S, roychowdhury V, Bose A, Acharya A. Protective Effect of Colocasia esculenta on TNBS Induced Ulcerative Colitis in Mice. RJPT 2022. [DOI: 10.52711/0974-360x.2022.00063] [Reference Citation Analysis]
154 Gabbiadini R, D'Amico F, De Marco A, Terrin M, Zilli A, Furfaro F, Allocca M, Fiorino G, Danese S. Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question. J Clin Med 2022;11:509. [PMID: 35159961 DOI: 10.3390/jcm11030509] [Reference Citation Analysis]
155 Lu JJ, Maimaiti M, Liu H, Liu WD, Hui WJ, Huang XL, Gao F. Potential Biomarkers Associated with Differential Manifestations of Ulcerative Colitis (UC) in Uyghur and Han Population in China. J Inflamm Res 2021;14:7431-41. [PMID: 35002277 DOI: 10.2147/JIR.S335293] [Reference Citation Analysis]
156 Yadav MK, Kumari I, Singh B, Sharma KK, Tiwari SK. Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics. Appl Microbiol Biotechnol. [DOI: 10.1007/s00253-021-11646-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
157 Wang YJ, Li QM, Zha XQ, Luo JP. Dendrobium fimbriatum Hook polysaccharide ameliorates dextran-sodium-sulfate-induced colitis in mice via improving intestinal barrier function, modulating intestinal microbiota, and reducing oxidative stress and inflammatory responses. Food Funct 2021. [PMID: 34874039 DOI: 10.1039/d1fo03003e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
158 Peda ES, Alexandrov TL, Baranova TA, Belous SS, Tishaeva IA, Nanaeva BA, Shapina MV, Knyazev OV, Eligulashvili RR, Belinskaya VA, Podolskaya DV. The effectiveness and safety of switching therapy with an original drug to biosimilars in treatment of inflammatory bowel diseases. jour 2022. [DOI: 10.31146/1682-8658-ecg-195-11-35-41] [Reference Citation Analysis]
159 Lal S, Kandiyal B, Ahuja V, Takeda K, Das B. Gut microbiome dysbiosis in inflammatory bowel disease. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.09.003] [Reference Citation Analysis]
160 Shi W, Xu N, Wang X, Vallée I, Liu M, Liu X. Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives. JIR 2022;Volume 15:475-91. [DOI: 10.2147/jir.s348079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
161 Singh K, Kaur T, Rao A. Therapeutic applications of probiotics and its regulatory framework. Biomedical Product and Materials Evaluation 2022. [DOI: 10.1016/b978-0-12-823966-7.00027-x] [Reference Citation Analysis]
162 Konoplyannikov M, Knyazev O, Timashev P, Baklaushev V. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_8-1] [Reference Citation Analysis]
163 Depoorter L, Vandenplas Y. Probiotics in pediatrics. Probiotics 2022. [DOI: 10.1016/b978-0-323-85170-1.00014-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Konoplyannikov M, Knyazev O, Timashev P, Baklaushev V. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_8] [Reference Citation Analysis]
165 Choi Y, Kim N. Inflammatory Bowel Diseases. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_19] [Reference Citation Analysis]
166 Lian YZ, Chang C, Chen Y, Tinkov AA, Skalny AV, Chao JC. <i>Lycium barbarum</i> polysaccharides and capsaicin modulate inflammatory cytokines and colonic microbiota in colitis rats induced by dextran sulfate sodium. J Clin Biochem Nutr . [DOI: 10.3164/jcbn.21-174] [Reference Citation Analysis]
167 Kim C. Innate Immunity Via Glycan-Binding Lectin Receptors. Glycobiology of Innate Immunology 2022. [DOI: 10.1007/978-981-16-9081-5_6] [Reference Citation Analysis]
168 Sun Y, Tang J, Li C, Liu J, Liu H. Sulforaphane attenuates dextran sodium sulphate induced intestinal inflammation via IL-10/STAT3 signaling mediated macrophage phenotype switching. Food Science and Human Wellness 2022;11:129-42. [DOI: 10.1016/j.fshw.2021.07.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
169 Peng V, Jaeger N, Colonna M. Innate Lymphoid Cells and Inflammatory Bowel Disease. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-981-16-8387-9_7] [Reference Citation Analysis]
170 Abdoli A, Badirzadeh A, Mojtabavi N, Meamar A, Falak R. Immunomodulatory effects of parasites on autoimmunity. Translational Autoimmunity 2022. [DOI: 10.1016/b978-0-12-824390-9.00005-0] [Reference Citation Analysis]
171 Liu P, Li Y, Wang R, Ren F, Wang X. Oxidative Stress and Antioxidant Nanotherapeutic Approaches for Inflammatory Bowel Disease. Biomedicines 2022;10:85. [DOI: 10.3390/biomedicines10010085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
172 Mishra S, Acharya S. A Brief Overview on Probiotics: The Health Friendly Microbes. Biomed Pharmacol J 2021;14:1869-80. [DOI: 10.13005/bpj/2285] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
173 Ahmed I, Yusuf K, Roy BC, Stubbs J, Anant S, Attard TM, Sampath V, Umar S. Dietary Interventions Ameliorate Infectious Colitis by Restoring the Microbiome and Promoting Stem Cell Proliferation in Mice. Int J Mol Sci 2021;23:339. [PMID: 35008767 DOI: 10.3390/ijms23010339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
174 Zou M, Zeng QS, Nie J, Yang JH, Luo ZY, Gan HT. The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe? Front Immunol 2021;12:769167. [PMID: 34956195 DOI: 10.3389/fimmu.2021.769167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
175 Baydi Z, Limami Y, Khalki L, Zaid N, Naya A, Mtairag EM, Oudghiri M, Zaid Y. An Update of Research Animal Models of Inflammatory Bowel Disease. ScientificWorldJournal 2021;2021:7479540. [PMID: 34938152 DOI: 10.1155/2021/7479540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
176 Verma A, Goel M, Prajapati S, Bhadkariya A. THE STUDY OF FREE RADICALS TO EVALUATE THE HEALING EFFECTS OF PUNICA GRANATUM PEEL ON ACETIC ACID-INDUCED COLITIS IN RATS. Asian J Pharm Clin Res 2021. [DOI: 10.22159/ajpcr.2022.v15i1.43894] [Reference Citation Analysis]
177 Verma A, Bhadkariya A, Sharma S, Toshi N. THE STUDY OF ANTIOXIDANTS TO EVALUATE THE HEALING EFFECTS OF PUNICA GRANATUM PEEL ON ACETIC ACID-INDUCED COLITIS IN CHARLES-FOSTER ALBINO RATS. Asian J Pharm Clin Res 2021. [DOI: 10.22159/ajpcr.2022.v15i2.43895] [Reference Citation Analysis]
178 Yan Z, Liu Y, Zhang T, Zhang F, Ren H, Zhang Y. Analysis of Microplastics in Human Feces Reveals a Correlation between Fecal Microplastics and Inflammatory Bowel Disease Status. Environ Sci Technol 2021. [PMID: 34935363 DOI: 10.1021/acs.est.1c03924] [Cited by in Crossref: 39] [Cited by in F6Publishing: 52] [Article Influence: 19.5] [Reference Citation Analysis]
179 Zeng Z, Xie Z, Chen G, Sun Y, Zeng X, Liu Z. Anti-inflammatory and gut microbiota modulatory effects of polysaccharides from Fuzhuan brick tea on colitis in mice induced by dextran sulfate sodium. Food Funct 2021. [PMID: 34932051 DOI: 10.1039/d1fo02702f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
180 Kapoor K, Eissa N, Tshikudi D, Bernstein CN, Ghia JE. Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditions. World J Gastroenterol 2021; 27(47): 8138-8155 [DOI: 10.3748/wjg.v27.i47.8138] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Li Y, Zhang H, Yang J, Zhan M, Hu X, Liu Y, Yu L, Yan X, Liang S, Zhang R, Lu Y, Li B, Liu C, Li M. P2Y12 receptor as a new target for electroacupuncture relieving comorbidity of visceral pain and depression of inflammatory bowel disease. Chin Med 2021;16:139. [PMID: 34930362 DOI: 10.1186/s13020-021-00553-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
182 Ward JM, Treuting PM, Washington MK. The Gastrointestinal Tract. Pathology of Genetically Engineered and Other Mutant Mice 2021. [DOI: 10.1002/9781119624608.ch13] [Reference Citation Analysis]
183 Liu N, Feng G, Zhang X, Hu Q, Sun S, Sun J, Sun Y, Wang R, Zhang Y, Wang P, Li Y. The Functional Role of Lactoferrin in Intestine Mucosal Immune System and Inflammatory Bowel Disease. Front Nutr 2021;8:759507. [PMID: 34901112 DOI: 10.3389/fnut.2021.759507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
184 Magro F, Alves C, Santiago M, Ministro P, Lago P, Correia L, Gonçalves R, Carvalho D, Portela F, Dias CC, Dignass A, Danese S, Peyrin-Biroulet L, Estevinho MM, Moreira P; on behalf GEDII (Portuguese IBD Group). Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis. United European Gastroenterol J 2021. [PMID: 34907660 DOI: 10.1002/ueg2.12183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Chen Y, Liu H, Zhang Q, Luo Y, Wu L, Zhong Y, Tang Z, Pu Y, Lu C, Yin G, Xie Q. Cinacalcet Targets the Neurokinin-1 Receptor and Inhibits PKCδ/ERK/P65 Signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis. Front Pharmacol 2021;12:735194. [PMID: 34880751 DOI: 10.3389/fphar.2021.735194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
186 Oh BS, Choi WJ, Kim JS, Ryu SW, Yu SY, Lee JS, Park SH, Kang SW, Lee J, Jung WY, Kim YM, Jeong JH, Lee JH. Cell-Free Supernatant of Odoribacter splanchnicus Isolated From Human Feces Exhibits Anti-colorectal Cancer Activity. Front Microbiol 2021;12:736343. [PMID: 34867852 DOI: 10.3389/fmicb.2021.736343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
187 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
188 El-Atrebi KA, Taher E, El Aguizy FH, Ali RM, Hegazy A, El-Sayed MM, Eysa B, El-Atreby AA, Mohammed AA, El-Bassyouni HT. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00131-6. [PMID: 34887218 DOI: 10.1016/j.rgmxen.2021.11.015] [Reference Citation Analysis]
189 Toyonaga T, Saruta M. Role of microRNAs in the Pathophysiology of Ulcerative Colitis. Immuno 2021;1:558-73. [DOI: 10.3390/immuno1040039] [Reference Citation Analysis]
190 Lee Y, Kamada N, Moon JJ. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome. Adv Drug Deliv Rev 2021;179:114021. [PMID: 34710529 DOI: 10.1016/j.addr.2021.114021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
191 Snyder EF, Davis S, Aldrich K, Veerabagu M, Larussa T, Abenavoli L, Boccuto L. Crohn disease: Identification, diagnosis, and clinical management. Nurse Pract 2021;46:22-30. [PMID: 34808643 DOI: 10.1097/01.NPR.0000798212.61425.4f] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
192 Ichihara M, Ogino T, Fujii M, Haraguchi N, Takahashi H, Miyoshi N, Uemura M, Doki Y, Eguchi H, Mizushima T. Usefulness of Bacterial Culture of Drainage Fluid for Predicting Surgical Site Infection After Crohn’s Disease Surgery. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12530] [Reference Citation Analysis]
193 Lee JG, Lee J, Lee AR, Jo SV, Park CH, Han DS, Eun CS. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model. J Nutr Biochem 2021;101:108926. [PMID: 34848335 DOI: 10.1016/j.jnutbio.2021.108926] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
194 Muehlbauer AL, Richards AL, Alazizi A, Burns MB, Gomez A, Clayton JB, Petrzelkova K, Cascardo C, Resztak J, Wen X, Pique-Regi R, Luca F, Blekhman R. Interspecies variation in hominid gut microbiota controls host gene regulation. Cell Rep 2021;37:110057. [PMID: 34818542 DOI: 10.1016/j.celrep.2021.110057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
195 Tang F, Cao F, Lu C, He X, Weng L, Sun L. Dvl2 facilitates the coordination of NF-κB and Wnt signaling to promote colitis-associated colorectal progression. Cancer Sci 2021. [PMID: 34807493 DOI: 10.1111/cas.15206] [Reference Citation Analysis]
196 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:790387. [PMID: 34790692 DOI: 10.3389/fnut.2021.790387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
197 Aldakheel FM. Allergic Diseases: A Comprehensive Review on Risk Factors, Immunological Mechanisms, Link with COVID-19, Potential Treatments, and Role of Allergen Bioinformatics. Int J Environ Res Public Health 2021;18:12105. [PMID: 34831860 DOI: 10.3390/ijerph182212105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Deng Z, Zhao Y, Ma Z, Zhang M, Wang H, Yi Z, Tuo B, Li T, Liu X. Pathophysiological role of ion channels and transporters in gastrointestinal mucosal diseases. Cell Mol Life Sci 2021;78:8109-25. [PMID: 34778915 DOI: 10.1007/s00018-021-04011-5] [Reference Citation Analysis]
199 Li Y, Chen J, Bolinger AA, Chen H, Liu Z, Cong Y, Brasier AR, Pinchuk IV, Tian B, Zhou J. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases. Inflamm Bowel Dis 2021;27:S38-62. [PMID: 34791293 DOI: 10.1093/ibd/izab190] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
200 Ntunzwenimana JC, Boucher G, Paquette J, Gosselin H, Alikashani A, Morin N, Beauchamp C, Thauvette L, Rivard MÈ, Dupuis F, Deschênes S, Foisy S, Latour F, Lavallée G, Daly MJ, Xavier RJ, Charron G, Goyette P, Rioux JD; iGenoMed Consortium. Functional screen of inflammatory bowel disease genes reveals key epithelial functions. Genome Med 2021;13:181. [PMID: 34758847 DOI: 10.1186/s13073-021-00996-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
201 Jung S, Ye BD, Lee HS, Baek J, Kim G, Park D, Park SH, Yang SK, Han B, Liu J, Song K. Identification of Three Novel Susceptibility Loci for Inflammatory Bowel Disease in Koreans in an Extended Genome-Wide Association Study. J Crohns Colitis 2021;15:1898-907. [PMID: 33853113 DOI: 10.1093/ecco-jcc/jjab060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Ouahed J, Kelsen JR, Spessott WA, Kooshesh K, Sanmillan ML, Dawany N, Sullivan KE, Hamilton KE, Slowik V, Nejentsev S, Neves JF, Flores H, Chung WK, Wilson A, Anyane-Yeboa K, Wou K, Jain P, Field M, Tollefson S, Dent MH, Li D, Naito T, McGovern DPB, Kwong AC, Taliaferro F, Ordovas-Montanes J, Horwitz BH, Kotlarz D, Klein C, Evans J, Dorsey J, Warner N, Elkadri A, Muise AM, Goldsmith J, Thompson B, Engelhardt KR, Cant AJ, Hambleton S, Barclay A, Toth-Petroczy A, Vuzman D, Carmichael N, Bodea C, Cassa CA, Devoto M, Maas RL, Behrens EM, Giraudo CG, Snapper SB. Variants in STXBP3 are Associated with Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation. J Crohns Colitis 2021;15:1908-19. [PMID: 33891011 DOI: 10.1093/ecco-jcc/jjab077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
203 Gao W, Zhang T, Wu H. Emerging Pathological Engagement of Ferroptosis in Gut Diseases. Oxid Med Cell Longev 2021;2021:4246255. [PMID: 34733403 DOI: 10.1155/2021/4246255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
204 Vargas-albores F, Martínez-córdova LR, Hernández-mendoza A, Cicala F, Lago-lestón A, Martínez-porchas M. Therapeutic modulation of fish gut microbiota, a feasible strategy for aquaculture? Aquaculture 2021;544:737050. [DOI: 10.1016/j.aquaculture.2021.737050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
205 Cao R, Wu X, Guo H, Pan X, Huang R, Wang G, Liu J. Naringin Exhibited Therapeutic Effects against DSS-Induced Mice Ulcerative Colitis in Intestinal Barrier-Dependent Manner. Molecules 2021;26:6604. [PMID: 34771012 DOI: 10.3390/molecules26216604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
206 Huangfu LX, Cai XT, Yang JN, Wang HC, Li YX, Dai ZF, Yang RL, Lin XH. Irisin attenuates inflammation in a mouse model of ulcerative colitis by altering the intestinal microbiota. Exp Ther Med 2021;22:1433. [PMID: 34707714 DOI: 10.3892/etm.2021.10868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
207 Casalegno Garduño R, Däbritz J. New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches. Front Immunol 2021;12:738762. [PMID: 34707610 DOI: 10.3389/fimmu.2021.738762] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
208 Ye R, Huang J, Wang Z, Chen Y, Dong Y. Trace Element Selenium Effectively Alleviates Intestinal Diseases. Int J Mol Sci 2021;22:11708. [PMID: 34769138 DOI: 10.3390/ijms222111708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
209 Yu R, Jin G, Fujimoto M. Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases. Front Oncol 2021;11:722331. [PMID: 34692496 DOI: 10.3389/fonc.2021.722331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
210 Fu Y, Ma G, Zhang Y, Wang W, Shi T, Zhu J, Zhang J, Huang Z, Chen J. HG-9-91-01 Attenuates Murine Experimental Colitis by Promoting Interleukin-10 Production in Colonic Macrophages Through the SIK/CRTC3 Pathway. Inflamm Bowel Dis 2021;27:1821-31. [PMID: 33988718 DOI: 10.1093/ibd/izab072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Khademi Z, Milajerdi A, Larijani B, Esmaillzadeh A. Dietary Intake of Total Carbohydrates, Sugar and Sugar-Sweetened Beverages, and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Front Nutr 2021;8:707795. [PMID: 34660658 DOI: 10.3389/fnut.2021.707795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
212 Zhao S, Zhu L, Feng W, Zhang L, Chen DD, Hu YC, Shen H. MicroRNA-602 prevents the development of inflammatory bowel diseases in a microbiota-dependent manner. Exp Ther Med 2021;22:1373. [PMID: 34659519 DOI: 10.3892/etm.2021.10808] [Reference Citation Analysis]
213 Cao Y, Gao J, Zhang L, Qin N, Zhu B, Xia X. Jellyfish skin polysaccharides enhance intestinal barrier function and modulate the gut microbiota in mice with DSS-induced colitis. Food Funct 2021;12:10121-35. [PMID: 34528649 DOI: 10.1039/d1fo02001c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
214 Yang C, Du Y, Ren D, Yang X, Zhao Y. Gut microbiota-dependent catabolites of tryptophan play a predominant role in the protective effects of turmeric polysaccharides against DSS-induced ulcerative colitis. Food Funct 2021;12:9793-807. [PMID: 34664583 DOI: 10.1039/d1fo01468d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
215 Ntunzwenimana JC, Boucher G, Paquette J, Gosselin H, Alikashani A, Morin N, Beauchamp C, Thauvette L, Rivard M, Dupuis F, Deschenes S, Foisy S, Latour F, Lavallée G, Daly MJ, Xavier RJ, Charron G, Goyette P, Rioux JD, the iGenoMed Consortium. Functional screen of Inflammatory bowel disease genes reveals key epithelial functions.. [DOI: 10.1101/2021.10.15.464566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Sakaram S, Hasin-Brumshtein Y, Khatri P, He YD, Sweeney TE. A Multi-mRNA Prognostic Signature for Anti-TNFα Therapy Response in Patients with Inflammatory Bowel Disease. Diagnostics (Basel) 2021;11:1902. [PMID: 34679598 DOI: 10.3390/diagnostics11101902] [Reference Citation Analysis]
217 Zheng C, Lu T, Fan Z. miR-200b-3p alleviates TNF-α-induced apoptosis and inflammation of intestinal epithelial cells and ulcerative colitis progression in rats via negatively regulating KHDRBS1. Cytotechnology 2021;73:727-43. [PMID: 34629748 DOI: 10.1007/s10616-021-00490-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
218 Evangelinellis MM, Souza RF, Mendes CE, Castelucci P. Effects of a P2X7 receptor antagonist on myenteric neurons in the distal colon of an experimental rat model of ulcerative colitis. Histochem Cell Biol 2021. [PMID: 34626216 DOI: 10.1007/s00418-021-02039-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
219 Balart MT, Russell L, Narula N, Bajaj G, Chauhan U, Khan KJ, Marwaha AN, Ching E, Biro J, Halder S, Tse F, Marshall JK, Collins SM, Moayyedi P, Bercik P, Verdu EF, Leontiadis GI, Armstrong D, Pinto-Sanchez MI. Declining Use of Corticosteroids for Crohn's Disease Has Implications for Study Recruitment: Results of a Pilot Randomized Controlled Trial. J Can Assoc Gastroenterol 2021;4:214-21. [PMID: 34617003 DOI: 10.1093/jcag/gwaa037] [Reference Citation Analysis]
220 Li J, Pan X, Ren Z, Li B, Liu H, Wu C, Dong X, de Vos P, Pan LL, Sun J. Protein arginine methyltransferase 2 (PRMT2) promotes dextran sulfate sodium-induced colitis by inhibiting the SOCS3 promoter via histone H3R8 asymmetric dimethylation. Br J Pharmacol 2021. [PMID: 34599829 DOI: 10.1111/bph.15695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
221 Achasova KM, Kozhevnikova EN, Borisova MA, Litvinova EA. Fucose Ameliorates Tritrichomonas sp.-Associated Illness in Antibiotic-Treated Muc2-/- Mice. Int J Mol Sci 2021;22:10699. [PMID: 34639039 DOI: 10.3390/ijms221910699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Vuyyuru SK, Kedia S, Kalaivani M, Sahu P, Kante B, Kumar P, Ranjan MK, Makharia G, Ananthakrishnan A, Ahuja V. Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta-analysis. Future Microbiol 2021;16:1215-27. [PMID: 34590904 DOI: 10.2217/fmb-2020-0242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
223 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:718356. [PMID: 34589512 DOI: 10.3389/fnut.2021.718356] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
224 El-atrebi K, Taher E, El Aguizy F, Ali R, Hegazy A, El-sayed M, Eysa B, El-atreby A, Mohammed A, El-bassyouni H. Estudio descriptivo de la enfermedad inflamatoria intestinal en un centro de atención terciario egipcio. Revista de Gastroenterología de México 2021. [DOI: 10.1016/j.rgmx.2021.03.004] [Reference Citation Analysis]
225 Song EM, Joo YH, Choe AR, Park Y, Tae CH, Hong JT, Moon CM, Kim SE, Jung HK, Shim KN, Cho KA, Jo I, Jung SA. Three-dimensional culture method enhances the therapeutic efficacies of tonsil-derived mesenchymal stem cells in murine chronic colitis model. Sci Rep 2021;11:19589. [PMID: 34599237 DOI: 10.1038/s41598-021-98711-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Hamilton MK, Wall ES, Guillemin K, Eisen JS. Enteric nervous system modulation of luminal pH modifies the microbial environment to promote intestinal health.. [DOI: 10.1101/2021.09.30.462512] [Reference Citation Analysis]
227 Chen M, Tian S, Li S, Pang X, Sun J, Zhu X, Lv F, Lu Z, Li X. β-Glucan Extracted from Highland Barley Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in C57BL/6J Mice. Molecules 2021;26:5812. [PMID: 34641356 DOI: 10.3390/molecules26195812] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
228 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
229 Pagnini C, Cominelli F. Tumor Necrosis Factor's Pathway in Crohn's Disease: Potential for Intervention. Int J Mol Sci 2021;22:10273. [PMID: 34638616 DOI: 10.3390/ijms221910273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Fernández-Tomé S, Ortega Moreno L, Chaparro M, Gisbert JP. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:10224. [PMID: 34638564 DOI: 10.3390/ijms221910224] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
231 Stankovic B, Kotur N, Nikcevic G, Gasic V, Zukic B, Pavlovic S. Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications. Genes (Basel) 2021;12:1438. [PMID: 34573420 DOI: 10.3390/genes12091438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
232 Kim MC, Kim KO, Kang MK, Jang BI. Chronic recurrent multifocal osteomyelitis of the left femur associated with ulcerative colitis: a case report. J Int Med Res 2021;49:3000605211042996. [PMID: 34510962 DOI: 10.1177/03000605211042996] [Reference Citation Analysis]
233 Bozward AG, Ronca V, Osei-Bordom D, Oo YH. Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy. Front Immunol 2021;12:711217. [PMID: 34512631 DOI: 10.3389/fimmu.2021.711217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
234 Stoian M, Stoica V. Clostridium Difficile Infection and Biliary Obstruction. Internal Medicine 2021;18:77-85. [DOI: 10.2478/inmed-2021-0177] [Reference Citation Analysis]
235 Shastri S, Shinde T, Woolley KL, Smith JA, Gueven N, Eri R. Short-Chain Naphthoquinone Protects Against Both Acute and Spontaneous Chronic Murine Colitis by Alleviating Inflammatory Responses. Front Pharmacol 2021;12:709973. [PMID: 34497514 DOI: 10.3389/fphar.2021.709973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Sun H, Lagarrigue F, Wang H, Fan Z, Lopez-Ramirez MA, Chang JT, Ginsberg MH. Distinct integrin activation pathways for effector and regulatory T cell trafficking and function. J Exp Med 2021;218:e20201524. [PMID: 33104169 DOI: 10.1084/jem.20201524] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
237 Indellicato R, Trinchera M. Epigenetic Regulation of Glycosylation. Adv Exp Med Biol 2021;1325:173-86. [PMID: 34495535 DOI: 10.1007/978-3-030-70115-4_8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
238 Park YM, Ha E, Gu KN, Shin GY, Lee CK, Kim K, Kim HJ. Host Genetic and Gut Microbial Signatures in Familial Inflammatory Bowel Disease. Clin Transl Gastroenterol 2020;11:e00213. [PMID: 32764209 DOI: 10.14309/ctg.0000000000000213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
239 Marchelletta RR, Krishnan M, Spalinger MR, Placone TW, Alvarez R, Sayoc-Becerra A, Canale V, Shawki A, Park YS, Bernts LH, Myers S, Tremblay ML, Barrett KE, Krystofiak E, Kachar B, McGovern DP, Weber CR, Hanson EM, Eckmann L, McCole DF. T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling. J Clin Invest 2021;131:e138230. [PMID: 34623320 DOI: 10.1172/JCI138230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
240 Xi-Zhang, Yuan XQ, Zhang XM. Melatonin reduces inflammation in intestinal cells, organoids and intestinal explants. Inflammopharmacology 2021;29:1555-64. [PMID: 34431007 DOI: 10.1007/s10787-021-00869-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
241 Günther C, Rothhammer V, Karow M, Neurath M, Winner B. The Gut-Brain Axis in Inflammatory Bowel Disease-Current and Future Perspectives. Int J Mol Sci 2021;22:8870. [PMID: 34445575 DOI: 10.3390/ijms22168870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
242 Singh A, Anderssen E, Fenton CG, Paulssen RH. Identifying anti-TNF response biomarkers in ulcerative colitis using a diffusion-based signalling model. Bioinform Adv 2021;1:vbab017. [PMID: 36700114 DOI: 10.1093/bioadv/vbab017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Pearl A, Bootz H, Melzer E, Sharon E, Abuchatzera S, Amidror S, Aretz E, Shoval I, Yaron O, Malnick S, Yissachar N. Diet-induced modifications to human microbiome reshape colonic homeostasis in irritable bowel syndrome.. [DOI: 10.1101/2021.08.15.456374] [Reference Citation Analysis]
244 Kim DH, Park J, Kim S, Yoon MY, Ma HW, Park IS, Son M, Kim JH, Kim TI, Kim WH, Yoon SS, Kim SW, Cheon JH. An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways. Free Radic Biol Med 2021;174:110-20. [PMID: 34358646 DOI: 10.1016/j.freeradbiomed.2021.08.002] [Reference Citation Analysis]
245 Yoganathan P, Rossel JB, Jordi SBU, Franc Y, Biedermann L, Misselwitz B, Hausmann M, Rogler G, Scharl M, Frey-Wagner I; Swiss IBD cohort study group. Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients. BMC Gastroenterol 2021;21:310. [PMID: 34344313 DOI: 10.1186/s12876-021-01880-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
246 Lamubol J, Ohto N, Kuwahara H, Mizuno M. Lactiplantibacillus plantarum 22A-3-induced TGF-β1 secretion from intestinal epithelial cells stimulated CD103+ DC and Foxp3+ Treg differentiation and amelioration of colitis in mice. Food Funct 2021;12:8044-55. [PMID: 34282811 DOI: 10.1039/d1fo00990g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
247 Yang WH, Westman JS, Heithoff DM, Sperandio M, Cho JW, Mahan MJ, Marth JD. Neu3 neuraminidase induction triggers intestinal inflammation and colitis in a model of recurrent human food-poisoning. Proc Natl Acad Sci U S A 2021;118:e2100937118. [PMID: 34266954 DOI: 10.1073/pnas.2100937118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
248 Ojo BA, VanDussen KL, Rosen MJ. The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis. Inflamm Bowel Dis 2022;28:299-308. [PMID: 34251431 DOI: 10.1093/ibd/izab161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
249 Chen G, Shen J. Artificial Intelligence Enhances Studies on Inflammatory Bowel Disease. Front Bioeng Biotechnol 2021;9:635764. [PMID: 34307315 DOI: 10.3389/fbioe.2021.635764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
250 Rabalais J, Kozan P, Lu T, Durali N, Okamoto K, Das B, Mcgeough MD, Lee JB, Barrett KE, Marchelletta R, Sivagnanam M. The Effect of a Fennel Extract on the STAT Signaling and Intestinal Barrier Function.. [DOI: 10.1101/2021.07.01.450766] [Reference Citation Analysis]
251 Miller MO, Kashyap PC, Becker SL, Thomas RM, Hodin RA, Miller G, Hundeyin M, Pushalkar S, Cohen D, Saxena D, Shogan BD, Morris-Stiff GJ. SSAT State-of-the-Art Conference: Advancements in the Microbiome. J Gastrointest Surg 2021;25:1885-95. [PMID: 32989690 DOI: 10.1007/s11605-020-04551-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
252 Chen L, Xu CJ, Wu W, Ding BJ, Liu ZJ. Anti-TNF and immunosuppressive combination therapy is preferential to inducing clinical remission in patients with active inflammatory bowel disease: A systemic review and meta-analysis. J Dig Dis 2021;22:408-18. [PMID: 34048629 DOI: 10.1111/1751-2980.13026] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
253 Hering L, Katkeviciute E, Schwarzfischer M, Niechcial A, Riggs JB, Wawrzyniak M, Atrott K, van de Sande M, Lang S, Becher B, Rogler G, Scharl M, Spalinger MR. Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis. Int J Mol Sci 2021;22:6820. [PMID: 34201918 DOI: 10.3390/ijms22136820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
254 Nishida A, Nishino K, Sakai K, Owaki Y, Noda Y, Imaeda H. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease? World J Gastroenterol 2021; 27(23): 3317-3326 [PMID: 34163114 DOI: 10.3748/wjg.v27.i23.3317] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
255 Tunç U, Yıldırım Y, Çelebi ARC, Kepez Yıldız B. Potential role of ocular surface microbiota in keratoconus etiopathogenesis. Expert Review of Ophthalmology 2021;16:333-41. [DOI: 10.1080/17469899.2021.1942844] [Reference Citation Analysis]
256 Rubalcava NS, Gadepalli SK. Inflammatory Bowel Disease in Children and Adolescents. Adv Pediatr 2021;68:121-42. [PMID: 34243849 DOI: 10.1016/j.yapd.2021.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
257 Zhang X, Song L, Li L, Zhu B, Huo L, Hu Z, Wang X, Wang J, Gao M, Zhang J, Hua Z. Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy. Signal Transduct Target Ther 2021;6:235. [PMID: 34131110 DOI: 10.1038/s41392-021-00626-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
258 Liang L, Lin R, Xie Y, Lin H, Shao F, Rui W, Chen H. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer. Int J Biol Sci 2021;17:2548-60. [PMID: 34326693 DOI: 10.7150/ijbs.58671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
259 Yang S, Park JS, Hwang SH, Cho KH, Na HS, Choi J, Jhun J, Kim SJ, Lee BI, Park SH, Cho ML. Metformin-Inducible Small Heterodimer Partner Interacting Leucine Zipper Protein Ameliorates Intestinal Inflammation. Front Immunol 2021;12:652709. [PMID: 34211461 DOI: 10.3389/fimmu.2021.652709] [Reference Citation Analysis]
260 Yu J, Liu Y, Zhang W, Yang X, Tang W, Liang H, Li S, Gao W, Yan J. Musculin Deficiency Aggravates Colonic Injury and Inflammation in Mice with Inflammatory Bowel Disease. Inflammation 2020;43:1455-63. [PMID: 32239394 DOI: 10.1007/s10753-020-01223-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Boucher G, Paradis A, Chabot-Roy G, Coderre L, Hillhouse EE, Bitton A, Des Rosiers C, Levings MK, Schumm LP, Lazarev M, Brant SR, Duerr R, McGovern D, Silverberg MS, Cho J, Lesage S, Rioux JD; iGenoMed Consortium, NIDDK IBD Genetics Consortium. Serum Analyte Profiles Associated With Crohn's Disease and Disease Location. Inflamm Bowel Dis 2022;28:9-20. [PMID: 34106269 DOI: 10.1093/ibd/izab123] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
262 Torun A, Hupalowska A, Trzonkowski P, Kierkus J, Pyrzynska B. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children. Front Immunol 2021;12:642166. [PMID: 34163468 DOI: 10.3389/fimmu.2021.642166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
263 Yu D, Zhao Y, Wang H, Kong D, Jin W, Hu Y, Qin Y, Zhang B, Li X, Hao J, Li G, Wang H. IL-1β pre-stimulation enhances the therapeutic effects of endometrial regenerative cells on experimental colitis. Stem Cell Res Ther 2021;12:324. [PMID: 34090510 DOI: 10.1186/s13287-021-02392-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
264 Townsend EM, Kelly L, Muscatt G, Box JD, Hargraves N, Lilley D, Jameson E. The Human Gut Phageome: Origins and Roles in the Human Gut Microbiome. Front Cell Infect Microbiol 2021;11:643214. [PMID: 34150671 DOI: 10.3389/fcimb.2021.643214] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
265 Bruscoli S, Febo M, Riccardi C, Migliorati G. Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice. Front Immunol 2021;12:691480. [DOI: 10.3389/fimmu.2021.691480] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
266 Zhang W, Michalowski CB, Beloqui A. Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment. Front Bioeng Biotechnol 2021;9:675194. [PMID: 34150733 DOI: 10.3389/fbioe.2021.675194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
267 Lopez LR, Barlogio CJ, Broberg CA, Wang J, Arthur JC. A nadA Mutation Confers Nicotinic Acid Auxotrophy in Pro-carcinogenic Intestinal Escherichia coli NC101. Front Microbiol 2021;12:670005. [PMID: 34149655 DOI: 10.3389/fmicb.2021.670005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
268 Khor TS, Claudtiz TS, Kővári B, Lauwers GY, Wallace MB, Kumarasinghe P. Inflammatory Conditions of the Colon. Gastrointestinal Pathology 2021. [DOI: 10.1002/9781119073048.ch10] [Reference Citation Analysis]
269 Bao X, Wu J. Impact of food-derived bioactive peptides on gut function and health. Food Res Int 2021;147:110485. [PMID: 34399481 DOI: 10.1016/j.foodres.2021.110485] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
270 Agista AZ, Rusbana TB, Islam J, Ohsaki Y, Sultana H, Hirakawa R, Watanabe K, Nochi T, Ardiansyah, Budijanto S, Yang SC, Koseki T, Aso H, Komai M, Shirakawa H. Fermented Rice Bran Supplementation Prevents the Development of Intestinal Fibrosis Due to DSS-Induced Inflammation in Mice. Nutrients 2021;13:1869. [PMID: 34070845 DOI: 10.3390/nu13061869] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
271 Perez de Arce E, Quera R, Ribeiro Barros J, Yukie Sassaki L. Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask. Int J Gen Med 2021;14:2003-15. [PMID: 34079340 DOI: 10.2147/IJGM.S308214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
272 Rye C, Rubin KH, Moller FT, Julsgaard M, Jess T, Andersen V. Positive Predictive Value of Diagnostic Codes for Inflammatory Bowel Disease in the Danish National Patient Registry Among Individuals 50+ Years, Using Patient Records as Reference Standard. Clin Epidemiol 2021;13:335-44. [PMID: 34079376 DOI: 10.2147/CLEP.S298770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
273 Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M, Taniguchi K. Inflammation-Induced Tumorigenesis and Metastasis. Int J Mol Sci 2021;22:5421. [PMID: 34063828 DOI: 10.3390/ijms22115421] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
274 Ashton JJ, Mossotto E, Stafford IS, Haggarty R, Coelho TAF, Batra A, Afzal NA, Mort M, Bunyan D, Beattie RM, Ennis S. Genetic Sequencing of Pediatric Patients Identifies Mutations in Monogenic Inflammatory Bowel Disease Genes that Translate to Distinct Clinical Phenotypes. Clin Transl Gastroenterol 2020;11:e00129. [PMID: 32463623 DOI: 10.14309/ctg.0000000000000129] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
275 Cotoraci C, Sasu A, Miutescu E, Iovanescu D, Gharbia S, Ciceu A, Herman H, Hermenean A. Immunohistochemical Expression Patterns of Tight Junction Proteins, Pro-Apoptotic and Anti-Apoptotic Factors on Progression of Intestinal Mucositis of Onco-Hematological Patients under Epirubicin-Based Chemotherapy. Applied Sciences 2021;11:4710. [DOI: 10.3390/app11104710] [Reference Citation Analysis]
276 Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 2021;302:211-27. [PMID: 33993489 DOI: 10.1111/imr.12974] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
277 Esposito S, Antoniol G, Labate M, Passadore L, Alvisi P, Daccò V, Ghizzi C, Colombo C, Principi N. Vaccines in Children with Inflammatory Bowel Disease: Brief Review. Vaccines (Basel) 2021;9:487. [PMID: 34064576 DOI: 10.3390/vaccines9050487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
278 Wei S, Bahl MI, Baunwall SMD, Hvas CL, Licht TR. Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances. Appl Environ Microbiol 2021;87:e00395-21. [PMID: 33741632 DOI: 10.1128/AEM.00395-21] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
279 Ahamad N, Kar A, Mehta S, Dewani M, Ravichandran V, Bhardwaj P, Sharma S, Banerjee R. Immunomodulatory nanosystems for treating inflammatory diseases. Biomaterials 2021;274:120875. [PMID: 34010755 DOI: 10.1016/j.biomaterials.2021.120875] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
280 Mahmoudi E, Mozhgani SH, Sharifinejad N. The role of mycobiota-genotype association in inflammatory bowel diseases: a narrative review. Gut Pathog 2021;13:31. [PMID: 33964975 DOI: 10.1186/s13099-021-00426-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
281 Pochard C, Gonzales J, Bessard A, Mahe MM, Bourreille A, Cenac N, Jarry A, Coron E, Podevin J, Meurette G, Neunlist M, Rolli-Derkinderen M. PGI(2) Inhibits Intestinal Epithelial Permeability and Apoptosis to Alleviate Colitis. Cell Mol Gastroenterol Hepatol 2021;12:1037-60. [PMID: 33971327 DOI: 10.1016/j.jcmgh.2021.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
282 Konoplyannikov MA, Knyazev OV, Baklaushev VP. MSC therapy for inflammatory bowel disease. Journal of Clinical Practice 2021;12:53-65. [DOI: 10.17816/clinpract64530] [Reference Citation Analysis]
283 Li W, Sun Y, Dai L, Chen H, Yi B, Niu J, Wang L, Zhang F, Luo J, Wang K, Guo R, Li L, Zou Q, Ma ZS, Miao Y. Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC). BMC Microbiol 2021;21:138. [PMID: 33947329 DOI: 10.1186/s12866-021-02201-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
284 Jiang P, Wu S, Luo Q, Zhao XM, Chen WH. Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships among Microbial Signatures and Powers Multidisease Diagnostic Models. mSystems 2021;6:e00112-21. [PMID: 33947803 DOI: 10.1128/mSystems.00112-21] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
285 Pandya VA, Patani R. Region-specific vulnerability in neurodegeneration: lessons from normal ageing. Ageing Res Rev 2021;67:101311. [PMID: 33639280 DOI: 10.1016/j.arr.2021.101311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
286 Xu P, Becker H, Elizalde M, Pierik M, Masclee A, Jonkers D. Interleukin-28A induces epithelial barrier dysfunction in CD patient-derived intestinal organoids. Am J Physiol Gastrointest Liver Physiol 2021;320:G689-99. [PMID: 33595362 DOI: 10.1152/ajpgi.00064.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
287 Khan F, Radovanovic A, Gojobori T, Kaur M. IBDDB: a manually curated and text-mining-enhanced database of genes involved in inflammatory bowel disease. Database (Oxford) 2021;2021:baab022. [PMID: 33929018 DOI: 10.1093/database/baab022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
288 Socha-Banasiak A, Sputa-Grzegrzółka P, Grzegrzółka J, Pacześ K, Dzięgiel P, Sordyl B, Romanowicz H, Czkwianianc E. Metallothioneins in Inflammatory Bowel Diseases: Importance in Pathogenesis and Potential Therapy Target. Can J Gastroenterol Hepatol 2021;2021:6665697. [PMID: 33987146 DOI: 10.1155/2021/6665697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
289 Lei Z, Yang L, Lei Y, Yang Y, Zhang X, Song Q, Chen G, Liu W, Wu H, Guo J. High dose lithium chloride causes colitis through activating F4/80 positive macrophages and inhibiting expression of Pigr and Claudin-15 in the colon of mice. Toxicology 2021;457:152799. [PMID: 33901603 DOI: 10.1016/j.tox.2021.152799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
290 Zhao J, Wang H, Zhou J, Qian J, Yang H, Zhou Y, Ding H, Gong Y, Qi X, Jiao Y, Ying P, Tang L, Sun Y, Zhu W. miR-130a-3p, a Preclinical Therapeutic Target for Crohn's Disease. J Crohns Colitis 2021;15:647-64. [PMID: 33022049 DOI: 10.1093/ecco-jcc/jjaa204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
291 Chesney KL, Men H, Hankins MA, Bryda EC. The Atg16l1 gene: characterization of wild type, knock-in, and knock-out phenotypes in rats. Physiol Genomics 2021;53:269-81. [PMID: 33818130 DOI: 10.1152/physiolgenomics.00114.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
292 Hsu CC, Okumura R, Motooka D, Sasaki R, Nakamura S, Iida T, Takeda K. Alleviation of colonic inflammation by Lypd8 in a mouse model of inflammatory bowel disease. Int Immunol 2021;33:359-72. [PMID: 33822948 DOI: 10.1093/intimm/dxab012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
293 Karthikeyan A, Young KN, Moniruzzaman M, Beyene AM, Do K, Kalaiselvi S, Min T. Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook. Pharmaceutics 2021;13:484. [PMID: 33918207 DOI: 10.3390/pharmaceutics13040484] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
294 Trilleaud C, Gauttier V, Biteau K, Girault I, Belarif L, Mary C, Pengam S, Teppaz G, Thepenier V, Danger R, Robert-Siegwald G, Néel M, Bruneau S, Glémain A, Néel A, Poupon A, Mosnier JF, Chêne G, Dubourdeau M, Blancho G, Vanhove B, Poirier N. Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution. Sci Adv 2021;7:eabd1453. [PMID: 33811066 DOI: 10.1126/sciadv.abd1453] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
295 Taman H, Fenton CG, Anderssen E, Florholmen J, Paulssen RH. DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis. PLoS One 2021;16:e0248905. [PMID: 33793617 DOI: 10.1371/journal.pone.0248905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
296 Sarmah R, Khan RA, Devi KR. Microbes in human oral cavity: a review. Reviews in Medical Microbiology 2021;32:75-82. [DOI: 10.1097/mrm.0000000000000227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
297 Zhou X, Xiang X, Zhou Y, Zhou T, Deng S, Zheng B, Zheng P. Protective effects of Antarctic krill oil in dextran sulfate sodium-induced ulcerative colitis mice. Journal of Functional Foods 2021;79:104394. [DOI: 10.1016/j.jff.2021.104394] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
298 Axelrad JE, Cadwell KH, Colombel JF, Shah SC. The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review. Therap Adv Gastroenterol 2021;14:17562848211004493. [PMID: 33868457 DOI: 10.1177/17562848211004493] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
299 Xu Q, Zhou X, Strober W, Mao L. Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules 2021;26:1725. [PMID: 33808793 DOI: 10.3390/molecules26061725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
300 Coelho T, Sonnenberg-Riethmacher E, Gao Y, Mossotto E, Khojanazarov A, Griffin A, Mukanova S, Ashimkhanova A, Haggarty R, Borissenko A, Ashton JJ, Stafford IS, Batra A, Afzal NA, Stanton MP, Vadgama B, Adrisova K, Beattie RM, Williams AP, Ennis S, Riethmacher D. Expression profile of the matricellular protein periostin in paediatric inflammatory bowel disease. Sci Rep 2021;11:6194. [PMID: 33737520 DOI: 10.1038/s41598-021-85096-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
301 Gomes TNF, de Azevedo FS, Argollo M, Miszputen SJ, Ambrogini O Jr. Clinical and Demographic Profile of Inflammatory Bowel Disease Patients in a Reference Center of São Paulo, Brazil. Clin Exp Gastroenterol 2021;14:91-102. [PMID: 33762838 DOI: 10.2147/CEG.S288688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
302 Zingel R, Bohlken J, Kostev K. Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study. J Alzheimers Dis 2021;80:1471-8. [PMID: 33720902 DOI: 10.3233/JAD-210103] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
303 Indellicato R, Trinchera M. Epigenetic Regulation of Glycosylation in Cancer and Other Diseases. Int J Mol Sci 2021;22:2980. [PMID: 33804149 DOI: 10.3390/ijms22062980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
304 Xiao L, Rao JN, Wang JY. RNA-binding proteins and long noncoding RNAs in intestinal epithelial autophagy and barrier function. Tissue Barriers 2021;9:1895648. [PMID: 33709880 DOI: 10.1080/21688370.2021.1895648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
305 Zhang Y, Qiao D, Chen R, Zhu F, Gong J, Yan F. The Association between Periodontitis and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Biomed Res Int 2021;2021:6692420. [PMID: 33778080 DOI: 10.1155/2021/6692420] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
306 Ruiz F, Wyss A, Rossel JB, Sulz MC, Brand S, Moncsek A, Mertens JC, Roth R, Clottu AS, Burri E, Juillerat P, Biedermann L, Greuter T, Rogler G, Pot C, Misselwitz B; Swiss IBD Cohort Study Group. A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease. Br J Pharmacol 2021;178:3157-75. [PMID: 33511653 DOI: 10.1111/bph.15395] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
307 Horowitz JE, Warner N, Staples J, Crowley E, Gosalia N, Murchie R, Van Hout C, Fiedler K, Welch G, King AK, Reid JG, Overton JD, Baras A, Shuldiner AR, Griffiths A, Gottesman O, Muise AM, Gonzaga-Jauregui C. Mutation spectrum of NOD2 reveals recessive inheritance as a main driver of Early Onset Crohn's Disease. Sci Rep 2021;11:5595. [PMID: 33692434 DOI: 10.1038/s41598-021-84938-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
308 Anderson A, Cherfane C, Click B, Ramos-Rivers C, Koutroubakis IE, Hashash JG, Babichenko D, Tang G, Dunn M, Barrie A, Proksell S, Dueker J, Johnston E, Schwartz M, Binion DG. Monocytosis Is a Biomarker of Severity in Inflammatory Bowel Disease: Analysis of a 6-Year Prospective Natural History Registry. Inflamm Bowel Dis 2022;28:70-8. [PMID: 33693659 DOI: 10.1093/ibd/izab031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
309 Ho SSC, Ross M, Keenan JI, Day AS. Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children. Front Pediatr 2020;8:609279. [PMID: 33748035 DOI: 10.3389/fped.2020.609279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
310 Han X, Ding S, Jiang H, Liu G. Roles of Macrophages in the Development and Treatment of Gut Inflammation. Front Cell Dev Biol 2021;9:625423. [PMID: 33738283 DOI: 10.3389/fcell.2021.625423] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
311 Borren NZ, Plichta D, Joshi AD, Bonilla G, Peng V, Colizzo FP, Luther J, Khalili H, Garber JJ, Janneke van der Woude C, Sadreyev R, Vlamakis H, Xavier RJ, Ananthakrishnan AN. Alterations in Fecal Microbiomes and Serum Metabolomes of Fatigued Patients With Quiescent Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2021;19:519-527.e5. [PMID: 32184182 DOI: 10.1016/j.cgh.2020.03.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
312 Zeng W, He D, Xing Y, Liu J, Su N, Zhang C, Wang Y, Xing X. Internal connections between dietary intake and gut microbiota homeostasis in disease progression of ulcerative colitis: a review. Food Science and Human Wellness 2021;10:119-30. [DOI: 10.1016/j.fshw.2021.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
313 Pagnini C, Picchianti-Diamanti A, Bruzzese V, Lorenzetti R, Luchetti MM, Martin LSM, Pica R, Scolieri P, Scribano ML, Zampaletta C, Chimenti MS, Lagana B. Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical Applications. Int J Mol Sci 2021;22:2456. [PMID: 33671090 DOI: 10.3390/ijms22052456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
314 Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front Immunol 2021;12:578386. [PMID: 33717063 DOI: 10.3389/fimmu.2021.578386] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 58.0] [Reference Citation Analysis]
315 Mata R, Yao Y, Cao W, Ding J, Zhou T, Zhai Z, Gao C. The Dynamic Inflammatory Tissue Microenvironment: Signality and Disease Therapy by Biomaterials. Research (Wash D C) 2021;2021:4189516. [PMID: 33623917 DOI: 10.34133/2021/4189516] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
316 Salem G, Ding K, Sakuraba A, Cohen R. Role of topical tacrolimus in the management of proctitis, perianal manifestations in Crohn's disease, and chronic pouchitis: a systematic review. J Investig Med 2021:jim-2020-001699. [PMID: 33622709 DOI: 10.1136/jim-2020-001699] [Reference Citation Analysis]
317 Matsuzawa-Ishimoto Y, Hine A, Shono Y, Rudensky E, Lazrak A, Yeung F, Neil JA, Yao X, Chen YH, Heaney T, Schuster SL, Zwack EE, Axelrad JE, Hudesman D, Tsai JJ, Nichols K, Dewan MZ, Cammer M, Beal A, Hoffman S, Geddes B, Bertin J, Liu C, Torres VJ, Loke P, van den Brink MRM, Cadwell K. An intestinal organoid-based platform that recreates susceptibility to T-cell-mediated tissue injury. Blood 2020;135:2388-401. [PMID: 32232483 DOI: 10.1182/blood.2019004116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
318 O'Connell L, Winter DC, Aherne CM. The Role of Organoids as a Novel Platform for Modeling of Inflammatory Bowel Disease. Front Pediatr 2021;9:624045. [PMID: 33681101 DOI: 10.3389/fped.2021.624045] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
319 Aleksandrova EN, Novikov AA, Lukina GV, Parfenov AI. Clinical value of antibodies in inflammatory bowel diseases. Terapevticheskii arkhiv 2021;93:228-235. [DOI: 10.26442/00403660.2021.02.200610] [Reference Citation Analysis]
320 Lopez LR, Barlogio CJ, Broberg CA, Wang J, Arthur JC. A nadA mutation confers nicotinic acid auxotrophy in pro-carcinogenic intestinal Escherichia coli NC101.. [DOI: 10.1101/2021.02.12.431052] [Reference Citation Analysis]
321 Morshedzadeh N, Shahrokh S, Chaleshi V, Karimi S, Mirmiran P, Zali MR. The effects of flaxseed supplementation on gene expression and inflammation in ulcerative colitis patients: An open-labelled randomised controlled trial. Int J Clin Pract 2021;75:e14035. [PMID: 33482045 DOI: 10.1111/ijcp.14035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
322 Dharmasiri S, Garrido-Martin EM, Harris RJ, Bateman AC, Collins JE, Cummings JRF, Sanchez-Elsner T. Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease. Inflamm Bowel Dis 2021;27:1641-52. [PMID: 33570153 DOI: 10.1093/ibd/izab029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
323 Konidari A, Dickens D, Pirmohamed M. Inflammatory Bowel Disease: A Personalized Approach. Front Pediatr 2020;8:620545. [PMID: 33643966 DOI: 10.3389/fped.2020.620545] [Reference Citation Analysis]
324 Khademi Z, Saneei P, Hassanzadeh-Keshteli A, Daghaghzadeh H, Tavakkoli H, Adibi P, Esmaillzadeh A. Association Between Inflammatory Potential of the Diet and Ulcerative Colitis: A Case-Control Study. Front Nutr 2020;7:602090. [PMID: 33681269 DOI: 10.3389/fnut.2020.602090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
325 Kim YN, Ji YK, Kim NH, Van Tu N, Rho JR, Jeong EJ. Isoquinolinequinone Derivatives from a Marine Sponge (Haliclona sp.) Regulate Inflammation in In Vitro System of Intestine. Mar Drugs 2021;19:90. [PMID: 33557170 DOI: 10.3390/md19020090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
326 Beheshti-Maal A, Shahrokh S, Ansari S, Mirsamadi ES, Yadegar A, Mirjalali H, Zali MR. Gut mycobiome: The probable determinative role of fungi in IBD patients. Mycoses 2021;64:468-76. [PMID: 33421192 DOI: 10.1111/myc.13238] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
327 Gonçalves BP, Flauzino T, Inoue CJ, de Paula JCC, Galvão TC, de Alcantara CC, Miyazaki PK, Rosa L, Westmore S, Lozovoy MAB, Reiche EMV, Simão ANC. IL6 genetic variants haplotype is associated with susceptibility and disease activity but not with therapy response in patients with inflammatory bowel disease. Int J Colorectal Dis 2021;36:383-93. [PMID: 33047210 DOI: 10.1007/s00384-020-03743-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
328 Elhennawy MG, Abdelaleem EA, Zaki AA, Mohamed WR. Cinnamaldehyde and hesperetin attenuate TNBS-induced ulcerative colitis in rats through modulation of the JAk2/STAT3/SOCS3 pathway. J Biochem Mol Toxicol 2021;35:e22730. [PMID: 33522063 DOI: 10.1002/jbt.22730] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
329 Furihata K, Ishiguro Y, Yoshimura N, Ito H, Katsushima S, Kaneko E, Shimabe M, Mukai M, Watanabe R, Morishige T. A Phase 1 Study of KHK4083: A Single-Blind, Randomized, Placebo-Controlled Single-Ascending-Dose Study in Healthy Adults and an Open-Label Multiple-Dose Study in Patients With Ulcerative Colitis. Clin Pharmacol Drug Dev 2021;10:870-83. [PMID: 33512065 DOI: 10.1002/cpdd.918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Fekete T, Bencze D, Bíró E, Benkő S, Pázmándi K. Focusing on the Cell Type Specific Regulatory Actions of NLRX1. Int J Mol Sci 2021;22:1316. [PMID: 33525671 DOI: 10.3390/ijms22031316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
331 Pawlak M, Detomaso D, zu Horste GM, Lee Y, Nyman J, Dionne D, Wang C, Wallrapp A, Burkett PR, Riesenfeld SJ, Anderson AC, Regev A, Xavier RJ, Yosef N, Kuchroo VK. Induction of a colitogenic phenotype in Th1 cells depends on IL-23R signaling.. [DOI: 10.1101/2021.01.24.426445] [Reference Citation Analysis]
332 Kuno R, Ito G, Kawamoto A, Hiraguri Y, Sugihara HY, Takeoka S, Nagata S, Takahashi J, Tsuchiya M, Anzai S, Mizutani T, Shimizu H, Yui S, Oshima S, Tsuchiya K, Watanabe M, Okamoto R. Notch and TNF-α signaling promote cytoplasmic accumulation of OLFM4 in intestinal epithelium cells and exhibit a cell protective role in the inflamed mucosa of IBD patients. Biochem Biophys Rep 2021;25:100906. [PMID: 33490652 DOI: 10.1016/j.bbrep.2020.100906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
333 Zakerska-Banaszak O, Tomczak H, Gabryel M, Baturo A, Wolko L, Michalak M, Malinska N, Mankowska-Wierzbicka D, Eder P, Dobrowolska A, Slomski R, Skrzypczak-Zielinska M. Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study. Sci Rep 2021;11:2166. [PMID: 33495479 DOI: 10.1038/s41598-021-81628-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
334 Georgiou AN, Ntritsos G, Papadimitriou N, Dimou N, Evangelou E. Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn's Disease and Ulcerative Colitis: A Mendelian Randomization Study. Inflamm Bowel Dis 2021;27:162-8. [PMID: 32628751 DOI: 10.1093/ibd/izaa152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
335 Dahiya D, Kichloo A, Singh J, Albosta M, Wani F. Histoplasmosis and inflammatory bowel disease: A case report. World J Gastrointest Endosc 2021; 13(1): 24-32 [PMID: 33520104 DOI: 10.4253/wjge.v13.i1.24] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
336 Kanke M, Kennedy MM, Connelly S, Schaner M, Shanahan MT, Wolber EA, Beasley C, Lian G, Jain A, Long MD, Barnes EL, Herfarth HH, Isaacs KL, Hansen JJ, Kapadia M, Gaston Guillem J, Furey TS, Sheikh SZ, Sethupathy P. Single-cell analysis of colonic epithelium reveals unexpected shifts in cellular composition and molecular phenotype in treatment-naïve adult Crohn’s disease.. [DOI: 10.1101/2021.01.13.426602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
337 Diener C, Reyes-Escogido ML, Jimenez-Ceja LM, Matus M, Gomez-Navarro CM, Chu ND, Zhong V, Tejero ME, Alm E, Resendis-Antonio O, Guardado-Mendoza R. Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort. Front Endocrinol (Lausanne) 2020;11:602326. [PMID: 33488518 DOI: 10.3389/fendo.2020.602326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
338 Cao Y, Su Q, Zhang B, Shen F, Li S. Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review. Stem Cell Res Ther 2021;12:32. [PMID: 33413661 DOI: 10.1186/s13287-020-02095-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
339 Wittmann Dayagi T, Werner L, Pinsker M, Salamon N, Barschak I, Weiss B, Shouval DS. Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis. Int J Exp Pathol 2021;102:4-10. [PMID: 33405352 DOI: 10.1111/iep.12382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
340 Hashimoto-hill S, Kelly D, Alenghat T. Epigenomics of intestinal disease. Medical Epigenetics 2021. [DOI: 10.1016/b978-0-12-823928-5.00018-9] [Reference Citation Analysis]
341 Shapiro JM, de Zoete MR, Palm NW, Laenen Y, Bright R, Mallette M, Bu K, Bielecka AA, Xu F, Hurtado-Lorenzo A, Shah SA, Cho JH, LeLeiko NS, Sands BE, Flavell RA, Clemente JC. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease. Cell Host Microbe 2021;29:83-93.e3. [PMID: 33385335 DOI: 10.1016/j.chom.2020.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
342 Kristjánsson VB, Lund SH, Gröndal G, Sveinsdóttir SV, Agnarsson HR, Jónasson JG, Björnsson ES. Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018. Scand J Gastroenterol 2021;56:46-52. [PMID: 33280485 DOI: 10.1080/00365521.2020.1854847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
343 Fakoya AOJ, Omole AE, Satyadev N, Okaruefe CO. Induced pluripotent stem cells in intestinal diseases. The Intestine 2021. [DOI: 10.1016/b978-0-12-821269-1.00003-5] [Reference Citation Analysis]
344 Melnik P, Soffair N, Matar M, Shamir R, Assa A. Positivity of Stool Pathogen Sampling in Pediatric Inflammatory Bowel Disease Flares and Its Association With Disease Course. J Pediatr Gastroenterol Nutr 2021;72:61-6. [PMID: 32796430 DOI: 10.1097/MPG.0000000000002895] [Reference Citation Analysis]
345 Dvornikova KA, Bystrova EY, Churilov LP, Lerner A. Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection. Mol Biol Rep 2021;48:5745-58. [PMID: 34296352 DOI: 10.1007/s11033-021-06565-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
346 Blachier F, Andriamihaja M, Larraufie P, Ahn E, Lan A, Kim E. Production of hydrogen sulfide by the intestinal microbiota and epithelial cells and consequences for the colonic and rectal mucosa. Am J Physiol Gastrointest Liver Physiol 2021;320:G125-35. [PMID: 33084401 DOI: 10.1152/ajpgi.00261.2020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
347 Antunes C, Dziadkowiec K, Charabaty A. Advances in Our Understanding of the Pathogenesis of Inflammatory Bowel Disease. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-81780-0_1] [Reference Citation Analysis]
348 Hossein-Khannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, Kadri N, Vosough M. Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results. Hum Cell 2021;34:1289-300. [PMID: 34057700 DOI: 10.1007/s13577-021-00560-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
349 Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues. Gastroenterology 2021;160:524-37. [PMID: 33253681 DOI: 10.1053/j.gastro.2020.09.056] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 51.5] [Reference Citation Analysis]
350 Fathema K, Alam R, Hassan M, Ahmed M, Hasan M. Very early-onset inflammatory bowel disease: A review. Paediatr Nephrol J Bangladesh 2021;6:43. [DOI: 10.4103/pnjb.pnjb_10_21] [Reference Citation Analysis]
351 Fan HN, Zhu P, Zhang J, Zhu JS. Mucosal microbiome dysbiosis associated with duodenum bulb inflammation. Microb Pathog 2021;150:104711. [PMID: 33385493 DOI: 10.1016/j.micpath.2020.104711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
352 Fallahi F, Borran S, Ashrafizadeh M, Zarrabi A, Pourhanifeh MH, Khaksary Mahabady M, Sahebkar A, Mirzaei H. Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials. Mol Immunol 2021;130:20-30. [PMID: 33348246 DOI: 10.1016/j.molimm.2020.11.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
353 Zobeiri M, Momtaz S, Parvizi F, Tewari D, Farzaei MH, Nabavi SM. Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. Curr Pharm Biotechnol 2020;21:1342-53. [PMID: 31840607 DOI: 10.2174/1389201021666191216122555] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
354 Tsai YW, Fu SH, Dong JL, Chien MW, Liu YW, Hsu CY, Sytwu HK. Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E9564. [PMID: 33334069 DOI: 10.3390/ijms21249564] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
355 Lee SA, Wang Y, Liu F, Riordan SM, Liu L, Zhang L. Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway. Infect Immun 2020;89:e00618-20. [PMID: 33046511 DOI: 10.1128/IAI.00618-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
356 Wang HQ, Zhang WH, Wang YQ, Geng XP, Wang MW, Fan YY, Guan J, Shen JL, Chen X. Colonic vitamin D receptor expression is inversely associated with disease activity and jumonji domain-containing 3 in active ulcerative colitis. World J Gastroenterol 2020; 26(46): 7352-7366 [PMID: 33362389 DOI: 10.3748/wjg.v26.i46.7352] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
357 Zhao Q, Duck LW, Huang F, Alexander KL, Maynard CL, Mannon PJ, Elson CO. CD4+ T cell activation and concomitant mTOR metabolic inhibition can ablate microbiota-specific memory cells and prevent colitis. Sci Immunol 2020;5:eabc6373. [PMID: 33310866 DOI: 10.1126/sciimmunol.abc6373] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
358 Liu H, Li T, Zhong S, Yu M, Huang W. Intestinal epithelial cells related lncRNA and mRNA expression profiles in dextran sulphate sodium-induced colitis. J Cell Mol Med 2021;25:1060-73. [PMID: 33300279 DOI: 10.1111/jcmm.16174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
359 Jacob EM, Borah A, Pillai SC, Kumar DS. Inflammatory Bowel Disease: The Emergence of New Trends in Lifestyle and Nanomedicine as the Modern Tool for Pharmacotherapy. Nanomaterials (Basel) 2020;10:E2460. [PMID: 33316984 DOI: 10.3390/nano10122460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
360 Lopetuso LR, Corbi M, Scaldaferri F, Petito V, Graziani C, Castri F, Neri M, Gasbarrini A, Sgambato A, Papa A. Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment. Eur J Gastroenterol Hepatol 2020;32:1527-32. [PMID: 32976192 DOI: 10.1097/MEG.0000000000001933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
361 Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 2020;49:643-54. [PMID: 33121686 DOI: 10.1016/j.gtc.2020.07.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 21.3] [Reference Citation Analysis]
362 Kong L, Lloyd-Price J, Vatanen T, Seksik P, Beaugerie L, Simon T, Vlamakis H, Sokol H, Xavier RJ. Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease. Gastroenterology 2020;159:2193-2202.e5. [PMID: 32860788 DOI: 10.1053/j.gastro.2020.08.045] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
363 Yang M, Zhang Y, Ma Y, Yan X, Gong L, Zhang M, Zhang B. Nanoparticle-based therapeutics of inflammatory bowel diseases: a narrative review of the current state and prospects. Journal of Bio-X Research 2020;3:157-73. [DOI: 10.1097/jbr.0000000000000078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
364 Gierse LC, Meene A, Schultz D, Schwaiger T, Karte C, Schröder C, Wang H, Wünsche C, Methling K, Kreikemeyer B, Fuchs S, Bernhardt J, Becher D, Lalk M, KoInfekt Study Group, Urich T, Riedel K. A Multi-Omics Protocol for Swine Feces to Elucidate Longitudinal Dynamics in Microbiome Structure and Function. Microorganisms 2020;8:E1887. [PMID: 33260576 DOI: 10.3390/microorganisms8121887] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
365 Liao ZQ, Ji QF, Zhou BJ. Strategies for inflammatory bowel disease drug research by targeting gut microbiota. Shijie Huaren Xiaohua Zazhi 2020; 28(22): 1112-1120 [DOI: 10.11569/wcjd.v28.i22.1112] [Reference Citation Analysis]
366 Ashton JJ, Boukas K, Davies J, Stafford IS, Vallejo AF, Haggarty R, Coelho TAF, Batra A, Afzal NA, Vadgama B, Williams AP, Beattie RM, Polak ME, Ennis S. Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naïve Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes. J Crohns Colitis 2021;15:774-86. [PMID: 33232439 DOI: 10.1093/ecco-jcc/jjaa236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
367 Kennelly JP, Carlin S, Ju T, van der Veen JN, Nelson RC, Buteau J, Thiesen A, Richard C, Willing BP, Jacobs RL. Intestinal Phospholipid Disequilibrium Initiates an ER Stress Response That Drives Goblet Cell Necroptosis and Spontaneous Colitis in Mice. Cell Mol Gastroenterol Hepatol 2021;11:999-1021. [PMID: 33238221 DOI: 10.1016/j.jcmgh.2020.11.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
368 Serramito-Gómez I, Boada-Romero E, Villamuera R, Fernández-Cabrera Á, Cedillo JL, Martín-Regalado Á, Carding S, Mayer U, Powell PP, Wileman T, García-Higuera I, Pimentel-Muiños FX. Regulation of cytokine signaling through direct interaction between cytokine receptors and the ATG16L1 WD40 domain. Nat Commun 2020;11:5919. [PMID: 33219218 DOI: 10.1038/s41467-020-19670-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
369 Yao Y, Feng Q, Shen J. Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn's disease. Expert Rev Clin Immunol 2020;16:1127-41. [PMID: 33183108 DOI: 10.1080/1744666X.2021.1850269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
370 Lan X, Liu F, Ma J, Chang Y, Lan X, Xiang L, Shen X, Zhou F, Zhao Q. Leukocyte immunoglobulin-like receptor A3 is increased in IBD patients and functions as an anti-inflammatory modulator. Clin Exp Immunol 2021;203:286-303. [PMID: 33006756 DOI: 10.1111/cei.13529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
371 Cavalcante RMS, Lima MM, Parente JML, Moura MSB, Nogueira NDN. Inflammatory Bowel Diseases and diet: an integrative review. Rev Assoc Med Bras (1992) 2020;66:1449-54. [PMID: 33174942 DOI: 10.1590/1806-9282.66.10.1449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
372 Geldof J, LeBlanc JF, Lucaciu L, Segal J, Lees CW, Hart A. Are we addressing the top 10 research priorities in IBD? Frontline Gastroenterol 2021;12:564-9. [PMID: 34917313 DOI: 10.1136/flgastro-2020-101579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
373 Wu F, Huang Y, Hu J, Shao Z. Mendelian randomization study of inflammatory bowel disease and bone mineral density. BMC Med 2020;18:312. [PMID: 33167994 DOI: 10.1186/s12916-020-01778-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
374 Lenoir M, Martín R, Torres-Maravilla E, Chadi S, González-Dávila P, Sokol H, Langella P, Chain F, Bermúdez-Humarán LG. Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes 2020;12:1-16. [PMID: 33054518 DOI: 10.1080/19490976.2020.1826748] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
375 Kupka T, Svoboda P, Bojková M, Blaho M, Vašura A, Hrabovský V, Dítě P. Bone metabolism in inflammatory bowel diseases 1. Vnitr Lek 2020;66:e3-e7. [DOI: 10.36290/vnl.2020.131] [Reference Citation Analysis]
376 van Hoeve K, Vermeire S. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place. Paediatr Drugs 2020;22:449-61. [PMID: 32797366 DOI: 10.1007/s40272-020-00411-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
377 Shawki A, Ramirez R, Spalinger MR, Ruegger PM, Sayoc-Becerra A, Santos AN, Chatterjee P, Canale V, Mitchell JD, Macbeth JC, Gries CM, Tremblay ML, Hsiao A, Borneman J, McCole DF. The autoimmune susceptibility gene, PTPN2, restricts expansion of a novel mouse adherent-invasive E. coli. Gut Microbes 2020;11:1547-66. [PMID: 32586195 DOI: 10.1080/19490976.2020.1775538] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
378 de Mesquita MB, Shouval DS. Evaluation of very early-onset inflammatory bowel disease. Curr Opin Gastroenterol 2020;36:464-9. [PMID: 32868508 DOI: 10.1097/MOG.0000000000000680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
379 Shao X, Sun C, Tang X, Zhang X, Han D, Liang S, Qu R, Hui X, Shan Y, Hu L, Fang H, Zhang H, Wu X, Chen C. Anti-Inflammatory and Intestinal Microbiota Modulation Properties of Jinxiang Garlic (Allium sativum L.) Polysaccharides toward Dextran Sodium Sulfate-Induced Colitis. J Agric Food Chem 2020;68:12295-309. [PMID: 33095019 DOI: 10.1021/acs.jafc.0c04773] [Cited by in Crossref: 66] [Cited by in F6Publishing: 80] [Article Influence: 22.0] [Reference Citation Analysis]
380 Wang S, Lin Y, Li F, Qin Z, Zhou Z, Gao L, Yang Z, Wang Z, Wu B. An NF-κB-driven lncRNA orchestrates colitis and circadian clock. Sci Adv 2020;6:eabb5202. [PMID: 33055157 DOI: 10.1126/sciadv.abb5202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
381 Liu W, Zhou Y, Qin Y, Yu L, Li R, Chen Y, Xu Y. Quercetin Intervention Alleviates Offspring's Oxidative Stress, Inflammation, and Tight Junction Damage in the Colon Induced by Maternal Fine Particulate Matter (PM2.5) Exposure through the Reduction of Bacteroides. Nutrients 2020;12:E3095. [PMID: 33050645 DOI: 10.3390/nu12103095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
382 Wang H, Tu L, Li Y, Bai T, Zou K, Xiao F, Li J, Chen M, Zhang H, Li G, Lu Y, Wang K, Jin S, Yang Y, Zhu L, Hou X. The Symptoms and Medications of Patients with Inflammatory Bowel Disease in Hubei Province after COVID-19 Epidemic. J Immunol Res. 2020;2020:2847316. [PMID: 33062719 DOI: 10.1155/2020/2847316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
383 Li F, Han Y, Cai X, Gu M, Sun J, Qi C, Goulette T, Song M, Li Z, Xiao H. Dietary resveratrol attenuated colitis and modulated gut microbiota in dextran sulfate sodium-treated mice. Food Funct 2020;11:1063-73. [PMID: 31825043 DOI: 10.1039/c9fo01519a] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
384 Zhang T, Kayani MUR, Hong L, Zhang C, Zhong J, Wang Z, Chen L. Dynamics of the Salivary Microbiome During Different Phases of Crohn's Disease. Front Cell Infect Microbiol 2020;10:544704. [PMID: 33123492 DOI: 10.3389/fcimb.2020.544704] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
385 Liu C, Li Y, Chen Y, Huang S, Wang X, Luo S, Su Y, Zhou L, Luo X. Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis. Mediators Inflamm 2020;2020:5918587. [PMID: 33082710 DOI: 10.1155/2020/5918587] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
386 Lemay JA, Yamamoto M, Kroezen Z, Shanmuganathan M, Ly R, Hart L, Pai N, Britz-McKibbin P. Lyophilized fecal short-chain fatty acid and electrolyte determination by capillary electrophoresis with indirect UV detection for assessment of pediatric inflammatory bowel disease. J Pharm Biomed Anal 2021;192:113658. [PMID: 33091761 DOI: 10.1016/j.jpba.2020.113658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
387 Eshelman MA, Harris L, Deiling S, Koltun WA, Jeganathan NA, Yochum GS. Transcriptomic analysis of ileal tissue from Crohn's disease patients identifies extracellular matrix genes that distinguish individuals by age at diagnosis. Physiol Genomics 2020;52:478-84. [PMID: 32866088 DOI: 10.1152/physiolgenomics.00062.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
388 Mancini NL, Rajeev S, Jayme TS, Wang A, Keita ÅV, Workentine ML, Hamed S, Söderholm JD, Lopes F, Shutt TE, Shearer J, McKay DM. Crohn's Disease Pathobiont Adherent-Invasive E coli Disrupts Epithelial Mitochondrial Networks With Implications for Gut Permeability. Cell Mol Gastroenterol Hepatol 2021;11:551-71. [PMID: 32992049 DOI: 10.1016/j.jcmgh.2020.09.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
389 Shastri S, Shinde T, Perera AP, Gueven N, Eri R. Idebenone Protects against Spontaneous Chronic Murine Colitis by Alleviating Endoplasmic Reticulum Stress and Inflammatory Response. Biomedicines 2020;8:E384. [PMID: 32998266 DOI: 10.3390/biomedicines8100384] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
390 Zhao D, Cai C, Chen Q, Jin S, Yang B, Li N. High-Fat Diet Promotes DSS-Induced Ulcerative Colitis by Downregulated FXR Expression through the TGFB Pathway. Biomed Res Int 2020;2020:3516128. [PMID: 33029504 DOI: 10.1155/2020/3516128] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
391 Stavropoulou E, Bezirtzoglou E. Probiotics in Medicine: A Long Debate. Front Immunol 2020;11:2192. [PMID: 33072084 DOI: 10.3389/fimmu.2020.02192] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 21.0] [Reference Citation Analysis]
392 Pan LL, Ren Z, Liu Y, Zhao Y, Li H, Pan X, Fang X, Liang W, Wang Y, Yang J, Sun J. A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4-dependent NLRP3 inflammasome activation. J Cell Mol Med 2020;24:12955-69. [PMID: 32945118 DOI: 10.1111/jcmm.15890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
393 Ananthakrishnan AN. Microbiome-Based Biomarkers for IBD. Inflamm Bowel Dis 2020;26:1463-9. [PMID: 32311010 DOI: 10.1093/ibd/izaa071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
394 Jagannath B, Lin KC, Pali M, Sankhala D, Muthukumar S, Prasad S. A Sweat-based Wearable Enabling Technology for Real-time Monitoring of IL-1β and CRP as Potential Markers for Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1533-42. [PMID: 32720974 DOI: 10.1093/ibd/izaa191] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 11.7] [Reference Citation Analysis]
395 Dragoni G, Innocenti T, Galli A. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches? Dig Dis 2021;39:190-203. [PMID: 32942275 DOI: 10.1159/000511641] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
396 Kim YS, Zhang H, Lee S, Park S, Noh M, Kim YM, Kwon YG. CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction. Front Pharmacol 2020;11:571266. [PMID: 33041812 DOI: 10.3389/fphar.2020.571266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
397 van der Lugt T, Opperhuizen A, Bast A, Vrolijk MF. Dietary Advanced Glycation Endproducts and the Gastrointestinal Tract. Nutrients 2020;12:E2814. [PMID: 32937858 DOI: 10.3390/nu12092814] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
398 Raftery AL, Tsantikos E, Harris NL, Hibbs ML. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease. Front Immunol 2020;11:2144. [PMID: 33042125 DOI: 10.3389/fimmu.2020.02144] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
399 Shodeinde AB, Murphy AC, Oldenkamp HF, Potdar AS, Ludolph CM, Peppas NA. Recent Advances in Smart Biomaterials for the Detection and Treatment of Autoimmune Diseases. Adv Funct Mater 2020;30:1909556. [PMID: 33071713 DOI: 10.1002/adfm.201909556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
400 Lin YH, Lin CL, Kao CH. Adults with inflammatory bowel disease are at a greater risk of developing chronic rhinosinusitis: A nationwide population-based study. Clin Otolaryngol 2021;46:196-205. [PMID: 32886858 DOI: 10.1111/coa.13647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
401 Vardi I, Chermesh I, Werner L, Barel O, Freund T, McCourt C, Fisher Y, Pinsker M, Javasky E, Weiss B, Rechavi G, Hagin D, Snapper SB, Somech R, Konnikova L, Shouval DS. Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a Diagnosis. Front Immunol 2020;11:1775. [PMID: 33013830 DOI: 10.3389/fimmu.2020.01775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
402 Arif M, Chi Z, Liu YJ, Liu CG. Preparation, characterization, and in vitro drug release behavior of thiolated alginate nanoparticles loaded budesonide as a potential drug delivery system toward inflammatory bowel diseases. J Biomater Sci Polym Ed 2020;31:2299-317. [PMID: 32727293 DOI: 10.1080/09205063.2020.1803034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
403 Thakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflamm Bowel Dis 2020;26:1423-8. [PMID: 31728520 DOI: 10.1093/ibd/izz280] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
404 Ghafouri-fard S, Eghtedarian R, Taheri M. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease. Biomedicine & Pharmacotherapy 2020;129:110507. [DOI: 10.1016/j.biopha.2020.110507] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
405 Dhillon P, Singh K. Therapeutic applications of probiotics in ulcerative colitis: An updated review. PharmaNutrition 2020;13:100194. [DOI: 10.1016/j.phanu.2020.100194] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
406 El‐mayta R, Zhang R, Shepherd SJ, Wang F, Billingsley MM, Dudkin V, Klein D, Lu HD, Mitchell MJ. A Nanoparticle Platform for Accelerated In Vivo Oral Delivery Screening of Nucleic Acids. Adv Therap 2021;4:2000111. [DOI: 10.1002/adtp.202000111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
407 Liu M, Xie W, Wan X, Deng T. Clostridium butyricum protects intestinal barrier function via upregulation of tight junction proteins and activation of the Akt/mTOR signaling pathway in a mouse model of dextran sodium sulfate-induced colitis. Exp Ther Med 2020;20:10. [PMID: 32934675 DOI: 10.3892/etm.2020.9138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
408 Jalanka J, Cheng J, Hiippala K, Ritari J, Salojärvi J, Ruuska T, Kalliomäki M, Satokari R. Colonic Mucosal Microbiota and Association of Bacterial Taxa with the Expression of Host Antimicrobial Peptides in Pediatric Ulcerative Colitis. Int J Mol Sci 2020;21:E6044. [PMID: 32842596 DOI: 10.3390/ijms21176044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
409 Boland BS, He Z, Tsai MS, Olvera JG, Omilusik KD, Duong HG, Kim ES, Limary AE, Jin W, Milner JJ, Yu B, Patel SA, Louis TL, Tysl T, Kurd NS, Bortnick A, Quezada LK, Kanbar JN, Miralles A, Huylebroeck D, Valasek MA, Dulai PS, Singh S, Lu LF, Bui JD, Murre C, Sandborn WJ, Goldrath AW, Yeo GW, Chang JT. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci Immunol 2020;5:eabb4432. [PMID: 32826341 DOI: 10.1126/sciimmunol.abb4432] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 16.7] [Reference Citation Analysis]
410 Hering L, Katkeviciute E, Schwarzfischer M, Busenhart P, Gottier C, Mrdjen D, Komuczki J, Wawrzyniak M, Lang S, Atrott K, Becher B, Rogler G, Scharl M, Spalinger MR. Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance. Front Immunol 2020;11:1856. [PMID: 32973765 DOI: 10.3389/fimmu.2020.01856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
411 Muehlbauer AL, Richards AL, Alazizi A, Burns M, Gomez A, Clayton JB, Petrzelkova K, Cascardo C, Resztak J, Wen X, Pique-regi R, Luca F, Blekhman R. Interspecies variation in hominid gut microbiota controls host gene regulation.. [DOI: 10.1101/2020.08.17.255059] [Reference Citation Analysis]
412 Morita T, Mitsuyama K, Yamasaki H, Mori A, Yoshimura T, Araki T, Morita M, Tsuruta K, Yamasaki S, Kuwaki K, Yoshioka S, Takedatsu H, Torimura T. Gene Expression of Transient Receptor Potential Channels in Peripheral Blood Mononuclear Cells of Inflammatory Bowel Disease Patients. J Clin Med 2020;9:E2643. [PMID: 32823895 DOI: 10.3390/jcm9082643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
413 Zhu L, Li Y, Zhou L, Yang G, Wang Y, Han J, Li L, Zhang S. Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease. Mediators Inflamm 2020;2020:5310180. [PMID: 32848509 DOI: 10.1155/2020/5310180] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
414 Sato N, Yuzawa M, Aminul MI, Tomokiyo M, Albarracin L, Garcia-Castillo V, Ideka-Ohtsubo W, Iwabuchi N, Xiao JZ, Garcia-Cancino A, Villena J, Kitazawa H. Evaluation of Porcine Intestinal Epitheliocytes as an In vitro Immunoassay System for the Selection of Probiotic Bifidobacteria to Alleviate Inflammatory Bowel Disease. Probiotics Antimicrob Proteins 2021;13:824-36. [PMID: 32779098 DOI: 10.1007/s12602-020-09694-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
415 Lin EY, Lai HJ, Cheng YK, Leong KQ, Cheng LC, Chou YC, Peng YC, Hsu YH, Chiang HS. Neutrophil Extracellular Traps Impair Intestinal Barrier Function during Experimental Colitis. Biomedicines 2020;8:E275. [PMID: 32764411 DOI: 10.3390/biomedicines8080275] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
416 Banfield E, Fulton W, Burd I, Kovler ML, Sodhi CP, Hackam DJ. The role of in utero endotoxin exposure in the development of inflammatory bowel disease in mice. Am J Reprod Immunol 2020;84:e13302. [PMID: 32662549 DOI: 10.1111/aji.13302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
417 Sebastian-delaCruz M, Olazagoitia-Garmendia A, Gonzalez-Moro I, Santin I, Garcia-Etxebarria K, Castellanos-Rubio A. Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease. Epigenomes 2020;4:16. [PMID: 34968289 DOI: 10.3390/epigenomes4030016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
418 Leccese G, Bibi A, Mazza S, Facciotti F, Caprioli F, Landini P, Paroni M. Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive Escherichia coli (AIEC) Virulence and Hamper IL-23/Th17 Axis in Ulcerative Colitis, but Not in Crohn's Disease. Cells 2020;9:E1824. [PMID: 32752244 DOI: 10.3390/cells9081824] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
419 Nadeem MS, Kumar V, Al-abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020;64:51-60. [DOI: 10.1016/j.semcancer.2019.05.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 24.0] [Reference Citation Analysis]
420 Oh C, Jeong J, Oh SK, Baek SH, Kim KI. Inhibition of LSD1 phosphorylation alleviates colitis symptoms induced by dextran sulfate sodiumInhibition of LSD1 phosphorylation alleviates colitis symptoms induced by dextran sulfate sodium. BMB Rep 2020;53:385-90. [DOI: 10.5483/bmbrep.2020.53.7.298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
421 Liu XH, Wu XR, Lan N, Zheng XB, Zhou C, Hu T, Chen YF, Cai ZR, Chen ZX, Lan P, Wu XJ. CD73 promotes colitis-associated tumorigenesis in mice. Oncol Lett 2020;20:1221-30. [PMID: 32724362 DOI: 10.3892/ol.2020.11670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
422 Baart VM, Houvast RD, de Geus-Oei LF, Quax PHA, Kuppen PJK, Vahrmeijer AL, Sier CFM. Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer. EJNMMI Res 2020;10:87. [PMID: 32725278 DOI: 10.1186/s13550-020-00673-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
423 Wu N, Chen D, Sun H, Tan J, Zhang Y, Zhang T, Han Y, Liu H, Ouyang X, Yang XD, Niu X, Zhong J, Wang Z, Su B. MAP3K2 augments Th1 cell differentiation via IL-18 to promote T cell-mediated colitis. Sci China Life Sci 2021;64:389-403. [PMID: 32737854 DOI: 10.1007/s11427-020-1720-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
424 Scott SA, Fu J, Chang PV. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc Natl Acad Sci USA. 2020;117:19376-19387. [PMID: 32719140 DOI: 10.1073/pnas.2000047117] [Cited by in Crossref: 138] [Cited by in F6Publishing: 145] [Article Influence: 46.0] [Reference Citation Analysis]
425 Loos BG, Van Dyke TE. The role of inflammation and genetics in periodontal disease. Periodontol 2000 2020;83:26-39. [PMID: 32385877 DOI: 10.1111/prd.12297] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 37.7] [Reference Citation Analysis]
426 Guz M, Dworzański T, Jeleniewicz W, Cybulski M, Kozicka J, Stepulak A, Celiński K. Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients. Biomed Res Int 2020;2020:4250329. [PMID: 32775420 DOI: 10.1155/2020/4250329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
427 Harbour SN, DiToro DF, Witte SJ, Zindl CL, Gao M, Schoeb TR, Jones GW, Jones SA, Hatton RD, Weaver CT. TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci Immunol. 2020;5. [PMID: 32680955 DOI: 10.1126/sciimmunol.aaw2262] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
428 Higashimura Y, Takagi T, Naito Y, Uchiyama K, Mizushima K, Tanaka M, Hamaguchi M, Itoh Y. Zinc Deficiency Activates the IL-23/Th17 Axis to Aggravate Experimental Colitis in Mice. J Crohns Colitis 2020;14:856-66. [PMID: 31783404 DOI: 10.1093/ecco-jcc/jjz193] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
429 Zhang D, Wang Y, Shen S, Hou Y, Chen Y, Wang T. The mycobiota of the human body: a spark can start a prairie fire. Gut Microbes 2020;11:655-79. [PMID: 32150513 DOI: 10.1080/19490976.2020.1731287] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
430 Shin MY, Yong CC, Oh S. Regulatory Effect of Lactobacillus brevis Bmb6 on Gut Barrier Functions in Experimental Colitis. Foods 2020;9:E864. [PMID: 32630643 DOI: 10.3390/foods9070864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
431 Domazetovic V, Iantomasi T, Bonanomi AG, Stio M. Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling. Int J Colorectal Dis 2020;35:1231-42. [PMID: 32314188 DOI: 10.1007/s00384-020-03576-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
432 Can G, Tezel HA. Inflammatory bowel diseases and genetic. Anadolu Güncel Tıp Dergisi 2020. [DOI: 10.38053/acmj.689278] [Reference Citation Analysis]
433 Chulkina MM, Pichugin AV, Ataullakhanov RI. Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G+ granulocytes and Ly6C+ monocytes. Peptides 2020;132:170364. [PMID: 32621844 DOI: 10.1016/j.peptides.2020.170364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
434 Can G, Tezel HA. İnflamatuvar barsak hastalıkları ve genetik. Anadolu Güncel Tıp Dergisi 2020. [DOI: 10.38053/agtd.689278] [Reference Citation Analysis]
435 Wang Z, Wang Z, Lu YY, Sun F, Zhu S. SolidBin: improving metagenome binning with semi-supervised normalized cut. Bioinformatics 2019;35:4229-38. [PMID: 30977806 DOI: 10.1093/bioinformatics/btz253] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
436 Boros É, Prontvai B, Kellermayer Z, Balogh P, Sarlós P, Vincze Á, Varga C, Maróti Z, Bálint B, Nagy I. Transcriptome Based Profiling of the Immune Cell Gene Signature in Rat Experimental Colitis and Human IBD Tissue Samples. Biomolecules 2020;10:E974. [PMID: 32610492 DOI: 10.3390/biom10070974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
437 Basak S, Duttaroy AK. Conjugated Linoleic Acid and Its Beneficial Effects in Obesity, Cardiovascular Disease, and Cancer. Nutrients 2020;12:E1913. [PMID: 32605287 DOI: 10.3390/nu12071913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
438 Venkataraman GR, Rivas MA. Rare and common variant discovery in complex disease: the IBD case study. Hum Mol Genet 2019;28:R162-9. [PMID: 31363759 DOI: 10.1093/hmg/ddz189] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
439 Al Nabhani Z, Berrebi D, Martinez-Vinson C, Montcuquet N, Madre C, Roy M, Ogier-Denis E, Dussaillant M, Cerf-Bensussan N, Zouali H, Daniel F, Barreau F, Hugot JP. Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine. J Crohns Colitis 2020;14:669-79. [PMID: 31784737 DOI: 10.1093/ecco-jcc/jjz196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
440 Ronchetti S, Gentili M, Ricci E, Migliorati G, Riccardi C. Glucocorticoid-Induced Leucine Zipper as a Druggable Target in Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:1017-25. [PMID: 31961437 DOI: 10.1093/ibd/izz331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
441 Zhang Y, Zhang Y, Sun K, Meng Z, Chen L. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development. J Mol Cell Biol. 2019;11:1-13. [PMID: 30239845 DOI: 10.1093/jmcb/mjy052] [Cited by in Crossref: 97] [Cited by in F6Publishing: 102] [Article Influence: 32.3] [Reference Citation Analysis]
442 Wu ZY, Sang LX, Chang B. Isoflavones and inflammatory bowel disease. World J Clin Cases 2020; 8(11): 2081-2091 [PMID: 32548137 DOI: 10.12998/wjcc.v8.i11.2081] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
443 d'Aldebert E, Quaranta M, Sébert M, Bonnet D, Kirzin S, Portier G, Duffas JP, Chabot S, Lluel P, Allart S, Ferrand A, Alric L, Racaud-Sultan C, Mas E, Deraison C, Vergnolle N. Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients. Front Cell Dev Biol 2020;8:363. [PMID: 32582690 DOI: 10.3389/fcell.2020.00363] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
444 Editorial A. CROHN'S DISEASE. CLINICAL RECOMMENDATIONS (PRELIMINARY VERSION). Koloproktologiâ 2020;19:8-38. [DOI: 10.33878/2073-7556-2020-19-2-8-38] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
445 Chen M, Yuan C, Xu T. An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol 2020;44:302-9. [PMID: 31447293 DOI: 10.1016/j.clinre.2019.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
446 Coelho T, Mossotto E, Gao Y, Haggarty R, Ashton JJ, Batra A, Stafford IS, Beattie RM, Williams AP, Ennis S. Immunological Profiling of Paediatric Inflammatory Bowel Disease Using Unsupervised Machine Learning. J Pediatr Gastroenterol Nutr 2020;70:833-40. [PMID: 32443043 DOI: 10.1097/MPG.0000000000002719] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
447 Sheng YH, Giri R, Davies J, Schreiber V, Alabbas S, Movva R, He Y, Wu A, Hooper J, McWhinney B, Oancea I, Kijanka G, Hasnain S, Lucke AJ, Fairlie DP, McGuckin MA, Florin TH, Begun J. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy. Cell Mol Gastroenterol Hepatol 2021;11:33-53. [PMID: 32497793 DOI: 10.1016/j.jcmgh.2020.05.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
448 Niccolai E, Boem F, Emmi G, Amedei A. The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit. Immunology Letters 2020;222:12-28. [DOI: 10.1016/j.imlet.2020.03.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
449 Mavropoulou E, Mechie NC, Knoop R, Petzold G, Ellenrieder V, Kunsch S, Pilavakis Y, Amanzada A. Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study. PLoS One. 2020;15:e0233811. [PMID: 32470973 DOI: 10.1371/journal.pone.0233811] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
450 Knudsen LA, Desdorf R, Möller S, Sørensen SB, Hansen AK, Andersen V. Translational Potential of Metabolomics on Animal Models of Inflammatory Bowel Disease-A Systematic Critical Review. Int J Mol Sci 2020;21:E3856. [PMID: 32485793 DOI: 10.3390/ijms21113856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
451 Gao X, Fan W, Tan L, Shi Y, Ding C, Liu S, Miao Y, Luo Y, Shi X, DeSaeger S, Song S. Soy isoflavones ameliorate experimental colitis by targeting ERα/NLRP3 inflammasome pathways. J Nutr Biochem 2020;83:108438. [PMID: 32563803 DOI: 10.1016/j.jnutbio.2020.108438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
452 Ishioka S, Hosokawa T, Ikeda T, Konuma N, Kaneda H, Ohashi K, Furuya T, Masuko T, Taniguchi H, Kano K, Koshinaga T, Matsumoto T. Therapeutic potential of mature adipocyte-derived dedifferentiated fat cells for inflammatory bowel disease. Pediatr Surg Int 2020;36:799-807. [PMID: 32448932 DOI: 10.1007/s00383-020-04681-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
453 Annese V. Genetics and epigenetics of IBD. Pharmacol Res 2020;159:104892. [PMID: 32464322 DOI: 10.1016/j.phrs.2020.104892] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
454 Pierre JF, La Torre D, Sidebottom A, Kambal A, Zhu X, Tao Y, Cham CM, Wang L, Harris KG, Zaborina O, Alverdy J, Herzog H, Witchley J, Noble SM, Leone V, Chang EB. Peptide YY: a novel Paneth cell antimicrobial peptide that maintains fungal commensalism.. [DOI: 10.1101/2020.05.15.096875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
455 Townsend CM, Nguyen TM, Cepek J, Abbass M, Parker CE, MacDonald JK, Khanna R, Jairath V, Feagan BG. Adalimumab for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2020;5:CD012877. [PMID: 32413933 DOI: 10.1002/14651858.CD012877.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
456 Zhang T, Mei Y, Dong W, Wang J, Huang F, Wu J. Evaluation of protein arginine deiminase-4 inhibitor in TNBS- induced colitis in mice. Int Immunopharmacol 2020;84:106583. [PMID: 32416455 DOI: 10.1016/j.intimp.2020.106583] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
457 Kim TO, Park DI, Han YK, Kang K, Park SG, Park HR, Yi JM. Genome-Wide Analysis of the DNA Methylation Profile Identifies the Fragile Histidine Triad (FHIT) Gene as a New Promising Biomarker of Crohn's Disease. J Clin Med 2020;9:E1338. [PMID: 32375395 DOI: 10.3390/jcm9051338] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
458 Shohan M, Dehghani R, Khodadadi A, Dehnavi S, Ahmadi R, Joudaki N, Houshmandfar S, Shamshiri M, Shojapourian S, Bagheri N. Interleukin-22 and intestinal homeostasis: Protective or destructive? IUBMB Life 2020;72:1585-602. [PMID: 32365282 DOI: 10.1002/iub.2295] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
459 Robinson BS, Saeedi B, Arthur CM, Owens J, Naudin C, Ahmed N, Luo L, Jones R, Neish A, Stowell SR. Galectin-9 Is a Novel Regulator of Epithelial Restitution. Am J Pathol 2020;190:1657-66. [PMID: 32380082 DOI: 10.1016/j.ajpath.2020.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
460 Hsu CY, Fu SH, Chien MW, Liu YW, Chen SJ, Sytwu HK. Post-Translational Modifications of Transcription Factors Harnessing the Etiology and Pathophysiology in Colonic Diseases. Int J Mol Sci 2020;21:E3207. [PMID: 32369982 DOI: 10.3390/ijms21093207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
461 Cui X, Bao L, Wang X, Chen C. The Nano–Intestine Interaction: Understanding the Location‐Oriented Effects of Engineered Nanomaterials in the Intestine. Small 2020;16:1907665. [DOI: 10.1002/smll.201907665] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
462 Lee BC, Lee JY, Kim J, Yoo JM, Kang I, Kim JJ, Shin N, Kim DJ, Choi SW, Kim D, Hong BH, Kang KS. Graphene quantum dots as anti-inflammatory therapy for colitis. Sci Adv 2020;6:eaaz2630. [PMID: 32494673 DOI: 10.1126/sciadv.aaz2630] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 17.3] [Reference Citation Analysis]
463 Yeshi K, Ruscher R, Hunter L, Daly NL, Loukas A, Wangchuk P. Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products. J Clin Med 2020;9:E1273. [PMID: 32354192 DOI: 10.3390/jcm9051273] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 15.3] [Reference Citation Analysis]
464 Mead BE, Hattori K, Levy L, Vukovic M, Sze D, Matute JD, Duan J, Langer R, Blumberg RS, Ordovas-montanes J, Shalek AK, Karp JM. High-throughput organoid screening enables engineering of intestinal epithelial composition.. [DOI: 10.1101/2020.04.27.063727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
465 Mizoguchi E, Low D, Ezaki Y, Okada T. Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models. Intest Res. 2020;18:151-167. [PMID: 32326669 DOI: 10.5217/ir.2019.09154] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 17.7] [Reference Citation Analysis]
466 Chen L, Shao J, Luo Y, Zhao L, Zhao K, Gao Y, Wang S, Liu Y. An integrated metabolism in vivo analysis and network pharmacology in UC rats reveal anti-ulcerative colitis effects from Sophora flavescens EtOAc extract. J Pharm Biomed Anal 2020;186:113306. [PMID: 32371325 DOI: 10.1016/j.jpba.2020.113306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
467 Sünderhauf A, Pagel R, Künstner A, Wagner AE, Rupp J, Ibrahim SM, Derer S, Sina C. Saccharin Supplementation Inhibits Bacterial Growth and Reduces Experimental Colitis in Mice. Nutrients 2020;12:E1122. [PMID: 32316544 DOI: 10.3390/nu12041122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
468 Bessman NJ, Mathieu JRR, Renassia C, Zhou L, Fung TC, Fernandez KC, Austin C, Moeller JB, Zumerle S, Louis S, Vaulont S, Ajami NJ, Sokol H, Putzel GG, Arvedson T, Sockolow RE, Lakhal-Littleton S, Cloonan SM, Arora M, Peyssonnaux C, Sonnenberg GF. Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing. Science 2020;368:186-9. [PMID: 32273468 DOI: 10.1126/science.aau6481] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 17.3] [Reference Citation Analysis]
469 Agliata I, Fernandez-Jimenez N, Goldsmith C, Marie JC, Bilbao JR, Dante R, Hernandez-Vargas H. The DNA methylome of inflammatory bowel disease (IBD) reflects intrinsic and extrinsic factors in intestinal mucosal cells. Epigenetics 2020;15:1068-82. [PMID: 32281463 DOI: 10.1080/15592294.2020.1748916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
470 Matijašić M, Meštrović T, Paljetak HČ, Perić M, Barešić A, Verbanac D. Gut Microbiota beyond Bacteria-Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD. Int J Mol Sci 2020;21:E2668. [PMID: 32290414 DOI: 10.3390/ijms21082668] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 19.7] [Reference Citation Analysis]
471 Gorczynski RM, Hoffmann G. Combined IMIG and immune Ig attenuates inflammatory colitis in mice. Int Immunopharmacol 2020;83:106464. [PMID: 32278130 DOI: 10.1016/j.intimp.2020.106464] [Reference Citation Analysis]
472 Kayama H, Tani H, Kitada S, Opasawatchai A, Okumura R, Motooka D, Nakamura S, Takeda K. BATF2 prevents T-cell-mediated intestinal inflammation through regulation of the IL-23/IL-17 pathway. Int Immunol 2019;31:371-83. [PMID: 30753547 DOI: 10.1093/intimm/dxz014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
473 Li B, Lu Q, Zhao H. An evaluation of noncoding genome annotation tools through enrichment analysis of 15 genome-wide association studies. Brief Bioinform 2019;20:995-1003. [PMID: 29106447 DOI: 10.1093/bib/bbx131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
474 Sheng Y, Wu T, Dai Y, Ji K, Zhong Y, Xue Y. The effect of 6-gingerol on inflammatory response and Th17/Treg balance in DSS-induced ulcerative colitis mice. Ann Transl Med 2020;8:442. [PMID: 32395486 DOI: 10.21037/atm.2020.03.141] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
475 Mari A, Khoury T, Ahamad HS, Bragazzi NL, Sbeit W, Mahamid A, Mahamid L, Nesseir W, Baker FA, Pellicano R, Amital H, Watad A, Mahamid M. Autoimmune diseases in first- and second-degree relatives of patients with inflammatory bowel diseases: a case-control survey in Israel. Minerva Med 2020;111. [DOI: 10.23736/s0026-4806.19.06389-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
476 Barra M, Danino T, Garrido D. Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases. Front Bioeng Biotechnol 2020;8:265. [PMID: 32296696 DOI: 10.3389/fbioe.2020.00265] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
477 Mentella MC, Scaldaferri F, Pizzoferrato M, Gasbarrini A, Miggiano GAD. Nutrition, IBD and Gut Microbiota: A Review. Nutrients 2020;12:E944. [PMID: 32235316 DOI: 10.3390/nu12040944] [Cited by in Crossref: 89] [Cited by in F6Publishing: 96] [Article Influence: 29.7] [Reference Citation Analysis]
478 Tian C, Huang Y, Wu X, Xu C, Bu H, Wang H. The Efficacy and Safety of Mesalamine and Probiotics in Mild-to-Moderate Ulcerative Colitis: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2020;2020:6923609. [PMID: 32308714 DOI: 10.1155/2020/6923609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
479 Trapecar M, Communal C, Velazquez J, Maass CA, Huang YJ, Schneider K, Wright CW, Butty V, Eng G, Yilmaz O, Trumper D, Griffith LG. Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty Acids. Cell Syst 2020;10:223-239.e9. [PMID: 32191873 DOI: 10.1016/j.cels.2020.02.008] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 22.7] [Reference Citation Analysis]
480 Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
481 Pelaseyed T, Hansson GC. Membrane mucins of the intestine at a glance. J Cell Sci 2020;133:jcs240929. [PMID: 32169835 DOI: 10.1242/jcs.240929] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 13.0] [Reference Citation Analysis]
482 Lichtenstern CR, Ngu RK, Shalapour S, Karin M. Immunotherapy, Inflammation and Colorectal Cancer. Cells 2020;9:E618. [PMID: 32143413 DOI: 10.3390/cells9030618] [Cited by in Crossref: 88] [Cited by in F6Publishing: 98] [Article Influence: 29.3] [Reference Citation Analysis]
483 Zeng L, Tan J, Xue M, Liu L, Wang M, Liang L, Deng J, Chen W, Chen Y. An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via Inhibiting NF-kB pathway. J Transl Med 2020;18:107. [PMID: 32122364 DOI: 10.1186/s12967-020-02272-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
484 Vennou KE, Piovani D, Kontou PI, Bonovas S, Bagos PG. Multiple outcome meta-analysis of gene-expression data in inflammatory bowel disease. Genomics 2020;112:1761-7. [DOI: 10.1016/j.ygeno.2019.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
485 van der Giessen J, Binyamin D, Belogolovski A, Frishman S, Tenenbaum-Gavish K, Hadar E, Louzoun Y, Peppelenbosch MP, van der Woude CJ, Koren O, Fuhler GM. Modulation of cytokine patterns and microbiome during pregnancy in IBD. Gut 2020;69:473-86. [PMID: 31167813 DOI: 10.1136/gutjnl-2019-318263] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 13.3] [Reference Citation Analysis]
486 Fan HN, Zhu P, Lu YM, Guo JH, Zhang J, Qu GQ, Zhu JS. Mild changes in the mucosal microbiome during terminal ileum inflammation. Microb Pathog 2020;142:104104. [PMID: 32120004 DOI: 10.1016/j.micpath.2020.104104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
487 Li XX, Xiao L, Chung HK, Ma XX, Liu X, Song JL, Jin CZ, Rao JN, Gorospe M, Wang JY. Interaction between HuR and circPABPN1 Modulates Autophagy in the Intestinal Epithelium by Altering ATG16L1 Translation. Mol Cell Biol 2020;40:e00492-19. [PMID: 31932481 DOI: 10.1128/MCB.00492-19] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 13.0] [Reference Citation Analysis]
488 Zhao M, Bendtsen F, Petersen AM, Larsen L, Dige A, Hvas C, Seidelin JB, Burisch J. Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study. BMJ Open 2020;10:e035756. [PMID: 32102828 DOI: 10.1136/bmjopen-2019-035756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
489 Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM, Posovszky C, Rodrigues A, Russell RK, Barakat F, Auth MKH, Heuschkel R, Zilbauer M, Fyderek K, Braegger C, Travis SP, Satsangi J, Parkes M, Thapar N, Ferry H, Matte JC, Gilmour KC, Wedrychowicz A, Sullivan P, Moore C, Sambrook J, Ouwehand W, Roberts D, Danesh J, Baeumler TA, Fulga TA, Karaminejadranjbar M, Ahmed A, Wilson R, Barrett JC, Elkadri A, Griffiths AM, Snapper SB, Shah N, Muise AM, Wilson DC, Uhlig HH, Anderson CA; COLORS in IBD group investigators., Oxford IBD cohort study investigators., INTERVAL Study., Swiss IBD cohort investigators., UK IBD Genetics Consortium., NIDDK IBD Genetics Consortium. Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease. Nat Commun 2020;11:995. [PMID: 32081864 DOI: 10.1038/s41467-019-14275-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
490 Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep 2020;47:3053-63. [PMID: 32086718 DOI: 10.1007/s11033-020-05318-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
491 Bhatti S, Jaafar I, Hassan H, Atassi H, Stocker A, Hughes M, Pinkston C, Dryden G, Abell T. Effects of Gastric Neuromodulation on Crohn's Disease in Patients With Coexisting Symptoms of Gastroparesis. Neuromodulation: Technology at the Neural Interface 2020;23:1196-200. [DOI: 10.1111/ner.13118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
492 Shinde T, Perera AP, Vemuri R, Gondalia SV, Beale DJ, Karpe AV, Shastri S, Basheer W, Southam B, Eri R, Stanley R. Synbiotic supplementation with prebiotic green banana resistant starch and probiotic Bacillus coagulans spores ameliorates gut inflammation in mouse model of inflammatory bowel diseases. Eur J Nutr 2020;59:3669-89. [PMID: 32067099 DOI: 10.1007/s00394-020-02200-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
493 Liu F, Zhang X, Ji Y. Total Flavonoid Extract from Hawthorn (Crataegus pinnatifida) Improves Inflammatory Cytokines-Evoked Epithelial Barrier Deficit. Med Sci Monit 2020;26:e920170. [PMID: 32065826 DOI: 10.12659/MSM.920170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
494 Argollo MC, Allocca M, Furfaro F, Peyrin-Biroulet L, Danese S. Interleukin-23 Blockers: Born to be First-line Biologic Agents in Inflammatory Bowel Disease? Curr Pharm Des 2019;25:25-31. [PMID: 31092171 DOI: 10.2174/1381612825666190313140811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
495 Murphy B, Kavanagh DO, Winter DC. Modern surgery for ulcerative colitis. Updates Surg 2020;72:325-33. [DOI: 10.1007/s13304-020-00719-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
496 deZoeten EF, Battista KD, Colson SB, Lovell MA, Kessler BE, Isfort RW, Fennimore BP, Onyiah JC, Kao DJ, Yeckes A, Keely S, Murray M, Hoffenberg EJ, Colgan SP, Gerich ME. Markers of Hypoxia Correlate with Histologic and Endoscopic Severity of Colitis in Inflammatory Bowel Disease. Hypoxia (Auckl) 2020;8:1-12. [PMID: 32104717 DOI: 10.2147/HP.S219049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
497 Li N, Shi RH. lncRNACNN3-206 activates intestinal epithelial cell apoptosis and invasion by sponging miR-212, an implication for Crohn's disease. World J Gastroenterol 2020; 26(5): 478-498 [PMID: 32089625 DOI: 10.3748/wjg.v26.i5.478] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
498 Saravanarajan K, Douglas AR, Ismail MS, Omorogbe J, Semenov S, Muphy G, O'Riordan F, McNamara D, Nakagome S. Genomic profiling of intestinal T-cell receptor repertoires in inflammatory bowel disease. Genes Immun 2020;21:109-18. [PMID: 32029881 DOI: 10.1038/s41435-020-0092-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
499 Fitzgibbon G, Mills KHG. The microbiota and immune-mediated diseases: Opportunities for therapeutic intervention. Eur J Immunol 2020;50:326-37. [PMID: 31991477 DOI: 10.1002/eji.201948322] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
500 Werner L, Lee YN, Rechavi E, Lev A, Yerushalmi B, Ling G, Shah N, Uhlig HH, Weiss B, Somech R, Snapper SB, Shouval DS. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD. Front Immunol 2020;11:109. [PMID: 32117262 DOI: 10.3389/fimmu.2020.00109] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
501 Ansari I, Raddatz G, Gutekunst J, Ridnik M, Cohen D, Abu-Remaileh M, Tuganbaev T, Shapiro H, Pikarsky E, Elinav E, Lyko F, Bergman Y. The microbiota programs DNA methylation to control intestinal homeostasis and inflammation. Nat Microbiol 2020;5:610-9. [PMID: 32015497 DOI: 10.1038/s41564-019-0659-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
502 Sokol H, Landman C, Seksik P, Berard L, Montil M, Nion-Larmurier I, Bourrier A, Le Gall G, Lalande V, De Rougemont A, Kirchgesner J, Daguenel A, Cachanado M, Rousseau A, Drouet É, Rosenzwajg M, Hagege H, Dray X, Klatzman D, Marteau P, Beaugerie L, Simon T; Saint-Antoine IBD Network. Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study. Microbiome 2020;8:12. [PMID: 32014035 DOI: 10.1186/s40168-020-0792-5] [Cited by in Crossref: 110] [Cited by in F6Publishing: 121] [Article Influence: 36.7] [Reference Citation Analysis]
503 Javkar T, Hughes KR, Sablitzky F, Behnke JM, Mahida YR. Slow cycling intestinal stem cell and Paneth cell responses to Trichinella spiralis infection. Parasitology International 2020;74:101923. [DOI: 10.1016/j.parint.2019.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
504 Zhang G, Liu M, Song M, Wang J, Cai J, Lin C, Li Y, Jin X, Shen C, Chen Z, Cai D, Gao Y, Zhu C, Lin C, Liu C. Patchouli alcohol activates PXR and suppresses the NF-κB-mediated intestinal inflammatory. Journal of Ethnopharmacology 2020;248:112302. [DOI: 10.1016/j.jep.2019.112302] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
505 Okabayashi S, Kobayashi T, Hibi T. Inflammatory Bowel Disease in Japan-Is It Similar to or Different from Westerns? J Anus Rectum Colon 2020;4:1-13. [PMID: 32002471 DOI: 10.23922/jarc.2019-003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
506 Maerz JK, Trostel C, Lange A, Parusel R, Michaelis L, Schäfer A, Yao H, Löw HC, Frick JS. Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses. Front Immunol 2019;10:3093. [PMID: 32038631 DOI: 10.3389/fimmu.2019.03093] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
507 Kumar M, Leon Coria A, Cornick S, Petri B, Mayengbam S, Jijon HB, Moreau F, Shearer J, Chadee K. Increased intestinal permeability exacerbates sepsis through reduced hepatic SCD-1 activity and dysregulated iron recycling. Nat Commun 2020;11:483. [PMID: 31980623 DOI: 10.1038/s41467-019-14182-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
508 Huang M, Wang Q, Long F, Di Y, Wang J, Zhun Zhu Y, Liu X. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice. FASEB J. 2020;34:4107-4119. [PMID: 31971317 DOI: 10.1096/fj.201902200rr] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
509 Fu Y, Ni J, Chen J, Ma G, Zhao M, Zhu S, Shi T, Zhu J, Huang Z, Zhang J, Chen J. Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease. Mol Ther 2020;28:1214-28. [PMID: 32087149 DOI: 10.1016/j.ymthe.2020.01.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
510 Kasendra M, Luc R, Yin J, Manatakis DV, Kulkarni G, Lucchesi C, Sliz J, Apostolou A, Sunuwar L, Obrigewitch J, Jang KJ, Hamilton GA, Donowitz M, Karalis K. Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model. Elife 2020;9:e50135. [PMID: 31933478 DOI: 10.7554/eLife.50135] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 30.7] [Reference Citation Analysis]
511 Tanaka A, Kanmura S, Morinaga Y, Kawabata K, Arima S, Sasaki F, Nasu Y, Tanoue S, Hashimoto S, Takeshita M, Takeda S, Ido A. Oral administration of Lactobacillus plantarum 06CC2 prevents experimental colitis in mice via an anti‑inflammatory response. Mol Med Rep 2020;21:1181-91. [PMID: 31922249 DOI: 10.3892/mmr.2020.10925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
512 Mei Y, Wang Z, Zhang Y, Wan T, Xue J, He W, Luo Y, Xu Y, Bai X, Wang Q, Huang Y. FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway. Front Immunol 2019;10:2969. [PMID: 31969881 DOI: 10.3389/fimmu.2019.02969] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
513 Alam MT, Amos GCA, Murphy ARJ, Murch S, Wellington EMH, Arasaradnam RP. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut Pathog 2020;12:1. [PMID: 31911822 DOI: 10.1186/s13099-019-0341-6] [Cited by in Crossref: 124] [Cited by in F6Publishing: 128] [Article Influence: 41.3] [Reference Citation Analysis]
514 Stolzer I, Kaden-Volynets V, Ruder B, Letizia M, Bittel M, Rausch P, Basic M, Bleich A, Baines JF, Neurath MF, Wirtz S, Weidinger C, Bischoff SC, Becker C, Günther C. Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation. Inflamm Bowel Dis 2020;26:66-79. [PMID: 31276162 DOI: 10.1093/ibd/izz142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
515 Vong LB, Nagasaki Y. Redox Polymeric Nanoparticle as an Effective Oral Nanotherapeutics for Inflammatory Bowel Disease and Cancer. IFMBE Proceedings 2020. [DOI: 10.1007/978-981-13-5859-3_31] [Reference Citation Analysis]
516 Moulari B, Shetab Boushehri MA, Pais de Barros J, Faber T, Béduneau A, Lagrost L, Pellequer Y, Lamprecht A. Nanosphere-shaped ammonio methacrylate copolymers: converting a pharmaceutical inactive ingredient to efficient therapeutics for experimental colitis. Nanoscale 2020;12:9590-602. [DOI: 10.1039/d0nr00465k] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
517 Wang Z, Chen T, Yang C, Bao T, Yang X, He F, Zhang Y, Zhu L, Chen H, Rong S, Yang S. Secoisolariciresinol diglucoside suppresses Dextran sulfate sodium salt-induced colitis through inhibiting NLRP1 inflammasome. International Immunopharmacology 2020;78:105931. [DOI: 10.1016/j.intimp.2019.105931] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
518 Ahmed Hassan E, El-Din Abd El-Rehim AS, Mohammed Kholef EF, Abd-Elgwad Elsewify W. Potential role of plasma miR-21 and miR-92a in distinguishing between irritable bowel syndrome, ulcerative colitis, and colorectal cancer. Gastroenterol Hepatol Bed Bench 2020;13:147-54. [PMID: 32308936] [Reference Citation Analysis]
519 Costrini NV. Clearing of the Clouds in Inflammatory Bowel Disease Management. Dig Dis Sci 2020;65:3411-7. [PMID: 33009978 DOI: 10.1007/s10620-020-06635-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
520 Boisaubert H, Sinoquet C. Machine Learning and Combinatorial Optimization to Detect Gene-gene Interactions in Genome-wide Real Data: Looking Through the Prism of Four Methods and Two Protocols. Biomedical Engineering Systems and Technologies 2020. [DOI: 10.1007/978-3-030-46970-2_8] [Reference Citation Analysis]
521 Bensted K, Grimm M. Mucosal Immunology; Immunoglobulins, Lymphocytes and TH1, TH2 Responses. Encyclopedia of Gastroenterology 2020. [DOI: 10.1016/b978-0-12-801238-3.65665-9] [Reference Citation Analysis]
522 Zhilin IV, Chashkova EY, Zhilina AA, Pushkarev BS, Korotaeva NS. The role of TNF-alpha gene (-238G/A and -308G/A) polymorphisms in the etiology and pathogenesis of inflammatory bowel diseases in various ethnic groups. Alʹm klin med 2019;47:548-558. [DOI: 10.18786/2072-0505-2019-47-067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
523 Majchrzak K, Fichna J. Biologic Therapy in Crohn's Disease-What We Have Learnt So Far. Curr Drug Targets 2020;21:792-806. [PMID: 31854272 DOI: 10.2174/1389450121666191218123203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
524 Yu TX, Chung HK, Xiao L, Piao JJ, Lan S, Jaladanki SK, Turner DJ, Raufman JP, Gorospe M, Wang JY. Long Noncoding RNA H19 Impairs the Intestinal Barrier by Suppressing Autophagy and Lowering Paneth and Goblet Cell Function. Cell Mol Gastroenterol Hepatol 2020;9:611-25. [PMID: 31862317 DOI: 10.1016/j.jcmgh.2019.12.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
525 Yang M, Bose S, Lim SK, Kim H. Preventive Effects of Pyungwi-san against Dextran Sulfate Sodium- and Clostridium difficile-Induced Inflammatory Bowel Disease in Mice. Int J Mol Sci. 2019;20:6346. [PMID: 31888274 DOI: 10.3390/ijms20246346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
526 Zou M, Jie Z, Cui B, Wang H, Feng Q, Zou Y, Zhang X, Yang H, Wang J, Zhang F, Jia H. Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases. FEBS Open Bio 2020;10:41-55. [PMID: 31622538 DOI: 10.1002/2211-5463.12744] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
527 Kumar M, Garand M, Al Khodor S. Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine. J Transl Med 2019;17:419. [PMID: 31836022 DOI: 10.1186/s12967-019-02174-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
528 Sharifi A, Vahedi H, Honarvar MR, Alipoor B, Nikniaz Z, Rafiei H, Hosseinzadeh-Attar MJ. Vitamin D Increases CTLA-4 Gene Expression in Patients with Mild to Moderate Ulcerative Colitis. Middle East J Dig Dis 2019;11:199-204. [PMID: 31824622 DOI: 10.15171/mejdd.2019.149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
529 D'Haens GRAM, Lindsay JO, Panaccione R, Schreiber S. Ulcerative Colitis: Shifting Sands. Drugs R D 2019;19:227-34. [PMID: 30827006 DOI: 10.1007/s40268-019-0263-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
530 Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019;2019:7247238. [PMID: 31886308 DOI: 10.1155/2019/7247238] [Cited by in Crossref: 227] [Cited by in F6Publishing: 243] [Article Influence: 56.8] [Reference Citation Analysis]
531 Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA. Treatment-Specific Composition of the Gut Microbiota Is Associated With Disease Remission in a Pediatric Crohn's Disease Cohort. Inflamm Bowel Dis 2019;25:1927-38. [PMID: 31276165 DOI: 10.1093/ibd/izz130] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
532 van der Post S, Jabbar KS, Birchenough G, Arike L, Akhtar N, Sjovall H, Johansson MEV, Hansson GC. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis. Gut 2019;68:2142-51. [PMID: 30914450 DOI: 10.1136/gutjnl-2018-317571] [Cited by in Crossref: 165] [Cited by in F6Publishing: 155] [Article Influence: 41.3] [Reference Citation Analysis]
533 Jiang P, Wu S, Luo Q, Zhao X, Chen W. Metagenomic analysis of common intestinal diseases reveals relationships among microbial signatures and powers multi-disease diagnostic models.. [DOI: 10.1101/19013136] [Reference Citation Analysis]
534 Seishima J, Iida N, Kitamura K, Yutani M, Wang Z, Seki A, Yamashita T, Sakai Y, Honda M, Yamashita T, Kagaya T, Shirota Y, Fujinaga Y, Mizukoshi E, Kaneko S. Gut-derived Enterococcus faecium from ulcerative colitis patients promotes colitis in a genetically susceptible mouse host. Genome Biol 2019;20:252. [PMID: 31767028 DOI: 10.1186/s13059-019-1879-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 49] [Article Influence: 10.5] [Reference Citation Analysis]
535 Scanlan PD. Microbial evolution and ecological opportunity in the gut environment. Proc Biol Sci 2019;286:20191964. [PMID: 31744431 DOI: 10.1098/rspb.2019.1964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
536 Boros É, Nagy I. The Role of MicroRNAs upon Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease. Cells 2019;8:E1461. [PMID: 31752264 DOI: 10.3390/cells8111461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
537 Bertoni S, Machness A, Tiboni M, Bártolo R, Santos HA. Reactive oxygen species responsive nanoplatforms as smart drug delivery systems for gastrointestinal tract targeting. Biopolymers 2020;111:e23336. [PMID: 31724750 DOI: 10.1002/bip.23336] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
538 Suls J, Green PA, Boyd CM. Multimorbidity: Implications and directions for health psychology and behavioral medicine. Health Psychol 2019;38:772-82. [PMID: 31436463 DOI: 10.1037/hea0000762] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
539 Liang YN, Yu JG, Zhang DB, Zhang Z, Ren LL, Li LH, Wang Z, Tang ZS. Indigo Naturalis Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice by Modulating the Intestinal Microbiota Community. Molecules. 2019;24. [PMID: 31726738 DOI: 10.3390/molecules24224086] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
540 Mazurskyy A, Howitt J. Initiation and Transmission of α-Synuclein Pathology in Parkinson's Disease. Neurochem Res 2019. [PMID: 31713092 DOI: 10.1007/s11064-019-02896-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
541 Zhang L, Li YY, Tang X, Zhao X. Faecal microbial dysbiosis in children with Wiskott-Aldrich syndrome. Scand J Immunol 2020;91:e12805. [PMID: 31267543 DOI: 10.1111/sji.12805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
542 Sun H, Kuk W, Rivera-Nieves J, Lopez-Ramirez MA, Eckmann L, Ginsberg MH. β7 Integrin Inhibition Can Increase Intestinal Inflammation by Impairing Homing of CD25(hi)FoxP3(+) Regulatory T Cells. Cell Mol Gastroenterol Hepatol 2020;9:369-85. [PMID: 31707128 DOI: 10.1016/j.jcmgh.2019.10.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
543 Lee SM, Kim NH, Lee S, Kim YN, Heo JD, Jeong EJ, Rho JR. Deacetylphylloketal, a New Phylloketal Derivative from a Marine Sponge, Genus Phyllospongia, with Potent Anti-Inflammatory Activity in In Vitro Co-Culture Model of Intestine. Mar Drugs 2019;17:E634. [PMID: 31717394 DOI: 10.3390/md17110634] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
544 Fois CAM, Le TYL, Schindeler A, Naficy S, McClure DD, Read MN, Valtchev P, Khademhosseini A, Dehghani F. Models of the Gut for Analyzing the Impact of Food and Drugs. Adv Healthc Mater 2019;8:e1900968. [PMID: 31592579 DOI: 10.1002/adhm.201900968] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
545 Li S, Xie A, Li H, Zou X, Zhang Q. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease. J Control Release 2019;316:66-78. [PMID: 31682913 DOI: 10.1016/j.jconrel.2019.10.054] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 7.8] [Reference Citation Analysis]
546 Günther C, Ruder B, Stolzer I, Dorner H, He GW, Chiriac MT, Aden K, Strigli A, Bittel M, Zeissig S, Rosenstiel P, Atreya R, Neurath MF, Wirtz S, Becker C. Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease. Gastroenterology 2019;157:1310-1322.e13. [PMID: 31352002 DOI: 10.1053/j.gastro.2019.07.031] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
547 Hwang JH, Kim TH, Kim YH, Noh JR, Choi DH, Kim KS, Lee EY, Kim BC, Kim MH, Kim H, Lee TG, Lee JS, Lee CH. Gadd45β promotes regeneration after injury through TGFβ-dependent restitution in experimental colitis. Exp Mol Med 2019;51:1-14. [PMID: 31666502 DOI: 10.1038/s12276-019-0335-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
548 Mohammadi A, Kelly OB, Smith MI, Kabakchiev B, Silverberg MS. Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects. J Crohns Colitis 2019;13:1459-69. [PMID: 31001642 DOI: 10.1093/ecco-jcc/jjz076] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
549 Misra R, Limdi J, Cooney R, Sakuma S, Brookes M, Fogden E, Pattni S, Sharma N, Iqbal T, Munkholm P, Burisch J, Arebi N. Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study. World J Gastroenterol 2019; 25(40): 6145-6157 [PMID: 31686769 DOI: 10.3748/wjg.v25.i40.6145] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
550 Chiu B, Chan J, Das S, Alshamma Z, Sergi C. Pediatric Sarcoidosis: A Review with Emphasis on Early Onset and High-Risk Sarcoidosis and Diagnostic Challenges. Diagnostics (Basel) 2019;9:E160. [PMID: 31731423 DOI: 10.3390/diagnostics9040160] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
551 Alaimo A, Rubert J. The Pivotal Role of TRP Channels in Homeostasis and Diseases throughout the Gastrointestinal Tract. Int J Mol Sci 2019;20:E5277. [PMID: 31652951 DOI: 10.3390/ijms20215277] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
552 Mishima Y, Sonoyama H, Ishihara S, Oshima N, Moriyama I, Kawashima K, Kinoshita Y. Interleukin-33 delays recovery of mucosal inflammation via downregulation of homeostatic ABCG5/8 in the colon. Lab Invest 2020;100:491-502. [DOI: 10.1038/s41374-019-0329-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
553 Nunes R, Neves JD, Sarmento B. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges. Nanomedicine (Lond) 2019;14:2631-44. [PMID: 31612773 DOI: 10.2217/nnm-2019-0191] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
554 Nold C, Jensen T, O'hara K, Stone J, Yellon SM, Vella AT. Replens prevents preterm birth by decreasing type I interferon strengthening the cervical epithelial barrier. Am J Reprod Immunol 2019;83. [DOI: 10.1111/aji.13192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
555 Han W, Xie B, Li Y, Shi L, Wan J, Chen X, Wang H. Orally Deliverable Nanotherapeutics for the Synergistic Treatment of Colitis-Associated Colorectal Cancer. Theranostics 2019;9:7458-73. [PMID: 31695780 DOI: 10.7150/thno.38081] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 11.5] [Reference Citation Analysis]
556 Wong J, Garcia-Carbonell R, Zelic M, Ho SB, Boland BS, Yao SJ, Desai SA, Das S, Planell N, Harris PA, Font-Burgada J, Taniguchi K, Bertin J, Salas A, Pasparakis M, Gough PJ, Kelliher M, Karin M, Guma M. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation. Cell Mol Gastroenterol Hepatol 2020;9:295-312. [PMID: 31606566 DOI: 10.1016/j.jcmgh.2019.10.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
557 Wan P, Peng Y, Chen G, Xie M, Dai Z, Huang K, Dong W, Zeng X, Sun Y. Dicaffeoylquinic acids from Ilex kudingcha attenuate dextran sulfate sodium-induced colitis in C57BL/6 mice in association with the modulation of gut microbiota. Journal of Functional Foods 2019;61:103468. [DOI: 10.1016/j.jff.2019.103468] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
558 Singh V, Yeoh BS, Walker RE, Xiao X, Saha P, Golonka RM, Cai J, Bretin ACA, Cheng X, Liu Q, Flythe MD, Chassaing B, Shearer GC, Patterson AD, Gewirtz AT, Vijay-Kumar M. Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation. Gut 2019;68:1801-12. [PMID: 30670576 DOI: 10.1136/gutjnl-2018-316250] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 25.3] [Reference Citation Analysis]
559 Morshedzadeh N, Shahrokh S, Aghdaei HA, Amin Pourhoseingholi M, Chaleshi V, Hekmatdoost A, Karimi S, Zali MR, Mirmiran P. Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis. Complementary Therapies in Medicine 2019;46:36-43. [DOI: 10.1016/j.ctim.2019.07.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
560 Lee HS, Kim K, Jung S, Hong M, Kim BM, Yoo DS, Moon JW, Baek J, Hwang SW, Park SH, Yang SK, Han B, Song K, Ye BD. Effects of smoking on the association of human leukocyte antigen with ulcerative colitis. J Gastroenterol Hepatol 2019;34:1777-83. [PMID: 31038770 DOI: 10.1111/jgh.14695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
561 Jung ES, Choi KW, Kim SW, Hübenthal M, Mucha S, Park J, Park Z, Ellinghaus D, Schreiber S, Franke A, Oh WY, Cheon JH. ZNF133 is associated with infliximab responsiveness in patients with inflammatory bowel diseases. J Gastroenterol Hepatol 2019;34:1727-35. [PMID: 30851117 DOI: 10.1111/jgh.14652] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
562 Ashton JJ, Latham K, Beattie RM, Ennis S. Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:885-900. [PMID: 31518029 DOI: 10.1111/apt.15485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
563 Wang Y, Miller M, Astrakhan Y, Petersen BS, Schreiber S, Franke A, Bromberg Y. Identifying Crohn's disease signal from variome analysis. Genome Med. 2019;11:59. [PMID: 31564248 DOI: 10.1186/s13073-019-0670-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
564 Oh SK, Kim D, Kim K, Boo K, Yu YS, Kim IS, Jeon Y, Im SK, Lee SH, Lee JM, Ko Y, Lee H, Park D, Fang S, Baek SH. RORα is crucial for attenuated inflammatory response to maintain intestinal homeostasis. Proc Natl Acad Sci U S A 2019;116:21140-9. [PMID: 31570593 DOI: 10.1073/pnas.1907595116] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
565 Sonoyama H, Mishima Y, Ishihara S, Oshima N, Moriyama I, Kawashima K, Chinuki Y, Morita E, Kinoshita Y. Ten-year follow-up study of linear immunoglobulin A dermatosis complicated with ulcerative colitis. Clin J Gastroenterol 2020;13:164-9. [PMID: 31555959 DOI: 10.1007/s12328-019-01047-w] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
566 Soskic B, Cano-Gamez E, Smyth DJ, Rowan WC, Nakic N, Esparza-Gordillo J, Bossini-Castillo L, Tough DF, Larminie CGC, Bronson PG, Willé D, Trynka G. Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases. Nat Genet 2019;51:1486-93. [PMID: 31548716 DOI: 10.1038/s41588-019-0493-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
567 Li C, Zhao Y, Cheng J, Guo J, Zhang Q, Zhang X, Ren J, Wang F, Huang J, Hu H, Wang R, Zhang J. A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota. Adv Sci (Weinh) 2019;6:1900610. [PMID: 31559126 DOI: 10.1002/advs.201900610] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 16.5] [Reference Citation Analysis]
568 Yamada T, Hino S, Iijima H, Genda T, Aoki R, Nagata R, Han KH, Hirota M, Kinashi Y, Oguchi H, Suda W, Furusawa Y, Fujimura Y, Kunisawa J, Hattori M, Fukushima M, Morita T, Hase K. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis. EBioMedicine 2019;48:513-25. [PMID: 31521614 DOI: 10.1016/j.ebiom.2019.09.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
569 Li J, Bao J, Zeng J, Yan A, Zhao C, Shu Q. Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. Bone Res 2019;7:27. [PMID: 31646017 DOI: 10.1038/s41413-019-0067-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
570 Mbachi C, Attar B, Oyenubi O, Yuchen W, Efesomwan A, Paintsil I, Madhu M, Ajiboye O, Simons-Linares CR, Trick WE, Kotwal V. Association between cannabis use and complications related to ulcerative colitis in hospitalized patients: A propensity matched retrospective cohort study. Medicine (Baltimore) 2019;98:e16551. [PMID: 31393356 DOI: 10.1097/MD.0000000000016551] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
571 Cai Y, Liu W, Lin Y, Zhang S, Zou B, Xiao D, Lin L, Zhong Y, Zheng H, Liao Q, Xie Z. Compound polysaccharides ameliorate experimental colitis by modulating gut microbiota composition and function. J Gastroenterol Hepatol 2019;34:1554-62. [PMID: 30589960 DOI: 10.1111/jgh.14583] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
572 Xiao L, Li XX, Chung HK, Kalakonda S, Cai JZ, Cao S, Chen N, Liu Y, Rao JN, Wang HY, Gorospe M, Wang JY. RNA-Binding Protein HuR Regulates Paneth Cell Function by Altering Membrane Localization of TLR2 via Post-transcriptional Control of CNPY3. Gastroenterology 2019;157:731-43. [PMID: 31103627 DOI: 10.1053/j.gastro.2019.05.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
573 Sireswar S, Ghosh I, Dey G. First and second generation probiotic therapeutics for Inflammatory Bowel Disease. PharmaNutrition 2019;9:100159. [DOI: 10.1016/j.phanu.2019.100159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
574 Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses. Gastroenterology 2019;157:647-659.e4. [PMID: 31014995 DOI: 10.1053/j.gastro.2019.04.016] [Cited by in Crossref: 236] [Cited by in F6Publishing: 234] [Article Influence: 59.0] [Reference Citation Analysis]
575 Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Mottaghi-Moghaddam A, Ghazaghi A, Ghandehari M, Alizade-Noghani M, Khazaei M, Ghayour-Mobarhan M, Ferns GA, Parizadeh SMR, Avan A. Vitamin D in inflammatory bowel disease: From biology to clinical implications. Complement Ther Med 2019;47:102189. [PMID: 31779998 DOI: 10.1016/j.ctim.2019.08.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
576 Khoshnevisan R, Vakili F, Klein C, Kotlarz D, Nasirian M, Sherkat R, Rezaei A. An analysis and survey of interleukin-10 receptor mutation in inflammatory bowel disease (IBD) in the first Iranian IBD cohort. Journal of Laboratory Medicine 2019;43:185-9. [DOI: 10.1515/labmed-2019-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
577 Sun F, Liang W, Tang K, Hong M, Qian J. Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer. PeerJ 2019;7:e7451. [PMID: 31523496 DOI: 10.7717/peerj.7451] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
578 Khor B, Conway KL, Omar AS, Biton M, Haber AL, Rogel N, Baxt LA, Begun J, Kuballa P, Gagnon JD, Lassen KG, Regev A, Xavier RJ. Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1. J Immunol 2019;203:1820-9. [PMID: 31451676 DOI: 10.4049/jimmunol.1800419] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
579 Shi X, Chen Q, Wang F. Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies. Stem Cell Res Ther 2019;10:266. [PMID: 31443677 DOI: 10.1186/s13287-019-1336-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
580 Yoo JH, Donowitz M. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases. World J Gastroenterol 2019; 25(30): 4125-4147 [PMID: 31435168 DOI: 10.3748/wjg.v25.i30.4125] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
581 Kasendra M, Luc R, Yin J, Manatakis DV, Apostolou A, Sunuwar L, Obrigewitch J, Hamilton GA, Donowitz M, Karalis K. Organoid-derived Duodenum Intestine-Chip for preclinical drug assessment in a human relevant system.. [DOI: 10.1101/723015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
582 Currie KS, Patel L, Sedillo KF. Small-molecule agents for the treatment of inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters 2019;29:2034-41. [DOI: 10.1016/j.bmcl.2019.06.042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
583 Zhao H, Liu Y, Huang X, Liu X, Chen F, Zhang X, Liu F, Lu X, Wang Y, Liu D. Pharmacological mechanism of Sishen Wan® attenuated experimental chronic colitis by inhibiting wnt/β-catenin pathway. Journal of Ethnopharmacology 2019;240:111936. [DOI: 10.1016/j.jep.2019.111936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
584 Wang X, Wang G, Shang J, Pan H, Zhang XA, Zhou F. Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis. J Int Med Res 2019;47:3534-49. [PMID: 31364448 DOI: 10.1177/0300060519864800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
585 Ettreiki C, Chango A, Barbezier N, Coeffier M, Anton PM, Delayre-Orthez C. Prevention of Adult Colitis by Oral Ferric Iron in Juvenile Mice Is Associated with the Inhibition of the Tbet Promoter Hypomethylation and Gene Overexpression. Nutrients 2019;11:E1758. [PMID: 31370166 DOI: 10.3390/nu11081758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
586 Wan P, Peng Y, Chen G, Xie M, Dai Z, Huang K, Dong W, Zeng X, Sun Y. Modulation of gut microbiota by Ilex kudingcha improves dextran sulfate sodium-induced colitis. Food Res Int. 2019;126:108595. [PMID: 31732076 DOI: 10.1016/j.foodres.2019.108595] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
587 Abdoli A, Mirzaian Ardakani H. Potential application of helminth therapy for resolution of neuroinflammation in neuropsychiatric disorders. Metab Brain Dis 2020;35:95-110. [PMID: 31352539 DOI: 10.1007/s11011-019-00466-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
588 Sonnenberg GF, Hepworth MR. Functional interactions between innate lymphoid cells and adaptive immunity. Nat Rev Immunol 2019;19:599-613. [PMID: 31350531 DOI: 10.1038/s41577-019-0194-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 116] [Article Influence: 27.3] [Reference Citation Analysis]
589 Batura V, Muise AM. Very early onset IBD: novel genetic aetiologies. Curr Opin Allergy Clin Immunol 2018;18:470-80. [PMID: 30299396 DOI: 10.1097/ACI.0000000000000486] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
590 Eftychi C, Schwarzer R, Vlantis K, Wachsmuth L, Basic M, Wagle P, Neurath MF, Becker C, Bleich A, Pasparakis M. Temporally Distinct Functions of the Cytokines IL-12 and IL-23 Drive Chronic Colon Inflammation in Response to Intestinal Barrier Impairment. Immunity 2019;51:367-380.e4. [PMID: 31350179 DOI: 10.1016/j.immuni.2019.06.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 11.5] [Reference Citation Analysis]
591 Diener C, Reyes L, Jimenez L, Matus M, Gomez C, Chu ND, Zhong V, Tejero E, Alm E, Resendis-antonio O, Guardado-mendoza R. Progressive shifts in the gut microbiome reflect prediabetes and diabetes development in a treatment-naive Mexican cohort.. [DOI: 10.1101/710152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
592 Hoefsmit EP, Rozeman EA, Haanen JBAG, Blank CU. Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events. ESMO Open 2019;4:e000472. [PMID: 31423333 DOI: 10.1136/esmoopen-2018-000472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
593 Trapecar M, Communal C, Velazquez J, Maass CA, Huang Y, Schneider K, Wright CW, Eng G, Yilmaz O, Trumper D, Griffith LG. Gut-Liver physiomimetics reveal paradoxical modulation of IBD-related inflammation by short-chain fatty acids.. [DOI: 10.1101/706812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
594 Nexoe AB, Pilecki B, Von Huth S, Husby S, Pedersen AA, Detlefsen S, Marcussen N, Moeller JB, Holmskov U, Sorensen GL. Colonic Epithelial Surfactant Protein D Expression Correlates with Inflammation in Clinical Colonic Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1349-56. [PMID: 30753482 DOI: 10.1093/ibd/izz009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
595 Yun CC. Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer. Cancers (Basel) 2019;11:E958. [PMID: 31323936 DOI: 10.3390/cancers11070958] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
596 Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ. Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice. Immunity 2019;50:212-224.e4. [PMID: 30650377 DOI: 10.1016/j.immuni.2018.12.015] [Cited by in Crossref: 228] [Cited by in F6Publishing: 245] [Article Influence: 57.0] [Reference Citation Analysis]
597 Oligschlaeger Y, Yadati T, Houben T, Condello Oliván CM, Shiri-Sverdlov R. Inflammatory Bowel Disease: A Stressed "Gut/Feeling". Cells 2019;8:E659. [PMID: 31262067 DOI: 10.3390/cells8070659] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
598 Jacenik D, Cygankiewicz AI, Mokrowiecka A, Małecka-Panas E, Fichna J, Krajewska WM. Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors. Int J Mol Sci 2019;20:E3175. [PMID: 31261736 DOI: 10.3390/ijms20133175] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
599 Zhu L, Han J, Li L, Wang Y, Li Y, Zhang S. Claudin Family Participates in the Pathogenesis of Inflammatory Bowel Diseases and Colitis-Associated Colorectal Cancer. Front Immunol 2019;10:1441. [PMID: 31316506 DOI: 10.3389/fimmu.2019.01441] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 11.3] [Reference Citation Analysis]
600 Lv WJ, Liu C, Li YF, Chen WQ, Li ZQ, Li Y, Xiong Y, Chao LM, Xu XL, Guo SN. Systems Pharmacology and Microbiome Dissection of Shen Ling Bai Zhu San Reveal Multiscale Treatment Strategy for IBD. Oxid Med Cell Longev 2019;2019:8194804. [PMID: 31341536 DOI: 10.1155/2019/8194804] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
601 Hansen IS, Schoonejans JM, Sritharan L, van Burgsteden JA, Ambarus CA, Baeten DLP, den Dunnen J. ER stress abrogates the immunosuppressive effect of IL-10 on human macrophages through inhibition of STAT3 activation. Inflamm Res 2019;68:775-85. [PMID: 31227842 DOI: 10.1007/s00011-019-01261-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
602 Sen A, Stark H. Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis. World J Gastroenterol 2019; 25(23): 2846-2862 [PMID: 31249444 DOI: 10.3748/wjg.v25.i23.2846] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
603 Gao C, Liu L, Zhou Y, Bian Z, Wang S, Wang Y. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chin Med 2019;14:23. [PMID: 31236131 DOI: 10.1186/s13020-019-0245-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
604 Rao MC. Physiology of Electrolyte Transport in the Gut: Implications for Disease. Compr Physiol 2019;9:947-1023. [PMID: 31187895 DOI: 10.1002/cphy.c180011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
605 Hwang JH, Yu CS. Depression and resilience in ulcerative colitis and Crohn's disease patients with ostomy. Int Wound J 2019;16 Suppl 1:62-70. [PMID: 30793856 DOI: 10.1111/iwj.13076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
606 Ulugöl S, Hering L, Manzini R, Montalban Arques A, Gottier C, Lang S, Scharl M, Spalinger MR. Deletion of Protein Tyrosine Phosphatase Nonreceptor Type 2 in Intestinal Epithelial Cells Results in Upregulation of the Related Phosphatase Protein Tyrosine Phosphatase Nonreceptor Type 23. Inflamm Intest Dis 2019;4:14-26. [PMID: 31172009 DOI: 10.1159/000499157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
607 Cohen LJ, Cho JH, Gevers D, Chu H. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases. Gastroenterology 2019;156:2174-89. [PMID: 30880022 DOI: 10.1053/j.gastro.2019.03.017] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 24.0] [Reference Citation Analysis]
608 Yamada T, Hino S, Iijima H, Genda T, Aoki R, Nagata R, Han H, Hirota M, Kinashi Y, Oguchi H, Suda W, Furusawa Y, Fujimura Y, Kunisawa J, Hattori M, Fukushima M, Morita T, Hase K. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis.. [DOI: 10.1101/655597] [Reference Citation Analysis]
609 Chen X, Yang K, Xu Y, Li K. Top-100 highest-cited original articles in inflammatory bowel disease: A bibliometric analysis. Medicine (Baltimore) 2019;98:e15718. [PMID: 31096525 DOI: 10.1097/MD.0000000000015718] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
610 Ramos GP, Papadakis KA. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clin Proc. 2019;94:155-165. [PMID: 30611442 DOI: 10.1016/j.mayocp.2018.09.013] [Cited by in Crossref: 275] [Cited by in F6Publishing: 289] [Article Influence: 68.8] [Reference Citation Analysis]
611 Parasar B, Zhou H, Xiao X, Shi Q, Brito IL, Chang PV. Chemoproteomic Profiling of Gut Microbiota-Associated Bile Salt Hydrolase Activity. ACS Cent Sci 2019;5:867-73. [PMID: 31139722 DOI: 10.1021/acscentsci.9b00147] [Cited by in Crossref: 23] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
612 Garcia-Carbonell R, Yao SJ, Das S, Guma M. Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut. Front Immunol 2019;10:1094. [PMID: 31164887 DOI: 10.3389/fimmu.2019.01094] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
613 Xu Y, Xia M, Chen T, Yang Y, Fu G, Ji P, Wu Q. Inferior alveolar nerve transection disturbs innate immune responses and bone healing after tooth extraction. Ann N Y Acad Sci 2019;1448:52-64. [DOI: 10.1111/nyas.14120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
614 Melhem H, Kaya B, Ayata CK, Hruz P, Niess JH. Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease. Cells. 2019;8. [PMID: 31091682 DOI: 10.3390/cells8050450] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
615 Zhao C, Hu Q, Wu X, Chen G, Wu H, Ren J. Alginate and Probiotics Synergistically Reversed Dextran Sulfate Sodium Salt (DSS)-Induced Gut Barrier Damage. Macromol Res 2019;27:888-94. [DOI: 10.1007/s13233-019-7122-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
616 Blander JM. A new approach for inflammatory bowel disease therapy. Nat Med 2019;25:545-6. [PMID: 30936545 DOI: 10.1038/s41591-019-0416-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
617 Han B, Akiyama M, Kim KK, Oh H, Choi H, Lee CH, Jung S, Lee HS, Kim EE, Cook S, Haritunians T, Yamazaki K, Park SH, Ye BD, McGovern DPB, Esaki M, Kawaguchi T, Khor SS, Taylor KD, Rotter JI, Suzuki Y, Matsui T, Motoya S, Bang SY, Kim TH, Momozawa Y, Kamatani Y, Tokunaga K, Kubo M, Okada Y, Yang SK, Song K. Amino acid position 37 of HLA-DRβ1 affects susceptibility to Crohn's disease in Asians. Hum Mol Genet 2018;27:3901-10. [PMID: 30084967 DOI: 10.1093/hmg/ddy285] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
618 Lee MR, Jeong YI, Kim HJ, Shin HE, Lee SE, Ju JW, Sohn WM, Cho SH. Metagonimus miyatai ameliorates dextran sodium sulfate-induced colitis in mice. Parasitol Int 2020;74:101924. [PMID: 31075526 DOI: 10.1016/j.parint.2019.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
619 Asadzadeh-Aghdaei H, Mashayekhi K, Koushki K, Azimzadeh P, Rostami-Nejad M, Amani D, Chaleshi V, Haftcheshmeh SM, Sahebkar A, Zali MR. V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease. J Cell Biochem 2019;120:15746-55. [PMID: 31069840 DOI: 10.1002/jcb.28844] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
620 Pituch-Zdanowska A, Kowalska-Duplaga K, Jarocka-Cyrta E, Stawicka A, Dziekiewicz M, Banaszkiewicz A. Dietary Beliefs and Behaviors Among Parents of Children with Inflammatory Bowel Disease. J Med Food. 2019;22:817-822. [PMID: 31063436 DOI: 10.1089/jmf.2018.0206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
621 Warren LR, Clarke JM, Arora S, Barahona M, Arebi N, Darzi A. Transitions of care across hospital settings in patients with inflammatory bowel disease. World J Gastroenterol 2019; 25(17): 2122-2132 [PMID: 31114138 DOI: 10.3748/wjg.v25.i17.2122] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
622 Schmitz JM, Tonkonogy SL, Dogan B, Leblond A, Whitehead KJ, Kim SC, Simpson KW, Sartor RB. Murine Adherent and Invasive E. coli Induces Chronic Inflammation and Immune Responses in the Small and Large Intestines of Monoassociated IL-10-/- Mice Independent of Long Polar Fimbriae Adhesin A. Inflamm Bowel Dis 2019;25:875-85. [PMID: 30576451 DOI: 10.1093/ibd/izy386] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
623 Zhang YW, Xu XY, Zhang J, Yao X, Lu C, Chen CX, Yu CH, Sun J. Missense mutation in PRKCQ is associated with Crohn's disease. J Dig Dis 2019;20:243-7. [PMID: 30828974 DOI: 10.1111/1751-2980.12717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
624 Zhao M, Xiong X, Ren K, Xu B, Cheng M, Sahu C, Wu K, Nie Y, Huang Z, Blumberg RS, Han X, Ruan HB. Deficiency in intestinal epithelial O-GlcNAcylation predisposes to gut inflammation. EMBO Mol Med 2018;10:e8736. [PMID: 29941542 DOI: 10.15252/emmm.201708736] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
625 Balla KM, Lažetić V, Troemel ER. Natural variation in the roles of C. elegans autophagy components during microsporidia infection. PLoS One 2019;14:e0216011. [PMID: 31013330 DOI: 10.1371/journal.pone.0216011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
626 Hansson GC. Mucus and mucins in diseases of the intestinal and respiratory tracts. J Intern Med 2019;285:479-90. [PMID: 30963635 DOI: 10.1111/joim.12910] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 19.5] [Reference Citation Analysis]
627 Burge K, Gunasekaran A, Eckert J, Chaaban H. Curcumin and Intestinal Inflammatory Diseases: Molecular Mechanisms of Protection. Int J Mol Sci 2019;20:E1912. [PMID: 31003422 DOI: 10.3390/ijms20081912] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 14.8] [Reference Citation Analysis]
628 Cao L, Xu H, Wang G, Liu M, Tian D, Yuan Z. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization. Int Immunopharmacol. 2019;72:264-274. [PMID: 31005036 DOI: 10.1016/j.intimp.2019.04.020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
629 Zhao J, Gao W, Cai X, Xu J, Zou D, Li Z, Hu B, Zheng Y. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease. Theranostics 2019;9:2843-55. [PMID: 31244927 DOI: 10.7150/thno.33727] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 20.0] [Reference Citation Analysis]
630 Zhuang L, Chen H, Zhang S, Zhuang J, Li Q, Feng Z. Intestinal Microbiota in Early Life and Its Implications on Childhood Health. Genomics Proteomics Bioinformatics 2019;17:13-25. [PMID: 30986482 DOI: 10.1016/j.gpb.2018.10.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 24.3] [Reference Citation Analysis]
631 Dai Y, Pei G, Zhao Z, Jia P. A Convergent Study of Genetic Variants Associated With Crohn's Disease: Evidence From GWAS, Gene Expression, Methylation, eQTL and TWAS. Front Genet 2019;10:318. [PMID: 31024628 DOI: 10.3389/fgene.2019.00318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
632 Kaur H, Moreau R. Role of mTORC1 in intestinal epithelial repair and tumorigenesis. Cell Mol Life Sci 2019;76:2525-46. [DOI: 10.1007/s00018-019-03085-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
633 Retnakumar SV, Muller S. Pharmacological Autophagy Regulators as Therapeutic Agents for Inflammatory Bowel Diseases. Trends Mol Med 2019;25:516-37. [PMID: 30952481 DOI: 10.1016/j.molmed.2019.03.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
634 Belarif L, Danger R, Kermarrec L, Nerrière-Daguin V, Pengam S, Durand T, Mary C, Kerdreux E, Gauttier V, Kucik A, Thepenier V, Martin JC, Chang C, Rahman A, Guen NS, Braudeau C, Abidi A, David G, Malard F, Takoudju C, Martinet B, Gérard N, Neveu I, Neunlist M, Coron E, MacDonald TT, Desreumaux P, Mai HL, Le Bas-Bernardet S, Mosnier JF, Merad M, Josien R, Brouard S, Soulillou JP, Blancho G, Bourreille A, Naveilhan P, Vanhove B, Poirier N. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease. J Clin Invest 2019;129:1910-25. [PMID: 30939120 DOI: 10.1172/JCI121668] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 12.0] [Reference Citation Analysis]
635 Friedrich M, Pohin M, Powrie F. Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. Immunity 2019;50:992-1006. [DOI: 10.1016/j.immuni.2019.03.017] [Cited by in Crossref: 257] [Cited by in F6Publishing: 204] [Article Influence: 64.3] [Reference Citation Analysis]
636 Zhang S, Li J, Xie P, Zang T, Shen H, Cao G, Zhu Y, Yue Z, Li Z. STAT3/c-Myc Axis-Mediated Metabolism Alternations of Inflammation-Related Glycolysis Involve with Colorectal Carcinogenesis. Rejuvenation Research 2019;22:138-45. [DOI: 10.1089/rej.2018.2089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
637 Gaujoux R, Starosvetsky E, Maimon N, Vallania F, Bar-Yoseph H, Pressman S, Weisshof R, Goren I, Rabinowitz K, Waterman M, Yanai H, Dotan I, Sabo E, Chowers Y, Khatri P, Shen-Orr SS; Israeli IBD research Network (IIRN). Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD. Gut 2019;68:604-14. [PMID: 29618496 DOI: 10.1136/gutjnl-2017-315494] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 27.0] [Reference Citation Analysis]
638 Marchelletta R, Yu J, Moon C, Kim MM. Evaluation of Compound Activity in Primary Human Intestinal Organoids Using Gene Expression and Histology. Curr Protoc Pharmacol 2019;85:e54. [PMID: 30920154 DOI: 10.1002/cpph.54] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
639 Ferraro S, Leonardi L, Convertino I, Blandizzi C, Tuccori M. Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies. Front Pharmacol 2019;10:247. [PMID: 30941038 DOI: 10.3389/fphar.2019.00247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
640 Abdoli A. Therapeutic Potential of Helminths and Helminth-Derived Antigens for Resolution of Inflammation in Inflammatory Bowel Disease. Arch Med Res 2019;50:58-9. [PMID: 30879759 DOI: 10.1016/j.arcmed.2019.03.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
641 Levy AN, Allegretti JR. Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease. Therap Adv Gastroenterol 2019;12:1756284819836893. [PMID: 30906424 DOI: 10.1177/1756284819836893] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
642 Dionne S, Restellini S, Koenekoop J, Salvador Escribano P, Piccirillo CA, Charlebois P, Liberman AS, Stein B, Duchatellier CF, Seidman EG. Characterization of myofibroblasts isolated from the intestine of patients with inflammatory bowel disease. F1000Res 2019;8:275. [DOI: 10.12688/f1000research.13906.1] [Reference Citation Analysis]
643 Ohashi W, Fukada T. Contribution of Zinc and Zinc Transporters in the Pathogenesis of Inflammatory Bowel Diseases. J Immunol Res 2019;2019:8396878. [PMID: 30984791 DOI: 10.1155/2019/8396878] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
644 Aschard H, Laville V, Tchetgen ET, Knights D, Imhann F, Seksik P, Zaitlen N, Silverberg MS, Cosnes J, Weersma RK, Xavier R, Beaugerie L, Skurnik D, Sokol H. Genetic effects on the commensal microbiota in inflammatory bowel disease patients. PLoS Genet. 2019;15:e1008018. [PMID: 30849075 DOI: 10.1371/journal.pgen.1008018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
645 Soskic B, Cano-gamez E, Smyth DJ, Rowan WC, Nakic N, Esparza-gordillo J, Bossini-castillo L, Tough DF, Larminie CGC, Bronson PG, Wille D, Trynka G. Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases.. [DOI: 10.1101/566810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
646 Chang YL, Rossetti M, Vlamakis H, Casero D, Sunga G, Harre N, Miller S, Humphries R, Stappenbeck T, Simpson KW, Sartor RB, Wu G, Lewis J, Bushman F, McGovern DPB, Salzman N, Borneman J, Xavier R, Huttenhower C, Braun J. A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol 2019;12:457-67. [PMID: 29695840 DOI: 10.1038/s41385-018-0022-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
647 Ambrose T, Simmons A. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease? J Crohns Colitis 2019;13:525-35. [PMID: 30418525 DOI: 10.1093/ecco-jcc/jjy185] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
648 Agliata I, Fernandez-jimenez N, Goldsmith C, Marie JC, Bilbao JR, Dante R, Hernandez-vargas H. The DNA Methylome of Inflammatory Bowel Disease (IBD) reflects intrinsic and extrinsic factors in intestinal epithelial cells.. [DOI: 10.1101/565200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
649 Di Narzo AF, Brodmerkel C, Telesco SE, Argmann C, Peters LA, Li K, Kidd B, Dudley J, Cho J, Schadt EE, Kasarskis A, Dobrin R, Hao K. High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease. J Crohns Colitis 2019;13:462-71. [PMID: 30445421 DOI: 10.1093/ecco-jcc/jjy190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
650 Body-Malapel M, Djouina M, Waxin C, Langlois A, Gower-Rousseau C, Zerbib P, Schmidt AM, Desreumaux P, Boulanger E, Vignal C. The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases. Mucosal Immunol 2019;12:468-78. [PMID: 30542111 DOI: 10.1038/s41385-018-0119-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
651 Eberhardson M, Hedin CRH, Carlson M, Tarnawski L, Levine YA, Olofsson PS. Towards improved control of inflammatory bowel disease. Scand J Immunol 2019;89:e12745. [DOI: 10.1111/sji.12745] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
652 Simčič S, Berlec A, Stopinšek S, Štrukelj B, Orel R. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa. World J Microbiol Biotechnol 2019;35:45. [PMID: 30810891 DOI: 10.1007/s11274-019-2615-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
653 Khare V, Krnjic A, Frick A, Gmainer C, Asboth M, Jimenez K, Lang M, Baumgartner M, Evstatiev R, Gasche C. Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation. Sci Rep 2019;9:2842. [PMID: 30809073 DOI: 10.1038/s41598-019-39401-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
654 Matthews SM, Eshelman MA, Berg AS, Koltun WA, Yochum GS. The Crohn's disease associated SNP rs6651252 impacts MYC gene expression in human colonic epithelial cells. PLoS One 2019;14:e0212850. [PMID: 30794691 DOI: 10.1371/journal.pone.0212850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
655 Zhu W, Yan J, Zhi C, Zhou Q, Yuan X. 1,25(OH) 2D3 deficiency-induced gut microbial dysbiosis degrades the colonic mucus barrier in Cyp27b1 knockout mouse model. Gut Pathog. 2019;11:8. [PMID: 30828386 DOI: 10.1186/s13099-019-0291-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
656 Ma H, Tao W, Zhu S. T lymphocytes in the intestinal mucosa: defense and tolerance. Cell Mol Immunol 2019;16:216-24. [PMID: 30787416 DOI: 10.1038/s41423-019-0208-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 11.5] [Reference Citation Analysis]
657 van Zyl WF, Deane SM, Dicks LMT. Bacteriocin production and adhesion properties as mechanisms for the anti-listerial activity of Lactobacillus plantarum 423 and Enterococcus mundtii ST4SA. Benef Microbes 2019;10:329-49. [PMID: 30773929 DOI: 10.3920/BM2018.0141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
658 Cao J, Cheng J, Xi S, Qi X, Shen S, Ge Y. Alginate/chitosan microcapsules for in-situ delivery of the protein, interleukin-1 receptor antagonist (IL-1Ra), for the treatment of dextran sulfate sodium (DSS)-induced colitis in a mouse model. Eur J Pharm Biopharm 2019;137:112-21. [PMID: 30779979 DOI: 10.1016/j.ejpb.2019.02.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
659 Ait-oudhia S, Lien YTK, Basu S, Lesko L, Schmidt S. Application of Pharmacometrics and Systems Pharmacology to Current and Emerging Biologics in Inflammatory Bowel Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases 2019. [DOI: 10.1002/9781119289234.ch10] [Reference Citation Analysis]
660 Meng Y, Li X, Chen S, Li F, Yin Y, Liu J, Lu F, Liu X. Impacts of diets fed after weaning on gut microbiota and susceptibility to DSS-induced colitis in mice.. [DOI: 10.1101/549501] [Reference Citation Analysis]
661 Wei D, Zhao N, Xie L, Huang B, Zhuang Z, Tang Y, Yu S, Wu Q. Electroacupuncture and Moxibustion Improved Anxiety Behavior in DSS-Induced Colitis Mice. Gastroenterol Res Pract. 2019;2019:2345890. [PMID: 30881446 DOI: 10.1155/2019/2345890] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
662 Drobin K, Assadi G, Hong MG, Andersson E, Fredolini C, Forsström B, Reznichenko A, Akhter T, Ek WE, Bonfiglio F, Hansen MB, Sandberg K, Greco D, Repsilber D, Schwenk JM, D'Amato M, Halfvarson J. Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk Loci. Inflamm Bowel Dis 2019;25:306-16. [PMID: 30358838 DOI: 10.1093/ibd/izy326] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
663 Erdmann P, Bruckmueller H, Martin P, Busch D, Haenisch S, Müller J, Wiechowska-kozlowska A, Partecke LI, Heidecke C, Cascorbi I, Drozdzik M, Oswald S. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis. Journal of Pharmaceutical Sciences 2019;108:1035-46. [DOI: 10.1016/j.xphs.2018.09.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
664 Xue F, Wang Y, Zhang Q, Han S, Zhang F, Jin T, Li C, Hu H, Zhang J. Self-assembly of affinity-controlled nanoparticles via host-guest interactions for drug delivery. Nanoscale 2018;10:12364-77. [PMID: 29682667 DOI: 10.1039/c8nr01518j] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
665 Werner L, Nunberg MY, Rechavi E, Lev A, Braun T, Haberman Y, Lahad A, Shteyer E, Schvimer M, Somech R, Weiss B, Lee YN, Shouval DS. Altered T cell receptor beta repertoire patterns in pediatric ulcerative colitis. Clin Exp Immunol 2019;196:1-11. [PMID: 30556140 DOI: 10.1111/cei.13247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
666 Sarwan N, Jurawan R, Singh R, Chattu VK. An Exploratory Study of Inflammatory Bowel Disease and the Psychosocial Factors Affecting Health-Related Quality of Life. Med Sci (Basel) 2019;7:E18. [PMID: 30691020 DOI: 10.3390/medsci7020018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
667 Lavoie S, Conway KL, Lassen KG, Jijon HB, Pan H, Chun E, Michaud M, Lang JK, Gallini Comeau CA, Dreyfuss JM, Glickman JN, Vlamakis H, Ananthakrishnan A, Kostic A, Garrett WS, Xavier RJ. The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response. Elife. 2019;8:e39982. [PMID: 30666959 DOI: 10.7554/elife.39982] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
668 Yamashita A, Inamine T, Suzuki S, Fukuda S, Unoike M, Kawafuchi Y, Machida H, Isomoto H, Nakao K, Tsukamoto K. Genetic variants of SMAD2/3/4/7 are associated with susceptibility to ulcerative colitis in a Japanese genetic background. Immunol Lett 2019;207:64-72. [PMID: 30653987 DOI: 10.1016/j.imlet.2019.01.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
669 An Analysis and Survey on Interleukin-10 Receptor Mutation in Inflammatory Bowel Disease in Iranian IBD Cohort. ABBSR 2019;2. [DOI: 10.33140/abbsr/02/01/00003] [Reference Citation Analysis]
670 Nabhani ZA, Berrebi D, Martinez-vinson C, Montcuquet N, Dietrich G, Singh G, Turner JR, Madre C, Roy M, Ogier-denis E, Dussaillant M, Cerf-bensussan N, Zouali H, Jung C, Daniel F, Barreau F, Hugot J. Nod2 protects remote small intestinal sites in case of colonic inflammation.. [DOI: 10.1101/510933] [Reference Citation Analysis]
671 Coffey JC, Bolger J. Microbiota in Pouchitis and De Novo Crohn’s Disease of the Ileal Pouch. Pouchitis and Ileal Pouch Disorders 2019. [DOI: 10.1016/b978-0-12-809402-0.00010-1] [Reference Citation Analysis]
672 Muise AM. Very Early Onset Inflammatory Bowel Disease (VEOIBD). Textbook of Autoinflammation 2019. [DOI: 10.1007/978-3-319-98605-0_21] [Reference Citation Analysis]
673 Somineni HK, Kugathasan S. The Microbiome in Patients With Inflammatory Diseases. Clin Gastroenterol Hepatol 2019;17:243-55. [PMID: 30196163 DOI: 10.1016/j.cgh.2018.08.078] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
674 Ashton JJ, Mossotto E, Ennis S, Beattie RM. Personalising medicine in inflammatory bowel disease-current and future perspectives. Transl Pediatr 2019;8:56-69. [PMID: 30881899 DOI: 10.21037/tp.2018.12.03] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
675 Escudero-hernández C, Koch S. The Epithelial Barrier. Molecular Genetics of Inflammatory Bowel Disease 2019. [DOI: 10.1007/978-3-030-28703-0_15] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
676 Hedayat KM, Lapraz J. Inflammatory bowel diseases. The Theory of Endobiogeny 2019. [DOI: 10.1016/b978-0-12-816964-3.00011-0] [Reference Citation Analysis]
677 Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014. Gut 2019;68:18-24. [PMID: 29785965 DOI: 10.1136/gutjnl-2017-315666] [Cited by in Crossref: 160] [Cited by in F6Publishing: 151] [Article Influence: 40.0] [Reference Citation Analysis]
678 Yao Y, Zhang H, Wang Z, Ding J, Wang S, Huang B, Ke S, Gao C. Reactive oxygen species (ROS)-responsive biomaterials mediate tissue microenvironments and tissue regeneration. J Mater Chem B 2019;7:5019-37. [DOI: 10.1039/c9tb00847k] [Cited by in Crossref: 110] [Cited by in F6Publishing: 120] [Article Influence: 27.5] [Reference Citation Analysis]
679 Tesfaye W, Suarez-lepe J, Loira I, Palomero F, Morata A. Dairy and Nondairy-Based Beverages as a Vehicle for Probiotics, Prebiotics, and Symbiotics: Alternatives to Health Versus Disease Binomial Approach Through Food. Milk-Based Beverages 2019. [DOI: 10.1016/b978-0-12-815504-2.00014-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
680 Maloy KJ. The IL-23/Th17 Axis in Intestinal Inflammation. Molecular Genetics of Inflammatory Bowel Disease 2019. [DOI: 10.1007/978-3-030-28703-0_13] [Reference Citation Analysis]
681 Zhu F, Li C, Gong J, Zhu W, Gu L, Li N. The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis. Dig Liver Dis 2019;51:38-42. [PMID: 30309751 DOI: 10.1016/j.dld.2018.09.017] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 17.5] [Reference Citation Analysis]
682 Ibáñez L, Rouleau M, Wakkach A, Blin-wakkach C. Microbiote et os. Revue du Rhumatisme 2019;86:46-51. [DOI: 10.1016/j.rhum.2018.01.012] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
683 Li Y, Tian X, Li S, Chang L, Sun P, Lu Y, Yu X, Chen S, Wu Z, Xu Z, Kang W. Total polysaccharides of adlay bran ( Coix lachryma-jobi L.) improve TNF-α induced epithelial barrier dysfunction in Caco-2 cells via inhibition of the inflammatory response. Food Funct 2019;10:2906-13. [DOI: 10.1039/c9fo00590k] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
684 Rahhal G, Levine M. When Should I Suspect Undiagnosed Inflammatory Bowel Disease in the Acute Care Setting? How Should I Manage a Suspected New Diagnosis of Inflammatory Bowel Disease? Gastrointestinal Emergencies 2019. [DOI: 10.1007/978-3-319-98343-1_94] [Reference Citation Analysis]
685 Dakubo GD. Body Fluid Microbiome as Cancer Biomarkers. Cancer Biomarkers in Body Fluids 2019. [DOI: 10.1007/978-3-030-24725-6_14] [Reference Citation Analysis]
686 Stenke E, Bourke B, Knaus UG. NAPDH Oxidases in Inflammatory Bowel Disease. Methods Mol Biol 2019;1982:695-713. [PMID: 31172500 DOI: 10.1007/978-1-4939-9424-3_38] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
687 Zimmermann EM. The Clinical Impact of Cross-Sectional Imaging on Crohn’s Disease Management. Cross-Sectional Imaging in Crohn’s Disease 2019. [DOI: 10.1007/978-3-319-96586-4_1] [Reference Citation Analysis]
688 Messaris E, Dassopoulos T. Concepts in Inflammatory Bowel Disease Management. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00161-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
689 Tyakht AV, Manolov AI, Kanygina AV, Ischenko DS, Kovarsky BA, Popenko AS, Pavlenko AV, Elizarova AV, Rakitina DV, Baikova JP, Ladygina VG, Kostryukova ES, Karpova IY, Semashko TA, Larin AK, Grigoryeva TV, Sinyagina MN, Malanin SY, Shcherbakov PL, Kharitonova AY, Khalif IL, Shapina MV, Maev IV, Andreev DN, Belousova EA, Buzunova YM, Alexeev DG, Govorun VM. Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn's disease discovered using metagenomic and genomic analyses. BMC Genomics 2018;19:968. [PMID: 30587114 DOI: 10.1186/s12864-018-5306-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
690 Iida T, Yokoyama Y, Wagatsuma K, Hirayama D, Nakase H. Impact of Autophagy of Innate Immune Cells on Inflammatory Bowel Disease. Cells. 2018;8. [PMID: 30583538 DOI: 10.3390/cells8010007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
691 Rojas-Feria M, Romero-García T, Fernández Caballero-Rico JÁ, Pastor Ramírez H, Avilés-Recio M, Castro-Fernandez M, Chueca Porcuna N, Romero-Gόmez M, García F, Grande L, Del Campo JA. Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers. World J Gastroenterol 2018; 24(46): 5223-5233 [PMID: 30581271 DOI: 10.3748/wjg.v24.i46.5223] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
692 Raza MH, Gul K, Arshad A, Riaz N, Waheed U, Rauf A, Aldakheel F, Alduraywish S, Rehman MU, Abdullah M, Arshad M. Microbiota in cancer development and treatment. J Cancer Res Clin Oncol 2019;145:49-63. [PMID: 30542789 DOI: 10.1007/s00432-018-2816-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 9.4] [Reference Citation Analysis]
693 da Silva VC, de Araújo AA, de Souza Araújo DF, Souza Lima MCJ, Vasconcelos RC, de Araújo Júnior RF, Langasnner SMZ, de Freitas Fernandes Pedrosa M, de Medeiros CACX, Guerra GCB. Intestinal Anti-Inflammatory Activity of the Aqueous Extract from Ipomoea asarifolia in DNBS-Induced Colitis in Rats. Int J Mol Sci 2018;19:E4016. [PMID: 30545135 DOI: 10.3390/ijms19124016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
694 Zhou L, Sonnenberg GF. Essential immunologic orchestrators of intestinal homeostasis. Sci Immunol. 2018;3. [PMID: 29440266 DOI: 10.1126/sciimmunol.aao1605] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
695 Yarani R, Mirza AH, Kaur S, Pociot F. The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol Med 2018;50:1-14. [PMID: 30523244 DOI: 10.1038/s12276-018-0188-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 13.0] [Reference Citation Analysis]
696 Sharp RC, Naser ES, Alcedo KP, Qasem A, Abdelli LS, Naser SA. Development of multiplex PCR and multi-color fluorescent in situ hybridization (m-FISH) coupled protocol for detection and imaging of multi-pathogens involved in inflammatory bowel disease. Gut Pathog 2018;10:51. [PMID: 30534203 DOI: 10.1186/s13099-018-0278-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
697 Lucafò M, Franca R, Selvestrel D, Curci D, Pugnetti L, Decorti G, Stocco G. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opin Drug Metab Toxicol 2018;14:1209-23. [PMID: 30465611 DOI: 10.1080/17425255.2018.1551876] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
698 Bharti S, Gavel P, Nath G. Gut Microbiota and Human Health with Special Reference to Autoimmunity. Journal of Gastrointestinal Infections 2018;8:32-38. [DOI: 10.5005/jp-journals-10068-0018] [Reference Citation Analysis]
699 Dotti I, Salas A. Potential Use of Human Stem Cell-Derived Intestinal Organoids to Study Inflammatory Bowel Diseases. Inflamm Bowel Dis 2018;24:2501-9. [PMID: 30169820 DOI: 10.1093/ibd/izy275] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
700 Ferrat M, Moulahoum H, Boumaza BMA, Mouzaoui S, Périanin A, Djerdjouri B. Gadolinium chloride attenuates acetic acid-evoked colitis in mice by reducing neutrophil infiltration and pro-oxidative enzyme activity. Naunyn Schmiedebergs Arch Pharmacol 2019;392:299-311. [PMID: 30483861 DOI: 10.1007/s00210-018-1592-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
701 Lin S, Haque A, Raeman R, Guo L, He P, Denning TL, El-Rayes B, Moolenaar WH, Yun CC. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon. FASEB J 2019;33:3623-35. [PMID: 30481488 DOI: 10.1096/fj.201801415RR] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
702 Jun JC, Yoon H, Choi YJ, Shin CM, Park YS, Kim N, Lee DH, Kim JS. The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease. Intest Res 2019;17:210-7. [PMID: 30477283 DOI: 10.5217/ir.2018.00081] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
703 An JH, Song WJ, Li Q, Kim SM, Yang JI, Ryu MO, Nam AR, Bhang DH, Jung YC, Youn HY. Prostaglandin E2 secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice. BMC Vet Res 2018;14:354. [PMID: 30453939 DOI: 10.1186/s12917-018-1684-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
704 Hong Z, Piao M. Effect of Quercetin Monoglycosides on Oxidative Stress and Gut Microbiota Diversity in Mice with Dextran Sodium Sulphate-Induced Colitis. Biomed Res Int 2018;2018:8343052. [PMID: 30539022 DOI: 10.1155/2018/8343052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
705 Glal D, Sudhakar JN, Lu HH, Liu MC, Chiang HY, Liu YC, Cheng CF, Shui JW. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol 2018;9:2522. [PMID: 30455690 DOI: 10.3389/fimmu.2018.02522] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
706 Gong Z, Zhao S, Zhou J, Yan J, Wang L, Du X, Li H, Chen Y, Cai W, Wu J. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production. Mol Immunol 2018;104:11-9. [PMID: 30396035 DOI: 10.1016/j.molimm.2018.09.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 17.0] [Reference Citation Analysis]
707 Ashton JJ, Batra A, Beattie RM. Paediatric inflammatory bowel disease- brief update on current practice. Paediatrics and Child Health 2018;28:507-14. [DOI: 10.1016/j.paed.2018.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
708 Salerno-Gonçalves R, Galen JE, Levine MM, Fasano A, Sztein MB. Manipulation of Salmonella Typhi Gene Expression Impacts Innate Cell Responses in the Human Intestinal Mucosa. Front Immunol 2018;9:2543. [PMID: 30443257 DOI: 10.3389/fimmu.2018.02543] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
709 Chao G, Li X, Ji Y, Zhu Y, Li N, Zhang N, Feng Z, Niu M. CTLA-4 regulates T follicular regulatory cell differentiation and participates in intestinal damage caused by spontaneous autoimmunity. Biochemical and Biophysical Research Communications 2018;505:865-71. [DOI: 10.1016/j.bbrc.2018.09.182] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
710 Taman H, Fenton CG, Hensel IV, Anderssen E, Florholmen J, Paulssen RH. Genome-wide DNA Methylation in Treatment-naïve Ulcerative Colitis. J Crohns Colitis 2018;12:1338-47. [PMID: 30137272 DOI: 10.1093/ecco-jcc/jjy117] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
711 Gemechu Y, Millrine D, Hashimoto S, Prakash J, Sanchenkova K, Metwally H, Gyanu P, Kang S, Kishimoto T. Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs. Proc Natl Acad Sci U S A 2018;115:11802-7. [PMID: 30373817 DOI: 10.1073/pnas.1814446115] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
712 Yao Y, Jin Z, Lee JH. An improved statistical model for taxonomic assignment of metagenomics. BMC Genet 2018;19:98. [PMID: 30373533 DOI: 10.1186/s12863-018-0680-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
713 Sireswar S, Dey G. Matrix-wise evaluation of in vivo and in vitro efficiencies of L. rhamnosus GG-fortified beverages. Food Res Int 2019;119:908-19. [PMID: 30884731 DOI: 10.1016/j.foodres.2018.10.077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
714 Weng MT, Tung CC, Chang YT, Leong YL, Wang YT, Wong JM, Wei SC. Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015. J Clin Med 2018;7:E394. [PMID: 30373275 DOI: 10.3390/jcm7110394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
715 Villanacci V, Cadei M, Lanzarotto F, Ricci C, Antonelli E, Cannatelli R, Gulotta T, Fontana L, Pasquali V, Sigala S, Salviato T, Nascimbeni R, Bassotti G. Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease. Ann Diagn Pathol 2019;38:20-5. [PMID: 30388432 DOI: 10.1016/j.anndiagpath.2018.10.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
716 Kreuter R, Wankell M, Ahlenstiel G, Hebbard L. The role of obesity in inflammatory bowel disease. Biochim Biophys Acta Mol Basis Dis 2019;1865:63-72. [PMID: 30352258 DOI: 10.1016/j.bbadis.2018.10.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
717 M’koma A. The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview. GastrointestDisord 2018;1:75-105. [DOI: 10.3390/gidisord1010007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
718 Aherne CM, Collins CB, Rapp CR, Olli KE, Perrenoud L, Jedlicka P, Bowser JL, Mills TW, Karmouty-Quintana H, Blackburn MR, Eltzschig HK. Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation. JCI Insight 2018;3:121521. [PMID: 30333323 DOI: 10.1172/jci.insight.121521] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
719 Simmen S, Cosin-Roger J, Melhem H, Maliachovas N, Maane M, Baebler K, Weder B, Maeyashiki C, Spanaus K, Scharl M, de Vallière C, Zeitz J, Vavricka SR, Hausmann M, Rogler G, Ruiz PA. Iron Prevents Hypoxia-Associated Inflammation Through the Regulation of Nuclear Factor-κB in the Intestinal Epithelium. Cell Mol Gastroenterol Hepatol 2019;7:339-55. [PMID: 30704983 DOI: 10.1016/j.jcmgh.2018.10.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
720 Bertoni S, Liu Z, Correia A, Martins JP, Rahikkala A, Fontana F, Kemell M, Liu D, Albertini B, Passerini N, Li W, Santos HA. pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel Disease. Adv Funct Mater 2018;28:1806175. [DOI: 10.1002/adfm.201806175] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
721 Taida T, Nakagawa T, Ohta Y, Hamanaka S, Okimoto K, Saito K, Maruoka D, Matsumura T, Arai M, Katsuno T, Kato N. Long-Term Outcome of Endoscopic Balloon Dilatation for Strictures in Patients with Crohn's Disease. Digestion 2018;98:26-32. [PMID: 29672285 DOI: 10.1159/000486591] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
722 Zou M, Jie Z, Cui B, Wang H, Feng Q, Zou Y, Zhang X, Yang H, Wang J, Zhang F, Jia H. Fecal microbiota transplantation brings about bacterial strain displacement in patients with inflammatory bowel diseases.. [DOI: 10.1101/439687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
723 Ponce de León-rodríguez MDC, Guyot J, Laurent-babot C. Intestinal in vitro cell culture models and their potential to study the effect of food components on intestinal inflammation. Critical Reviews in Food Science and Nutrition 2019;59:3648-66. [DOI: 10.1080/10408398.2018.1506734] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
724 Miao X, Sun X, Li Q, Cui L, Wang X, Zhuang G, Deng T. Pectic polysaccharides extracted from Rauvolfia verticillata (Lour.) Baill. var. hainanensis Tsiang ameliorate ulcerative colitis via regulating the MAPK s and NF ‐κB pathways in dendritic cells. Clin Exp Pharmacol Physiol 2018;46:48-55. [DOI: 10.1111/1440-1681.13026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
725 Suman S, Kumar S, Fornace AJ Jr, Datta K. The effect of carbon irradiation is associated with greater oxidative stress in mouse intestine and colon relative to γ-rays. Free Radic Res 2018;52:556-67. [PMID: 29544379 DOI: 10.1080/10715762.2018.1452204] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
726 Sedda S, Bevivino G, Monteleone G. Targeting IL-23 in Crohn’s disease. Expert Review of Clinical Immunology 2018;14:907-13. [DOI: 10.1080/1744666x.2018.1524754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
727 Balla KM, Lažetić V, Troemel E. Natural variation in the roles of C. elegans autophagy components during microsporidia infection.. [DOI: 10.1101/418749] [Reference Citation Analysis]
728 Quraishi MN, Critchlow T, Bhala N, Sharma N, Iqbal T. Faecal transplantation for IBD management-pitfalls and promises. Br Med Bull 2017;124:181-90. [PMID: 29140453 DOI: 10.1093/bmb/ldx040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
729 Sprockett D, Fischer N, Boneh RS, Turner D, Kierkus J, Sladek M, Escher JC, Wine E, Yerushalmi B, Dias JA, Shaoul R, Kori M, Snapper SB, Holmes S, Bousvaros A, Levine A, Relman DA. Treatment-Specific Composition of Gut Microbiota Is Associated with Disease Remission in a Pediatric Crohn’s Disease Cohort.. [DOI: 10.1101/412890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
730 Coburn LA, Singh K, Asim M, Barry DP, Allaman MM, Al-Greene NT, Hardbower DM, Polosukhina D, Williams CS, Delgado AG, Piazuelo MB, Washington MK, Gobert AP, Wilson KT. Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis. Oncogene 2019;38:1067-79. [PMID: 30202097 DOI: 10.1038/s41388-018-0492-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
731 Gaifem J, Gonçalves LG, Dinis-Oliveira RJ, Cunha C, Carvalho A, Torrado E, Rodrigues F, Saraiva M, Castro AG, Silvestre R. L-Threonine Supplementation During Colitis Onset Delays Disease Recovery. Front Physiol 2018;9:1247. [PMID: 30233416 DOI: 10.3389/fphys.2018.01247] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
732 Tu T, Yu M, Zhang Y, Shi X, Xu J, Hu J, Gan J, He W, Dong L, Han J, Huang Z, Pan Y, Zhang J. A novel fluorinated triazole derivative suppresses macrophage activation and alleviates experimental colitis via a Twist1-dependent pathway. Biochemical Pharmacology 2018;155:275-87. [DOI: 10.1016/j.bcp.2018.07.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
733 Ananthakrishnan AN. Debate session: So what causes inflammatory bowel disease? It's all in the environment. J Gastroenterol Hepatol 2018;33 Suppl 3:24. [PMID: 30187567 DOI: 10.1111/jgh.14429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
734 Khalili H, Chan SSM, Lochhead P, Ananthakrishnan AN, Hart AR, Chan AT. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2018;15:525-35. [PMID: 29789682 DOI: 10.1038/s41575-018-0022-9] [Cited by in Crossref: 124] [Cited by in F6Publishing: 105] [Article Influence: 24.8] [Reference Citation Analysis]
735 Kerur B, Machan JT, Shapiro JM, Cerezo CS, Markowitz J, Mack DR, Griffiths AM, Otley AR, Pfefferkorn MD, Rosh JR, Keljo DJ, Boyle B, Oliva-Hemker M, Kay MH, Saeed SA, Grossman AB, Sudel B, Kappelman MD, Schaefer M, Tomer G, Bousvaros A, Lerer T, Hyams JS, LeLeiko NS. Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children. Clin Gastroenterol Hepatol 2018;16:1467-73. [PMID: 29486253 DOI: 10.1016/j.cgh.2018.02.027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
736 Sunkara T, Rawla P, Ofosu A, Gaduputi V. Fecal microbiota transplant - a new frontier in inflammatory bowel disease. J Inflamm Res 2018;11:321-8. [PMID: 30214266 DOI: 10.2147/JIR.S176190] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
737 Wein MN, Foretz M, Fisher DE, Xavier RJ, Kronenberg HM. Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 2018;29:723-35. [PMID: 30150136 DOI: 10.1016/j.tem.2018.08.004] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
738 Chattopadhyay A, Mythili S. The journey of gut microbiome – An introduction and its influence on metabolic disorders. Front Biol 2018;13:327-41. [DOI: 10.1007/s11515-018-1490-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
739 Jing Y, Li A, Liu Z, Yang P, Wei J, Chen X, Zhao T, Bai Y, Zha L, Zhang C. Absorption of Codonopsis pilosula Saponins by Coexisting Polysaccharides Alleviates Gut Microbial Dysbiosis with Dextran Sulfate Sodium-Induced Colitis in Model Mice. Biomed Res Int 2018;2018:1781036. [PMID: 30211217 DOI: 10.1155/2018/1781036] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
740 Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50:103. [PMID: 30115904 DOI: 10.1038/s12276-018-0126-x] [Cited by in Crossref: 484] [Cited by in F6Publishing: 505] [Article Influence: 96.8] [Reference Citation Analysis]
741 Wang Y, Tang Q, Duan P, Yang L. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol Immunotoxicol 2018;40:476-82. [PMID: 30111198 DOI: 10.1080/08923973.2018.1469145] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
742 de Meij TGJ, de Groot EFJ, Peeters CFW, de Boer NKH, Kneepkens CMF, Eck A, Benninga MA, Savelkoul PHM, van Bodegraven AA, Budding AE. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients. PLoS One 2018;13:e0197649. [PMID: 30102706 DOI: 10.1371/journal.pone.0197649] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
743 Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, Trancassini M, Passariello C, Pantanella F, Schippa S. Rebuilding the Gut Microbiota Ecosystem. Int J Environ Res Public Health 2018;15:E1679. [PMID: 30087270 DOI: 10.3390/ijerph15081679] [Cited by in Crossref: 155] [Cited by in F6Publishing: 164] [Article Influence: 31.0] [Reference Citation Analysis]
744 Diezmos EF, Markus I, Perera DS, Gan S, Zhang L, Sandow SL, Bertrand PP, Liu L. Blockade of Pannexin-1 Channels and Purinergic P2X7 Receptors Shows Protective Effects Against Cytokines-Induced Colitis of Human Colonic Mucosa. Front Pharmacol 2018;9:865. [PMID: 30127744 DOI: 10.3389/fphar.2018.00865] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
745 Corfield AP. The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human. Microorganisms 2018;6:E78. [PMID: 30072673 DOI: 10.3390/microorganisms6030078] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 14.6] [Reference Citation Analysis]
746 Sandborn WJ, Bhandari BR, Randall C, Younes ZH, Romanczyk T, Xin Y, Wendt E, Chai H, McKevitt M, Zhao S, Sundy JS, Keshav S, Danese S. Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease. J Crohns Colitis 2018;12:1021-9. [PMID: 29767728 DOI: 10.1093/ecco-jcc/jjy049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
747 Bauer E, Thiele I. From metagenomic data to personalized in silico microbiotas: predicting dietary supplements for Crohn's disease. NPJ Syst Biol Appl 2018;4:27. [PMID: 30083388 DOI: 10.1038/s41540-018-0063-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 9.2] [Reference Citation Analysis]
748 Szántó K, Nyári T, Bálint A, Bor R, Milassin Á, Rutka M, Fábián A, Szepes Z, Nagy F, Molnár T, Farkas K. Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center. PLoS One 2018;13:e0200824. [PMID: 30059523 DOI: 10.1371/journal.pone.0200824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
749 Noh CK, Kim BS, Hong G, Cheong JY, Lee KJ. Effects of the Administration of Probiotics on Fecal Microbiota Diversity and Composition in Healthy Individuals. J Neurogastroenterol Motil 2018;24:452-9. [PMID: 29969860 DOI: 10.5056/jnm17140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
750 Mikami Y, Takada Y, Hagihara Y, Kanai T. Innate lymphoid cells in organ fibrosis. Cytokine Growth Factor Rev 2018;42:27-36. [PMID: 30104153 DOI: 10.1016/j.cytogfr.2018.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
751 Boros É, Kellermayer Z, Balogh P, Strifler G, Vörös A, Sarlós P, Vincze Á, Varga C, Nagy I. Elevated Expression of AXL May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients. Mediators Inflamm 2018;2018:3241406. [PMID: 30140167 DOI: 10.1155/2018/3241406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
752 Zhang X, Deeke SA, Ning Z, Starr AE, Butcher J, Li J, Mayne J, Cheng K, Liao B, Li L, Singleton R, Mack D, Stintzi A, Figeys D. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun 2018;9:2873. [PMID: 30030445 DOI: 10.1038/s41467-018-05357-4] [Cited by in Crossref: 129] [Cited by in F6Publishing: 138] [Article Influence: 25.8] [Reference Citation Analysis]
753 Cuchet-Lourenço D, Eletto D, Wu C, Plagnol V, Papapietro O, Curtis J, Ceron-Gutierrez L, Bacon CM, Hackett S, Alsaleem B, Maes M, Gaspar M, Alisaac A, Goss E, AlIdrissi E, Siegmund D, Wajant H, Kumararatne D, AlZahrani MS, Arkwright PD, Abinun M, Doffinger R, Nejentsev S. Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation. Science 2018;361:810-3. [PMID: 30026316 DOI: 10.1126/science.aar2641] [Cited by in Crossref: 130] [Cited by in F6Publishing: 133] [Article Influence: 26.0] [Reference Citation Analysis]
754 Wang Y, Gu Y, Fang K, Mao K, Dou J, Fan H, Zhou C, Wang H. Lactobacillus acidophilus and Clostridium butyricum ameliorate colitis in murine by strengthening the gut barrier function and decreasing inflammatory factors. Benef Microbes. 2018;9:775-787. [PMID: 30014710 DOI: 10.3920/bm2017.0035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
755 Li J, Wang H, Zheng Z, Luo L, Wang P, Liu K, Namani A, Jiang Z, Wang XJ, Tang X. Mkp-1 cross-talks with Nrf2/Ho-1 pathway protecting against intestinal inflammation. Free Radic Biol Med. 2018;124:541-549. [PMID: 30061089 DOI: 10.1016/j.freeradbiomed.2018.07.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
756 Jeschke JC, Mayne CG, Ziegelbauer J, DeCiantis CL, Singh S, Kumar SN, Suchi M, Iwakura Y, Drobyski WR, Salzman NH, Williams CB. A model of TH17-associated ileal hyperplasia that requires both IL-17A and IFNγ to generate self-tolerance and prevent colitis. Mucosal Immunol 2018;11:1127-37. [PMID: 29728642 DOI: 10.1038/s41385-018-0023-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
757 Shouval DS, Kowalik M, Snapper SB. The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies. J Clin Immunol 2018;38:579-88. [DOI: 10.1007/s10875-018-0524-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
758 Omidbakhsh A, Saeedi M, Khoshnia M, Marjani A, Hakimi S. Micro-RNAs -106a and -362-3p in Peripheral Blood of Inflammatory Bowel Disease Patients. Open Biochem J 2018;12:78-86. [PMID: 30069249 DOI: 10.2174/1874091X01812010078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
759 Kang JE, Kim HD, Park SY, Pan JG, Kim JH, Yum DY. Dietary Supplementation With a Bacillus Superoxide Dismutase Protects Against γ-Radiation-induced Oxidative Stress and Ameliorates Dextran Sulphate Sodium-induced Ulcerative Colitis in Mice. J Crohns Colitis 2018;12:860-9. [PMID: 29547907 DOI: 10.1093/ecco-jcc/jjy034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
760 Oshi MA, Naeem M, Bae J, Kim J, Lee J, Hasan N, Kim W, Im E, Jung Y, Yoo JW. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease. Carbohydr Polym 2018;198:434-42. [PMID: 30093020 DOI: 10.1016/j.carbpol.2018.06.107] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0]